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ABSTRACT
Antimicrobial drugs are used for maintaining or improving animal health. Non-judicious
antimicrobial use (AMU) is a modifiable factor driving antimicrobial resistance (AMR). Using
qualitative and quantitative approaches, this doctoral dissertation examined the epidemiology of
veterinary AMU among clinicians at The University of Tennessee Veterinary Medical Center
(UTVMC), and cattle producers in Tennessee (TN), and identified strategies for antimicrobial
stewardship (AMS). First, an online survey was sent to UTVMC clinicians to identify factors
influencing their AMU practices, analyze their concerns regarding AMU and AMR. Compared
to clinicians who obtained their veterinary degree from 1970–1999, those who graduated from
2000–2009 and 2010–2016 were 3.96 (P = 0.034) and 5.39 (P = 0.01) times less concerned about
AMR, respectively. Second, a qualitative study was undertaken to identify and document the
factors driving AMU, alternatives, knowledge, and perceptions towards AMU among TN beef
cattle producers. The findings suggested that clinical signs, culture & susceptibility testing drive
AMU and more awareness of drivers for AMR, and continuing education for producers on
prudent AMU is needed. Third, a mixed methods study that was conducted with TN dairy
producers showed that use of culture and sensitivity test results for antimicrobial selection was a
widespread and common practice, and blanket dry cow therapy was still commonly practiced.
Fourth, a survey of TN beef cattle producers was conducted to identify the factors driving their
AMU, as well as their alternatives, knowledge, and perceptions towards AMU. The findings
showed that controlling for type of cattle operation, age was significantly associated with the
producer’s degree of concern about AMR (P = 0.022). Additionally, survey findings suggested a
need to promote the use of written antimicrobial treatment protocols among TN beef producers,
and continued training for producers on infection prevention/control and prudent AMU. Fifth, a
v

mixed methods study was conducted to identify the perceptions of TN cattle producers regarding
the Veterinary Feed Directive. The findings suggested a likely compensatory increase in the use
of injectable antimicrobials for therapeutic and prophylactic purposes that should be further
investigated. Overall, the entire project identified key strategies for improving AMU in TN.
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INTRODUCTION
The emergence and spread of antimicrobial resistance (AMR) is a global threat to human
and animal health, and is accelerated by non-judicious antimicrobial use (AMU) in animals and
humans [1]. Ensuring judicious AMU both in animals and humans is a key strategy for
containing AMR [2]. To preserve the efficacy of medically important antimicrobials, the World
Health Organization (WHO) recommended complete restriction of AMU for growth promotion
and disease prevention in food-producing animals [3]. Interventions, designed to ensure
judicious AMU have been implemented and are supported in many countries [4, 5]. To ensure
judicious AMU, there is a global call for veterinary practices to develop and implement
antimicrobial stewardship (AMS) programs. Beginning January 1, 2017, the United States Food
and Drug Administration implemented the Veterinary Feed Directive (VFD) to ensure judicious
AMU in food animals [6].
In the United States, AMU for disease management in food-producing animals has
minimal veterinary oversight due to lack of food animal veterinarians in some areas and use in
food-producing animals for growth promotion or improved feed efficiency is perceived as nonjudicious [7]. Data on AMU is generally scarce in many countries. Just like in many parts of the
world, current knowledge of veterinary antimicrobial usage in Tennessee and the United States
in general is limited due to little research in this area. The overall goal of this dissertation was to
fill this knowledge gap by generating veterinary AMU data from clinicians at UTVMC and cattle
producers in TN as the starting point. The studies reported in this dissertation contribute new
knowledge on AMU by providing insights into: (1) the AMU practices of clinicians at UTVMC,
(2) the practices, drivers, alternatives, knowledge, perceptions and concerns of Tennessee beef
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cattle producers towards AMU, (3) the practices, drivers, alternatives, knowledge, perceptions
and concerns of Tennessee dairy cattle producers towards AMU, and (4) perceptions of
Tennessee cattle producers regarding the VFD.

Overview of this dissertation
This dissertation is organized in a manuscript format and is composed of a
comprehensive literature review and five individual studies that collectively address a common
challenge. Overall, there are six chapters presented in this dissertation. Chapter 1 is a review of
literature while chapters 2, 3, 4, 5, and 6 are complete individual studies, each with distinct
sections (abstract, introduction/background, materials and methods, results, discussion and
conclusions).
The overall aims of the studies reported in this dissertation were to:
1.

Provide current work that has been performed in the area of AMU (Chapter 1).

2. Provide insight into the AMU practices of clinicians at UTVMC (Chapter 2).
3. Identify and document the factors driving AMU, alternatives, knowledge, and
perceptions towards AMU among Tennessee cattle producers (Chapters 3, 4 and 5).
4. Identify the perceptions of TN cattle producers regarding the Veterinary Feed
Directive (Chapter 6).
Lastly, presented at the end of the dissertation are general conclusions, recommendations, future
research directions, appendices, and my VITA.
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CHAPTER 1
Literature review
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Key definitions
This dissertation adopts the WHO definition of the terms antibacterial, antibiotic,
antimicrobial, antimicrobial class, and antimicrobial resistance [1] as provided below.
Antibacterial drug: A drug that inhibits bacterial growth or kills bacteria.
Antibiotic: An antibiotic is an agent or substance produced from microorganisms that
can kill or inhibit the growth of another living microorganism.
Antimicrobial drug: An antimicrobial drug as an agent or substance, derived from any
source (microorganisms, plants, animals, synthetic or semi-synthetic) that acts against
any type of microorganism: bacteria (antibacterial), mycobacteria (antimycobacterial),
fungi (antifungal), parasite antiparasitic, and viruses (antivirals). All antibiotics are
antimicrobials, but not all antimicrobials are antibiotics. Antimicrobial agents or
substances that are synthetic or semi-synthetic and antimicrobials of plant or animal
origin are not considered antibiotics.
Antimicrobial class: A group of antimicrobial agents with related molecular structures,
often with similar mode of action because of interaction with a similar target and thus
subject to similar mechanisms of resistance.
Antimicrobial resistance: Antimicrobial resistance (AMR) is a clinical phenomenon in
which the clinical efficacy of an antimicrobial is lost because the targeted pathogens have
metabolic and other defense mechanisms against the antimicrobial agent. Antimicrobial
resistance occurs when microorganisms (e.g. bacteria, fungi, viruses, parasites) change
(morphologically, physiologically, and metabolically) when exposed to antimicrobial
drugs resulting in the antimicrobial drug becoming clinically ineffective, and persistence
5

of the infections. Compared to susceptible microorganisms of the same species,
antimicrobial resistant microbes (un-susceptible microbes) can multiply and persist in the
presence of increased levels of a given antimicrobial drug.
In this dissertation, the words “veterinary antimicrobial(s)” refer to antimicrobial(s) of veterinary
importance. In line with the WHO definition of an antimicrobial [1], this dissertation is limited to
the use of antibacterial antimicrobials by veterinary professionals and cattle producers.

Medically important antimicrobial classes
Medically important antimicrobials are antimicrobial classes used in humans and in nonhuman medical settings such as in food-producing animals and categorized by WHO as critically
important, highly important or important for human medicine [2]. Because of the need to prevent
potential adverse public health consequences of use of medically important antimicrobials in
food-producing animals, the World health Assembly adopted the global action plan on AMR.
This plan seeks to contain AMR using multifaceted measures such as reduction in unnecessary
AMU both in humans and animals [2]. The WHO guidelines [2, 3] recommend the following in
food-producing animals (1) overall reduction in use of all medically important antimicrobials, (2)
complete restriction of use of all medically important antimicrobials for growth promotion, (3)
complete restriction of use of all medically important antimicrobials for prevention of
undiagnosed infectious diseases, (4) antimicrobials classified as critically important for human
medicine should be used for control of the spread of a clinically diagnosed infectious disease
identified within a group of food-producing animals (metaphylaxis), (5) antimicrobials classified
as highest priority critically important for human medicine should not be used for treatment of
food-producing animals with a clinically diagnosed infectious disease. However, to maintain
animal health and to promote animal welfare, veterinary professionals can make exceptions to
6

some of the WHO recommendations based on C/S test results showing that the selected
antimicrobial must inevitably be used due to lack of any other alternative [2, 3].

Critically important antimicrobials for human medicine
In June 2017, an updated WHO “ranking of medically important antimicrobials for risk
management of AMR due to non-human AMU” was published. In that updated classification, the
WHO ranked antimicrobials as critically important, highly important and important to human
medicine [1]. Based on this ranking, critically important antimicrobial classes include:
Aminoglycosides e.g. gentamycin, Ansamycins e.g. rifampicin, carbapenems and other penems
e.g. meropenem, cephalosporins (3rd, 4th, and 5th generation) e.g. ceftriaxone, cefepime, and
ceftaroline, glycopeptides e.g. vancomycin, glycylcyclines e.g. tigecycline, lipopeptides e.g.
daptomycin, macrolides and ketolides e.g. erythromycin, and telithromycin, monobactams e.g.
aztreonam, oxazolidinones e.g. linezolid, penicillins (natural, aminopenicillins, and
antipseudomonal) e.g. ampicillin, phosphonic acid derivatives e.g. Fosfomycin, polymyxins e.g.
colistin, quinolones e.g. ciprofloxacin, drugs solely used for treatment of tuberculosis or other
mycobacterial diseases e.g. isoniazid. Highly important antimicrobial classes include
amidinopenicillins e.g. mecillinam, amphenicols e.g. chloramphenicol, cephalosporins (1st and
2nd generation) and cephamycins e.g. cefazolin, lincosamides e.g. clindamycin, penicillins (antistaphylococcal) e.g. oxacillin, pseudomonic acids e.g. mupirocin, Riminofenazines e.g.
clofazimine, steroid antibacterials e.g. fusidic acid, streptogramins e.g. quinupristin/dalfopristin,
sulfonamides, dihydrofolate reductase inhibitors and combinations e.g. sulfamethoxazole,
trimethoprim, sulfones e.g. dapsone, tetracyclines e.g. chlortetracycline. Important antimicrobial
classes include: aminocyclitols e.g. spectinomycin, cyclic polypeptides e.g. bacitracin,
nitrofurantoins e.g. nitrofurantoin, nitroimidazoles e.g. metronidazole, pleuromutilins e.g.
7

retapamulin. Among the critically important antimicrobials, quinolones, third, fourth and fifth
generation cephalosporins, macrolides and ketolides, glycopeptides and polymyxins are
categorized as highest priority critically important antimicrobials while other critically important
antimicrobials were subclassified as high priority critically important antimicrobials [1].

The problem of antimicrobial resistance
Antimicrobials are a non-renewable resource that are endangered by AMR development
[4] and AMR is now considered a one health issue whose containment requires a
multidisciplinary effort from all actors in the one health arena [5-7]. Compared to antimicrobial
susceptible infections, AMR infections have been found to have worse clinical outcomes (more
septicemia, longer hospitalizations) [8]. Antimicrobial use as well as abuse of antimicrobials in
human medicine, veterinary medicine, and environmental sectors, spread of resistant bacteria and
resistance determinants within and between humans, animals and the environment, drive AMR
[9]. In other words, in addition to prudent and non-prudent AMU in human and veterinary
medicine, animal agriculture, waste and environmental contamination from pharmaceutical
industries, application of untreated manure in crop production are other sources of AMR [6, 1012]. Also use of poor quality antimicrobials (inadequate amounts of active agent(s), ineffective
release, occurrence of impurities and degradation of active compounds) in food animals
especially in low-and middle income countries is believed to be contributing to the problem of
AMR by exposing microbes to low levels (subtherapeutic levels) of active antimicrobials and
subsequently selecting for resistance [13]. Additionally, there is evidence that use of nonantibiotic antimicrobial agents e.g. biocides (disinfectants, antiseptics and preservatives), and
heavy metals (zinc and copper) as growth promoters and therapeutic agents for some animals
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also induce/select for AMR [14-16]. Specifically, use of zinc oxide as a growth promoter in
livestock has been associated with the emergence of Livestock-Associated MRSA [17, 18].
Researchers have shown through metagenomic analysis of ancient samples that AMR is
ancient and occurs naturally [19]. Also, a study that evaluated the efficacy of 21 antimicrobials
(both old and new) against ~ 500 spore-forming soil bacteria found MDR in all sampled bacteria
with each bacterium resistant to 7-8 antimicrobials, suggested that MDR could be naturally
occurring in most microbes [20, 21]. However, non-judicious use of antimicrobials is known to
select for AMR. Wildlife species including migrating species such as birds have been found to
harbor antimicrobial resistant microorganisms and are thought to be exposed to antimicrobial
resistant organisms through inadequately treated animal and human waste products (exposure to
antimicrobial resistant bacteria reservoirs such as contaminated soil, water or crops) [22, 23].
Antimicrobial resistance mechanisms include: bacterial production of enzymes that
inactivate antimicrobial drugs e.g. beta-lactamases that inactivate beta lactam antimicrobials),
removal of antimicrobials through efflux pumps, modification of antimicrobial binding sites
(target sites) such that the antimicrobial fails to bind to its target on the bacteria, antimicrobial
bypass mechanisms such as modification of bacterial cell surface to prevent entry by the
antimicrobial agent [20, 24, 25]. A study conducted at a US tertiary university referral hospital
found MDR in 19 out of 70 isolates obtained from dogs in the Intensive Care Unit [26]. That
study also found that MDR was observed in samples taken after 48 hours of hospitalization,
suggesting that length of hospitalization may be associated with infections with AMR organisms.
Although public concerns about AMR is widespread, a UK study that compared public views
regarding drivers of AMR to expert views regarding drivers of AMR found that the public did
not fully understand the multifaceted nature of AMR causation [27]. In that study, it was found
9

that 192/405 (47.4%) of study participants believed that overuse/misuse of antimicrobials in
humans was a major driver of AMR while 66/405 (16.3%) respondents believed that misuse of
antimicrobials in animal health was a major driver of AMR. In the U.S., there is no published
study that has evaluated public views about key contributing factors to AMR. A study comparing
current public views regarding drivers of AMR with the views of AMR/AMU experts would
prove useful.

The burden of AMR in the United States
According to the Centers for Disease Control and Prevention (CDC), at least 2 million
people become infected with AMR bacteria annually in the U.S. and at least 23,000 human
deaths occur annually directly from AMR bacterial infections [28]. More than 400,000 AMRrelated illnesses in the U.S. are attributed to drug-resistant non-typhoidal Salmonella and
Campylobacter [8]. Additionally, as of 2013, the CDC estimated that Campylobacter AMR
increased from 13% in 1997 to almost 25% in 2011 while about 5% of non-typhoidal Salmonella
tested by CDC were resistant to five or more antimicrobials [28]. Both Campylobacter and nontyphoidal Salmonella are zoonotic. Currently in the US, the national Antimicrobial Resistance
Monitoring System (NARMS) is charged with the duty of monitoring AMR among foodborne
pathogens from humans, retail meats and animals [8].

Mechanisms of action of antimicrobial drugs and selection for AMR
Generally, the mechanisms of action of antimicrobials include: prevention of microbial
DNA or RNA synthesis; blockade of nucleic acid synthesis by prevention of folate synthesis;
destruction of bacterial cell wall/membrane; and prevention of bacterial protein synthesis by
interfering with ribosome function [24]. All use of antimicrobials whether for therapeutic
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purpose, prophylactic use, metaphylactic use, judicious or non-judicious exerts selection pressure
on microbes that can result in AMR [29, 30]. However, some researchers [31] state that although
sub-optimal AMU in hospitals, in the community, and in agriculture may be drivers of AMR,
there is no evidence showing the extent to which these perceived drivers contribute to the
development, emergence and spread of AMR. A review of the impact of AMU in lactating and
non-lactating cows in the US concluded that although AMU in adult dairy cows and other food
producing-animals contributes to AMR, there was no widespread emergence of AMR among
pathogens isolated from dairy cattle [32]. Another review found that there is scientific evidence
that AMU in farms contributes to AMR [33].

Evidence of and methods of transfer of AMR between animals and humans
Although the direction of transfer of pathogens between animals and humans may not
have been proven empirically, review studies provided scientific evidence that MDR organisms
are shared between companion animals and humans. For example, researchers have reported
transfer of Methicillin-resistant Staphylococcus aureus (MRSA) between companion animals and
their owners and MRSA isolated from a dog was found to be related to a human epidemic
MRSA cluster [34-37]. The organisms originating from companion animals that may directly or
indirectly cause disease or colonize humans include: MRSA, methicillin-resistant
Staphylococcus pseudointermedius, Staphylococcus intermedius, Vancomycin-Resistant
Enterococci (VRE), Extended Spectrum Beta Lactamases (ESBL) or Carbapenemase-producing
Enterobacteriaceae and gram-negative bacteria [34, 38-40]. Strains of MRSA that predominate
humans have been found in companion animals while people working with MRSA colonized or
infected horses reportedly acquired zoonotic infections while high rates of colonization with
MRSA have been reported in veterinary personnel from different countries [41]. Also, evidence
11

of transmission of MRSA from a horse to a young girl in the Netherlands is documented [42] and
a review study [18] provided evidence of transmission of livestock associated MRSA to humans.
The perceived public health impacts of AMU in food animals on AMR in human
pathogens have generated prolonged controversial, and on-going debate [17]. Marshall and Levy
provide evidence showing that animal-to-human spread of AMR from food animals may occur
directly through human contact with colonized or infected food animals especially among
veterinarians, farm workers, slaughterhouse workers or indirectly through the food chain, water
and manure application for crop production [30]. The horizontal gene transfer of genetic
elements e.g. plasmids through conjugation (bacterial mating), increases the direct and indirect
animal-to-human spread of AMR [30]. However, a systematic review [43] found no concrete
evidence of the direction of transfer of AMR between animals and humans. Other investigators
assert that AMR pathogens disseminate from animals to people and vice-versa through
environmental pathways such as via foodstuffs, animal wastes, and water sources [44].
Additionally, a review by Nordstrom and others found that E.coli isolates from human urinary
tract infection (UTI) cases were genetically related to E. coli isolates from food animals and
retail meat, and that a case-control study found that occurrence of MDR UTIs in women was
associated with consumption of chicken and pork [45]. This review suggested that retail meats,
especially poultry, were important reservoirs for human exposure to antimicrobial resistant E.
coli with infection of humans occurring through ingestion of the uro-pathogenic E. coli and its
transfer from the hosts gastrointestinal tract to the urinary tract through ascending infections. A
study of flies captured using revenge sticky tapes from cattle farms in Georgia showed that flies
could be effective mechanical vectors of antimicrobial resistant Salmonella and antimicrobial
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resistant genes on cattle farms [46]. In that Georgia study, Salmonella resistant to tetracycline, blactams, and streptomycin were isolated.

Antimicrobial use in veterinary medicine and the scarcity of data
A lot of studies on veterinary AMU have been conducted in Europe, where AMU is
reported to vary substantially between countries [47]. However, data on AMU in North America
and particularly in the U.S. is generally scanty, suggesting a need for more in-depth research in
the area of AMU in the U.S., both in companion and in food animals. This long-standing gap of
lack of AMU data in the U.S. animal industry makes identifying AMR drivers in U.S. difficult
[8]. Additionally, species-specific AMU data in US agricultural settings is not available [8]. Such
data is crucial for the identification of AMR drivers in livestock production. A review article
concluded that more AMU data related to on-farm management practices and species-specific
quantities of AMU are needed in the US so that AMR trends can be better understood for
targeted interventions to reduce AMR and protection of public health [8].
A 2001/2002 survey conducted in 113 dairy herds in Pennsylvania found that only 50%
of the surveyed farms kept antibiotic treatment records, only 21% had written plans for treatment
of sick animals, 32% sought veterinarian’s advice prior to initiating animal antibiotic treatments
and in 93% of the farms, antimicrobial treatments were done by the farmer/manager or
designated herdsman [48]. In that survey, producers mostly used beta lactams and tetracyclines,
and records from 33 farms showed that antimicrobials were mainly used to treat enteritis and
pneumonia in calves, and foot rot in cattle. A 2000/2001 survey of conventional and organic
dairy farms in the US found that ceftiofur was the most commonly used antimicrobial in both
farming types. In that survey, antimicrobials were used in heifer calves in the majority of
conventional farms (74.7%) and in a few organic herds (21.9%) [49]. In Washington state, it was
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found that veterinarians most commonly prescribed beta lactam antimicrobials [50]. Also, at the
Ohio State University Veterinary Medical Center, it was found that beta lactams were the most
used antimicrobial class in dogs [51]. A study conducted at a veterinary teaching hospital in
Italy, found that broad-spectrum antimicrobials such as penicillins with beta-lactamase
inhibitors, first-generation cephalosporins, and fluoroquinolones were the most prescribed [52].
In that Italian study, use of C/S testing to decide choice of antimicrobial was conducted in only
5% of cases. A dairy CAFO in New York state was found to use approximately 493 kg of
antibiotics (79 kg penicillin, 16.5 Kg lincosamide, 8 kg aminogylcosides,7.7kg sulfamides,3.4 kg
cephalosporin, 2 kg macrolides, 0.7 kg amphenicols, 0.1 kg fluoroquinolones and 376 kg
ionophores [53].
Classes of antimicrobials used seem to vary by geographic region. A 2003/2005 survey
conducted in Washington State found that penicillin, ceftiofur, and oxytetracycline were the most
commonly cited drugs used for treatment by dairy producers [54]. In the Washington state
survey, 37% of dairy producers believed that antimicrobials that worked well in the past were no
longer effective in the treatment of the same conditions. That survey identified areas of
improvement in dairy production in that state to be: reducing the use of medicated milk replacer;
increasing veterinarian involvement in AMU decisions; implementing treatment protocols;
enhancing biosecurity and ensuring optimal cow and calf immunity. This Washington study
concluded that further research was needed to identify and test management practices that would
lead to improved antimicrobial stewardship.
In Wisconsin, a survey of conventional and organic dairy producers found that among
conventional dairy producers, penicillin was most used for dry cow therapy and cephapirin was
mostly used to treat clinical mastitis while organic dairy producers reportedly used non14

antimicrobial agents for disease treatment and prevention [55]. That survey of conventional and
organic dairy producers concluded that two-thirds of antimicrobials used at the farm level were
for dry cow therapy; penicillin, streptomycin, and cephapirin were the antimicrobials most
commonly used for dry cow therapy while cephapirin, pirlimycin, and amoxicillin were the most
commonly used for treatment of clinical mastitis. A study of AMU in Canadian dairy farms
found geographic variations in commonly used classes [56]. Dairy herds in Ontario mainly used
third generation cephalosporins (ceftiofur) compared to Quebec. Alberta dairy herds used
tetracyclines the most compared to Maritimes. A study of AMU in 24 beef farms in Ontario
found that among injectable antimicrobials, oxytetracycline, penicillin, macrolides, florfenicol,
and spectinomycin were the most commonly used, while monensin, tylosin, lasalocid,
tetracyclines were commonly used in feed [57]. Lincomycin-spectinomycin, chlortetracycline,
and oxytetracycline were commonly used in water. This Ontario beef study found that extra-label
use of lincomycin-spectinomycin and tiamulin was prevalent. However, this study did not report
if the extra-label use was under veterinary oversight and guidance.
A cross-sectional survey of antimicrobial prescribing patterns in UK small animal
veterinary practice found that clinicians in non-referral hospitals were more likely to prescribe an
incorrect dose of antimicrobials compared to those in referral hospitals; clinicians who used
pharmaceutical companies as sources of information were more likely to prescribe an incorrect
dose compared to those who did not; an association was found between prescribing unlicensed
antimicrobials and the position of the clinician in practice [58]. That study found that locums
were more likely to prescribe unlicensed antimicrobials compared to practice partners. A study
that evaluated antimicrobial prescription patterns in 8 mixed veterinary practices in Switzerland
found that clinicians prescribed penicillins and cephalosporins most frequently (37% of
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treatments), followed by aminoglycosides (18 %), tetracyclines (14%), and sulphonamides
(11%) respectively [59]. This swiss study concluded that most prescriptions in the study
practices adhered with prudent use guidelines.
In Australia, Hardefeldt et al suggest that labeling of antimicrobials could be a potential
contributor to inappropriate AMU by veterinarians. These authors asserted that some specified
doses on antimicrobial drug labels in Australia are inappropriate in light of currently available
drug dosage recommendations [60]. No research on appropriateness of veterinary antimicrobial
labelling in the U.S. was found in the reviewed literature. Although national estimates of AMU
based on sales data may be available, there is currently no reliable data on AMU in the US that is
publicly available. This has been the case for many years [61].
An online survey conducted in Finland in 2016 found that of 715 dairy farms, 558 (78%)
commonly used selective dry cow therapy, 95/715 (13.3%) used blanket dry cow therapy while
62/715 (8.7%) did not use dry cow therapy at all [62]. There are no documented studies reporting
use of dry cow therapy in Tennessee. A study conducted among Ohio Bovine veterinarians
reported that the surveyed veterinarians mentioned that producers used antimicrobials without
prior veterinary consultation and suggested that veterinarians should encourage producers to seek
more veterinary consultation or a treatment protocol approved by a herd veterinarian before
treating animals with antimicrobials [63].
Data on antimicrobial usage in many countries is generally scarce because many
countries do not collect such data [64]. Although the FDA annually publishes national data on
sales and distribution for all antimicrobial drugs approved for use in food-producing animals
[65], such data at state or county level is lacking. Studies quantifying on-farm veterinary
antimicrobial use in the US are scarce and yet detailed data on antimicrobial consumption could
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be useful in detecting inappropriate use [66]. Quantities of antimicrobial drugs consumed could
be measured in terms of pharmaceutical firm turnover, treatment costs, weight (total weight or
dose equivalent, treatment doses (daily dose and prescribed daily dose, or number of items or
packages sold [67]. Although prices and costs may not be good indicators due to price changes
with time. Use of records of items purchased and translating them into weight of active drug
would give a better indicator of quantities of AMU consumed on-farm [67].

Antimicrobial stewardship: Its role in containing AMR
Antimicrobial stewardship (AMS) is a multi-faceted (multi-dimensional) term that
describes integrated and multi-disciplinary approaches that are intended to maintain clinical
efficacy of antimicrobials through optimization of drug use, choice, route of administration,
duration of treatment, and dosage rates while minimizing AMR development and minimizing
adverse drug effects [68, 69]. Other scholars have defined AMS as “a coherent set of actions
which promote using antimicrobials responsibly” [70]. Although AMS is being championed as a
means to minimize AMR development, a recent systematic review of studies evaluating the
effectiveness of antimicrobial stewardship programs (ASPs) in human hospitals found no solid
evidence of the effectiveness of ASPs in reducing AMR [71].
The goal of an ASP is to preserve the currently available antimicrobials for future
generations. Antimicrobial stewardship involves all stakeholders (in human, animal, and
environmental health) responsible in some way or another for AMU [72]. The key elements of
AMS include: use of practice guidelines (in-practice guidelines, local, national and international
guidelines); dosage considerations (knowledge of pharmacokinetic and pharmacodynamic
aspects of antimicrobial treatment and knowledge of factors affecting antimicrobial treatment),
clinical microbiology data (use of diagnostic microbiology e.g. C/S, point-of-care diagnostics),
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AMR and AMU surveillance (knowledge of critical resistance problems and understanding
AMR and AMU locally, nationally and internationally); infection control practices (development
and use of local, national and international infection control policies and procedures);
alternatives to antimicrobials (use of vaccines and immunostimulants); national and international
regulations (knowledge and compliance with set standards); owner/producer compliance (owner
education and compliance assessment, educational materials); continued education to ensure
AMU best use practices; acceptance of responsibility for AMR as a potential effect of AMU
[72].
Generally, the three approaches that have been recommended for limiting AMR include
preventing disease occurrence, reducing overall AMU and improved AMU [29]. To mitigate the
development of AMR in the environment, Bengtsson-Palme and others [73] suggest: avoiding
the creation of settings that select for, mobilize and allow persistence of AMR genes in bacterial
communities; reduction of AMR spread routes; and limiting the selection pressure for AMR
pathogens through prudent AMU. In the Netherlands, one study that examined variation in AMU
in dairy farmer groups and the effects of external factors on AMU at herd level found large
variations in AMU between herds. This study also found that increasing AMU awareness was an
important factor in reducing AMU and variation in AMU among herds [74]. This study
concluded that the main reason for AMU among the dairy farmers studied was maintenance and
restoration of cow udder health. To reduce antimicrobial use in food animals, some authors have
suggested imposition of user fees and regulatory caps on use of veterinary antimicrobial drugs
[75]. It has also been suggested that behavioral interventions in farmers such as educational
campaigns or increased veterinary support could lead to rational AMU among farmers [76].
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Ensuring prudent use (judicious AMU) is a key strategy in containing AMR [77]. The
world organization for animal health (OIE) Terrestrial Code defines prudent AMU as comprising
a series of practical measures and recommendations which confer benefits to animal and public
health while preserving and maintaining the therapeutic efficacy of antimicrobials while the
WHO defines prudent AMU as AMU which maximizes therapeutic effect while minimizing the
development of AMR [78]. To promote judicious AMU, Michigan State University and
University of Minnesota, with support from the CDC, developed an on-line suite of educational
materials on AMR targeting veterinary medical students [79]. Additionally, the Association of
Public and Land Grant Universities (APLU) and the Association of American Veterinary
Medical colleges (AAVMC) recognize the need to better educate veterinarians on AMS/AMR
and to that end have developed a national strategy to contain AMR [80] . Fanning and others
suggested a holistic education of future veterinarians on AMR and AMU given that most
veterinary curricula are crowded with no modules specifically dedicated to antimicrobial use
[81]. However, in Australia, a study found that compared to older graduates, veterinarians who
graduated after 2011 had lower odds of compliance with AMU guidelines [82]. Additionally, an
Australian study of factors that influence effective AMS in veterinary practices found that lack of
AMS governance structures, client expectations, competition among practices, cost of C/S
testing, lack of access to continued education and training resources were barriers to effective
AMS. They found concern for the role of veterinary AMU on the development of AMR in
humans and willingness to change prescribing behaviors were enablers of AMS [83].

Drivers of AMU in human health
Non-prescription AMU in humans is common worldwide [84] and overuse and
inappropriate AMU in humans are known to drive the occurrence of AMR [28, 85, 86]. In
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developing countries, poverty and poverty-related factors, self-medication, non-compliance, and
advertising pressures drive inappropriate use of antimicrobials [87]. Also, pressure from patients
influences physicians to prescribe antimicrobials [86, 88, 89]. Some approaches used by patients
to exert pressure on the doctor to prescribe antimicrobials include: direct request, portraying
severity of illness, reporting a possible diagnosis to the doctor, reporting previous positive
experience with an antimicrobial [88].
In an Irish study of general practitioners, patients reportedly requested for antimicrobials
from general practitioners and in some situations, specified to the doctor the treatment required
[86]. In an Australian study, general practitioners felt pressured to prescribe antimicrobials by
their patients with upper respiratory tract infections (URTI) and reported that 10-30% of their
patients with URTI demanded antimicrobials [90]. Other than patient demand and pressure, other
factors influencing antimicrobial prescription by physicians include severity of illness,
uncertainty of diagnosis, duration of infections, availability and supply of antimicrobials, fear of
losing patients, and pharmaceutical company marketing activities [89]. However, a qualitative
study conducted in Ireland found that medical general practitioners believed over use and misuse of antimicrobials by veterinarians and in agriculture was part of the problem contributing to
AMR [86].

Sources of information and drivers of antimicrobial use among veterinarians
Peer reviewed literature, textbooks or drug hand books were identified as the most
important sources of antimicrobial information for veterinarians at one US veterinary teaching
hospital [91]. A survey conducted in the UK small animal veterinary practices found that
pharmaceutical company representatives were considered an important source of AMU
information for 70% of survey respondents, veterinary science degree course notes (46.3%), the
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Veterinary Medicines Directorate (22.2%), the British Small Animal Veterinary Association
(BSAVA) formulary (14.8%), practice policy (14.3%), and scientific journals ( 8.0%) [58].
Among veterinarians in Europe, prescribing behavior was strongly influenced by sensitivity
tests, veterinarians own experience, ease of administration and the risk of AMR developing [92].
Factors other than clinical evidence and scientific knowledge such as social norms have been
shown to influence antimicrobial use among veterinarians [93]. In Ireland, non-clinical factors
such as professional stress and non-pharmacological issues such as the veterinarian’s
experience, cost of antimicrobial, farmer’s ability to administer the antimicrobial influenced the
veterinarian’s choice of antimicrobial [94]. In a UK study, perceived efficacy and perceived
owner compliance, and clinician’s experience were some of the factors that influenced
veterinarian’s choice of antimicrobials [93]. Although dairy veterinarians in New Zealand
considered technical reasons when prescribing antimicrobials, non-technical factors such as
client feedback about perceived efficacy and perceptions of cost/benefit did influence
veterinarians prescribing of antimicrobials [95]. Among UK pig veterinary surgeons, external
pressures (pressure from clients, legislation and public perception) were identified as strong
influencers of antimicrobial prescribing [96]. In the Netherlands, financial dependency on
clients, risk avoidance, lack of farmers adherence to veterinary advice, public health interests,
personal beliefs regarding the veterinary contribution to AMR reportedly influenced
antimicrobial prescribing behavior of farm animal veterinarians [97]. In Ontario Canada, dairy
veterinarians ranked antimicrobial drug efficacy as the most important factor considered when
choosing an antimicrobial for treating dairy animals followed by label indications for dairy cows,
and drug withdrawal times [98].
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Factors influencing antimicrobial use among cattle producers
In Flanders and the Netherlands, veterinarians perceived insufficient biosecurity
measures, insufficient immunity of young animals, and economic considerations of farmers to be
important drivers of high antimicrobial use in farm animals [99]. The need for AMU to prevent
infectious bovine diseases for economic gain, and reduce the risk of disease transmission is one
factor driving AMU among beef producers [64]. In dairy cattle, mastitis is a key disease for
which antimicrobials are used [100]. In England and Wales, the most influential source of
information on AMU for dairy producers was the producers’ own veterinarian while approval of
reduced AMU from social referents (other producers, milk buyers, retail consumers) was an
important driver towards reduced AMU [101]. In New Zealand, veterinary advice, personal onfarm experience, price (financial consideration), short drug withdrawal period, ease of using an
antimicrobial, packaging and syringe design, perceived drug efficacy, were important influencers
of AMU among dairy producers [95]. In South Carolina, majority of dairy producers relied on
their own experience when deciding to use antimicrobials [102]. In Europe, a qualitative study
found that social referents such as herd veterinarians, other producers influenced dairy farmers
decision making on the duration of treatment for clinical mastitis [103]. In this qualitative study,
it was concluded that veterinarians being positive social referents for farmers would be
invaluable in communicating evidence-based information to farmers so as to cause change in
AMU for mastitis treatment.
A study conducted among dairy producers in Michigan, Pennsylvania, and Florida found
that maintaining and reviewing treatment records was strongly associated with a producer’s use
of antimicrobials systemically or for intra-mammary use. Farmer’s education level and type of
cow bedding were significantly associated with systemic AMU [104]. In that study, dairy
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producers with less than high school education were 1.7 times likely to use antimicrobials
systemically compared to those with other education levels. While the odds of systemic AMU in
dairy farms that used a mattress with straw, sawdust or wood shavings, and those that used sand
were 0.5 times the odds of systemic AMU in dairy farms with other cow bedding types. This
study concluded that attitudes and beliefs of dairy farmers may influence antimicrobial
therapeutic choices for clinical mastitis. A Danish study of dairy farmers found that high somatic
cell counts and high milk yield were associated with high probability of AMU for udder health
management [105]. This Danish study concluded that determinants of AMU varied among dairy
farms, and that improved udder health and prudent AMU would be achieved through farmspecific interventions that factor in how dairy farmers decide which animals to treat with
antimicrobials. A French study found the dairy farming system (type of dairy operation) had very
little influence on the farmers AMU. All organic dairy farmers practiced selective treatment of
their dairy herds [106]. A 2007/2008 survey of Tennessee beef producers regarding AMU found
that herd size, participation in Beef Quality Assurance and master beef certification programs,
quarantining of newly purchased cattle, use of written instructions for animal treatment and
observation of drug withdrawal periods were strongly associated with higher AMU [107].
However, it is possible that over time, AMU practices could have changed in Tennessee such
that these factors may not be currently associated with higher AMU.

Alternatives to antimicrobials
Alternatives to antimicrobials have been defined as non-compound approaches (nonclassic antibacterial compounds) that target bacteria or approaches that target the host in the
treatment of bacterial infections [108]. Vaccines are an important alternative to antimicrobials in
that vaccines can reduce the prevalence of AMR by reducing the need for AMU [24, 109]. Use
23

of probiotics to improve animal health is also suggested as an alternative to AMU [110]. A study
conducted in the U.S. among dairy producers in Michigan and Ohio, found that alternative
antimicrobial therapies (with little documented clinical efficacy) were used by both organic and
conventional producers; with garlic, aloe Vera, and other herbal remedies being used by majority
of organic dairy producers [111]. In that study among dairy farmers, the authors suggested that
more research on antimicrobial alternatives needed to be conducted, that treatment protocols
needed to be applied widely in the farms, and recommended farm personnel education and
training on diagnostic criteria for initiation of AMU. A 2015 French study that analyzed dairy
producer’s choice of antimicrobials and alternative medicine for mastitis treatment found that
whereas producers are more willing to try alternative antimicrobial therapies for mastitis
treatment, veterinarians and farm advisors poorly supported use of alternative antimicrobial
therapies because of lack of scientific evidence for their efficacy [106]. In France, dairy farmers
use aromatherapy, essential oils, homeopathy, phytotherapy as alternative therapies for mastitis.
That 2015 French study recommended an evaluation of use of alternative therapies for mastitis
therapy in different countries.

Use of culture and sensitivity test results
In a New Zealand study, dairy producers perceived the use of culture and
sensitivity/susceptibility (C/S) testing to be of limited value because producers believed C/S
results did not affect what antimicrobial was prescribed by the veterinarian [95]. In a survey of
European veterinarians, 37.8% of practitioners reported to frequently use C/S before starting
antimicrobial treatment while 44.3% only undertook AST when prompted by poor response or
complicated clinical cases [92]. In that European survey, cheaper and rapid sensitivity testing
were identified as factors that would encourage use of C/S testing by veterinarians. In
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Washington state, cost was identified as a barrier to conducting C/S testing to guide veterinarians
in antimicrobial therapy [50]. Implementation of national pet insurance schemes that cover the
costs of C/S testing have been suggested as a method to increase use of C/S test results [72].
However national pet health insurance schemes are unavailable in most countries. A veterinary
expert opinion study conducted in 3 European countries found that C/S testing was rarely used
for selecting antimicrobials and the time lag (long waiting time) between C/S testing and
obtaining the results was a reason for the rare use of C/S [112]. In that veterinary expert opinion
study, C/S was also perceived to not be helpful in clinical decision making (or on the selection of
the antimicrobial for clinical use). This finding from the European study resonates well with the
opinions of the New Zealand dairy farmers where dairy producers perceived C/S testing to be of
limited use because producers believed C/S results did not affect what antimicrobial was
prescribed by the veterinarian [95].

Farmers knowledge of AMR
Dairy producers in New Zealand were reported to have limited knowledge or concern
about AMR [95]. Similarly, dairy producers in south Carolina were reported to be unaware of the
significance of AMR [102]. In a European survey of pig producers, producers generally
perceived their AMU to be lower than that of their peers and these farmers were generally less
concerned (less worried) about AMR and more concerned about financial and legal issues
surrounding their production [113]. A survey conducted in four European countries found that
survey respondents were neutral regarding the risks associated with AMU and AMR (the risks
associated with AMU were rated by farmers to be moderate) suggesting a need for more farmer
awareness about AMU and public health risks of AMR [114]. A survey conducted in Germany
found that compared to respondents from the general public (non-pig farmers, non-health
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professionals), pig farmers had much better knowledge of AMR [115]. The authors of that
Germany survey suggested that when addressing interventions to contain AMR, farmers should
at least be treated as semi-professionals (instead of regarding them as lay people).

Knowledge of AMU/AMR among consumers and general public
A 2016 survey of public acceptance of AMU in Canada (where AMU for growth
promotion, prophylaxis and therapeutic use was allowed) and Germany (where AMU was more
limited) found disparities in individuals willingness to consume animal products from
antimicrobial treated animals [116]. The findings of that survey suggested that there was a low
understanding amongst the public (study population) of how antimicrobials are used in animal
production and of the benefits of antimicrobials in animal production. Findings from a crosssectoral survey of physicians, veterinarians, farmers and the general public found that
respondents from the general public had lower basic knowledge of AMR compared to pig
farmers [115].
A qualitative study conducted in Denmark reported the unintended outcome of increased
medical and public health focus on AMR with increased public criticism of farmers [117]. This
research study found that pig farmers and their families (children, spouses, relatives) experience
stigmatization in society because of their use of antimicrobials since they are perceived to be
carriers of resistant bacteria such as MRSA [117]. This stigmatization of Danish pig farmers and
their families is associated with increased public concern about AMR linked to conventional pig
farming in that country. To prevent introduction to hospitals, and to prevent nosocomial
infections, Cuny and others suggested that farmers and veterinarians with livestock contacts
should be screened at hospital admittance for MRSA colonization [18]. Health care facilities in
countries where Livestock Associated-MRSA is reportedly endemic, take precautionary
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measures when caring for persons in contact with pigs [118]. There is no documented evidence
of stigmatization of US livestock producers associated with their use of antimicrobials. However,
there is a possibility that such stigmatization of farmers (associated with AMU and carriage of
AMR bacteria) may get infused into the US public as concerns about AMR occurrence and nonjudicious AMU in livestock production increases.

The impact of AMU regulations on animal health and welfare
There have been various reports of the effect/impact of the ban of AGPs in Europe. One
report states that in Denmark, Finland, Norway, and Sweden, the ban of antimicrobial growth
promoters led to significantly decreased AMU and reduced AMR in enterococci previously
resistant to antimicrobials used for growth promotion [119]. While others state that although the
ban on antimicrobials for growth promotion in Denmark led to decreased total AMU, resistance
in key zoonotic bacteria had not reduced [120]. In the Netherlands, a 56% reduction in
antimicrobial use in farm animals was realized between 2007 and 2012 due compulsory and
voluntary efforts by stakeholders within the livestock sector [121]. One systematic review has
shown that interventions that restrict AMU in food-producing animals are associated with a
reduction in the occurrence of AMR in those animals [122]. A Dutch study found that farmers in
the Netherlands quickly adopted selective dry cow therapy and abandoned blanket dry cow
therapy when preventive AMU in animal husbandry was prohibited in 2013 [123].
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Abstract
Indiscriminate antimicrobial use (AMU) is a factor contributing to antimicrobial
resistance (AMR). The objectives of this study were to (1) identify factors influencing AMU
practices of veterinary clinicians at The University of Tennessee Veterinary Medical Center
(UTVMC), (2) analyze the clinicians’ preferential choices of antimicrobials, and (3) evaluate
their perceptions, opinions, and concerns regarding AMU and AMR. A total of 121 clinicians
were surveyed. Among the 62 respondents, culture and susceptibility test results and pressure
from clients were the most and least important factors in their antimicrobial prescription
decision-making, respectively. Compared to clinicians who obtained their veterinary degree from
1970–1999, those who graduated from 2000–2009 and 2010–2016 were 3.96 (P = 0.034) and
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5.39 (P = 0.01) times less concerned about AMR, respectively. There is a critical need to
increase awareness about judicious AMU practices among clinicians, increase emphasis about
AMR in the present veterinary curriculum, and implement antimicrobial stewardship program
(AMS) in this institution. Educational activities in combination with awareness campaigns and
the stewardship programs could be used to improve AMU practices at this hospital. More client
education on AMR is needed.

Key words
Antimicrobial resistance; antimicrobial stewardship; ordinal logistic regression; questionnaire;

survey.

Introduction
Antimicrobial drugs in veterinary practice are primarily prescribed for the purposes of
maintaining or improving animal health and increasing productivity [1]. However, the
emergence and spread of antimicrobial resistant microorganisms is eroding the value of
antimicrobial drugs [2, 3]. Although antimicrobial resistance (AMR) is an ancient phenomenon
[4, 5], indiscriminate antimicrobial use (AMU) is an important risk factor for the development of
AMR [6]. The increase in the prevalence of microorganisms resistant to antimicrobials, both in
veterinary and human medicine, is now widely attributed to AMU [7, 8].
Shedding of drug resistant microorganisms by animals can directly (through contact) or
indirectly lead to human infections/colonization by commensal bacteria [1, 9, 10]. These bacteria
carry transferable resistance genes across species through multiple pathways like food, water,
fomites, sludge and manure applications to food crop soils [1, 11-13], as well as household
environments with pets carrying resistant bacteria and other environments contaminated with pet
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feces [14]. Multi-drug resistant infections exert a huge burden on veterinary medical care [15]
and pose public health risks [16, 17].
To reduce indiscriminate use and to improve AMU practices, veterinary practices are
encouraged to develop and implement antimicrobial stewardship (AMS) programs. Such
stewardship programs include effective infection control, bacteriologic culture and antimicrobial
susceptibility testing, and the use of individual practice guidelines for AMS [18, 19]. According
to the American Veterinary Medical Association [20] and the U.S. Food and Drug
Administration [21], veterinarians in the U.S. are required to direct AMU only within the context
of a valid veterinarian-client-patient-relationship (VCPR) to ensure judicious use. In the context
of VCPR, the veterinarian can write a prescription or dispense prescription drugs only when all
of the following five requirements are observed (1) the veterinarian assumes the responsibility of
providing health care for the patient and the client agrees to follow the veterinarian’s
instructions, (2) the veterinarian is sufficiently knowledgeable of the patient to initiate care and is
well acquainted with the keeping and care provided to the patient either through patient
evaluation or through timely visits to the operation where the patient is managed, (3) the
veterinarian is available for follow-up evaluations or has planned for emergency health coverage,
continuing veterinary care and treatment, (4) the veterinarian provides oversight of treatment,
compliance and outcome, and (5) patient records are well kept. The VCPR can be applied to
individual animals as well as a group or groups of animals within an operation (production
system).
Research conducted from May 2008 to May 2009 at a veterinary teaching hospital in the
northeastern U.S. suggests clinicians are frequently prescribing antimicrobials without proper
documentation in medical records or without indicating their use [22]. In a 2014 survey,
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veterinarians in North Carolina State University veterinary teaching hospital believed the
veterinary practice over-prescribed antimicrobials, were concerned about AMR, and supported
the idea of restricting the use of certain antimicrobial classes in companion animals [23]. Prior to
the present study, the factors that influenced AMU practices of veterinary clinicians at University
of Tennessee Veterinary Medical Center (UTVMC) were unknown. Similarly, their perceptions,
opinions, and concerns about AMU, AMS, and AMR were undocumented. Additionally, the
association between the effort allocation to veterinary clinical practice and the frequency of
antimicrobial prescriptions for therapeutic treatment of infectious diseases had not been
explored. This study contributes to the wider knowledge of AMU by providing insights into the
AMU practices of clinicians at a veterinary teaching hospital.
The objectives of this study were to (1) identify factors influencing AMU practices of
veterinary clinicians at the UTVMC, (2) analyze the clinicians’ preferential choices of
antimicrobials, and (3) evaluate their perceptions, opinions, and concerns regarding AMU, AMS,
and AMR. These findings will be beneficial in improving AMS programs and educational
training on judicious AMU. Ultimately, these efforts could prolong the efficacy of current
antimicrobials and reduce the burden of AMR within veterinary medicine and public health.

Materials and methods
Study design and administration of survey
A questionnaire (see appendix 1) was developed and validated by four professionals with
expertise in survey design and the University of Tennessee Knoxville Institutional Review Board
for the Protection of Human Subjects in Research approved the study (Protocol number: UTK
IRB-16- 103 02956-XP). A survey software (Qualtrics software, Provo, UT) housed the 36questions questionnaire, which were adapted for computer, tablet, and cell phone responses.
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These questions targeted the respondent’s demographics and their antimicrobial prescription
practices, perceptions, opinions, and concerns about AMU, AMS, and AMR. The anonymize
function in the software was optimized, so responses were not attached to any personal
identifiers. The questionnaire was pre-tested among four veterinary clinicians at UTVMC and
their comments were used to improve questionnaire clarity.
Targeted demographic information included gender, the nature of the clinical position
(faculty versus house officers), the primary type of patients seen (small animal, food animal,
equine, etc.), where the veterinary degree was obtained (U.S. versus non-U.S.), and year of
graduation from veterinary school/total number of years in clinical practice from time of
graduation. Biological age of respondents was not included because year of graduation and
number of years in clinical practice were considered to be more clinically relevant to the research
question. This demographic information were our explanatory variables of interest. Our two
outcomes of interest were (1) the frequency of antimicrobial prescription and (2) the degree of
concern about antimicrobial resistant infections. Most of the survey questions were closed-ended
while a few were free-text (open questions). Three-point scales and ordinal Likert scales were
used to capture participant responses to most of the closed-ended survey questions relating to
perceptions about AMU practices and AMR. Regarding antimicrobial class preference based on
clinician’s frequency of prescription, participants were asked to rank medically important classes
of antimicrobials on a five-point Likert scale ranging from a strong dislike (never prescribed) to
a strong preference (always prescribed).
During departmental meetings approximately a week before the study’s start date,
eligible participants (all faculty members with clinical appointments, residents, and interns at
UTVMC) were notified of the upcoming survey in an effort to increase response rate.

50

Subsequently, a notification email was sent to all potential respondents an hour before the survey
went live. Afterwards, all 121 eligible participants received an email invitation about the survey,
which was optimized to accept only one response from each respondent. To minimize potential
selection bias, the survey was sent to all clinicians at the hospital irrespective of whether their
primary clinical duties directly or indirectly involved AMU. The survey remained open for 6
weeks (January 27, 2017 through March 10, 2017). Weekly follow-up email reminders were sent
to non-respondents. No incentive was provided to clinicians for participation or completion but a
thank you message was sent to all respondents at the end of the study.

Statistical analysis
Descriptive and inferential analyses was completed using commercial statistical software
(SAS, version 9.4, SAS Institute Inc, Cary, NC). Descriptive statistics (frequencies and
proportions) were used to summarize the data. Side-by-side bar charts and stacked bar charts for
responses on the three-point scales and on the Likert scales were created using another
commercial software (Tableau software, version 8.2, Seattle, WA). No corrections were made on
missing data.
To test for associations between the captured demographic information and the two
outcomes of interest, both univariable and multivariable analysis were performed using ordinal
logistic regression. The model fit was assessed using the Score Test for the Proportional Odds
Assumption, Deviance, and Pearson Goodness-of-Fit Statistics, and a plot of the empirical
cumulative logit function. The proportional-odds assumption for the ordinal logistic regression
models was evaluated using the Score Test for the Proportional Odds Assumption, and a plot of
the empirical cumulative logit function. A plot yielding approximately parallel empirical
cumulative logits was indicative of an appropriate proportional odds model. Specifically, ordinal
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logistic regression was used to investigate the effects of antimicrobial class on clinicians’
frequency of prescription and to identify differences in preference between classes of
antimicrobials. To validate the data on ranking of classes of antimicrobials based on frequency of
prescription, the commonly prescribed antimicrobial drugs captured as free text (generic or
trades names) from clinician responses were further grouped into classes as described previously
[23, 24]. From these classes, we isolated the medically important antimicrobial classes as
grouped by the United States Food and Drug Administration [25]. These medically important
classes included: aminoglycosides e.g. gentamicin; cephalosporins e.g. ceftriaxone, cefazolin;
fluoroquinolones e.g. ciprofloxacin; lincosamides e.g. clindamycin, lincomycin; macrolides e.g.
erythromycin; penicillins e.g. amoxicillin, ampicillin; sulfonamides e.g. sulfadiazine,
sulfathiazole; and tetracyclines e.g. doxycycline, oxytetracycline. The United States Food and
Drug Administration groups antimicrobials as medically important in line with the World Health
Organization’s classification of antimicrobials. Preferential ordering of the medically important
antimicrobial classes was analyzed based on the main categories of patients seen by clinicians.
The preference ordering was assessed based on the relative magnitudes of the parameter
estimates from the model. Preferential ordering refers to the order in which antimicrobial classes
were preferred from the least preferred to the most preferred. During the modeling, tetracyclines
was selected as the reference class and the probability of disliking another class of antimicrobial
in comparison to tetracyclines was estimated. Spearman’s rank correlation was used to evaluate
for correlations and quantify the strength of association between two ranked variables: for
example, the proportion of total professional activity dedicated to clinical practice (effort
allocation to clinical practice) and the frequency of prescription of antimicrobials for therapeutic
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purposes; number of years in clinical practice from the time of graduation from veterinary school
and year of graduation from veterinary school.
In assessing the clinicians’ degree of concern about AMR, a multivariable ordinal logistic
regression model was manually fitted using backwards elimination method. Briefly, potential
predictors at a P ≤ 0.20 from the univariable analyses were included in the multivariable model
building and variables were dropped if they were either non-significant (P > 0.05) or nonconfounders. Possible effects of confounding were evaluated by comparing a change in
parameter estimates with and without the suspected variables [26, 27]. A predictor variable that
caused a ≥ 20% change in another parameter estimate upon removal from the model was
considered a confounder and was retained in the final model regardless of its statistical
significance [28]. For two predictor variables that were highly correlated (number of years in
clinical practice from the time of graduation from veterinary school and year of graduation from
veterinary school), only one variable was used in the multivariable model building based on
completeness of data or ease in clinical interpretation. Year of graduation was captured as a free
text and was later classified into 3 quantiles (1970 – 1999, 2000 – 2009, and 2010 – 2016) as
done in a previous study [23]. In the final model, two-way interactions (e.g., year of graduation
and clinician’s primary patient load) were assessed based on plausibility and standard multiple
pairwise comparisons were obtained.

Results
Study site
The UTVMC is the veterinary teaching hospital of UTCVM and the only academic
veterinary medical center in the US state of Tennessee. This veterinary college is under the
Institute of Agriculture at the University of Tennessee and employs a total of 99 faculty
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members and 174 staff. There are currently three academic departments at UTCVM namely:
biomedical and diagnostic sciences (29 faculty members and 54 Staff), large animal clinical
sciences (21 faculty members and 29 Staff) and small animal clinical sciences (49 faculty
members and 91 Staff). As of fiscal year, 2017, the average annual large animal caseload
(both clinic and ambulatory) was 15,031 patients. The annual small animal case load was
estimated to be more than 15,000 patients and the avian caseload was estimated to be 1,500
per year.

Descriptive statistics
Of the 121 invited participants, 62 (51.2%) responded to the survey. Complete responses
were provided in most questions except for a few responses that were unanswered. The
demographic information of the 62 respondents is presented in Table 2.1.
Among the factors that influence the choice of antimicrobial drug(s) for clinical use at
UTVMC (Figure 2.1), results from bacteriological culture and antimicrobial susceptibility tests
were the most important. Pressure from clients/producers to the clinician to prescribe
antimicrobials and the fear of litigation by the client/producer in the event of an undesirable
clinical outcome were the two least important factors. Peer-reviewed scientific literature and
textbooks/drug handbooks were the most important sources of information on antimicrobial
drugs for these clinicians while pharmaceutical company representatives and online resources
(e.g., blogs or media searches) were the least important sources of information (Figure 2.2).
Frequency of prescriptions differed among these clinicians. Twenty clinicians (32.3%)
prescribed antimicrobials for therapeutic purposes more than five times a week, while 35 of 62
(56.5%) clinicians prescribed antimicrobials for prophylactic purposes (Figure 2.3). Of these 35
clinicians, 23 (65.7%) prescribed antimicrobials for pre-operative surgical prophylaxis, 29
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(85.3%) for post-operative surgical prophylaxis, and 29 (82.9%) for peri-operative surgical
prophylaxis (Figure 2.4).

Table 2.1: Demographics of clinicians (n = 62) on an online survey to identify determinants
of antimicrobial use practices at the University of Tennessee Veterinary Medical Center,
2017
Variable
Gender
Female
Male
Preferred not to report gender
Nature Clinical Position
Faculty members
House officers
Not reported
Year of graduation from veterinary school
1970 - 1999
2000 - 2009
2010 - 2016
College where veterinary degree was obtained
U.S. veterinary school
Non-U.S. veterinary school
Primary patient load
Small animal
Equine
Food animal
Others (mixed animal, exotics)
Specialty board certification
Obtained specialty board certification
No specialty board certification
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Number (%) of respondents
37 (59.7)
21 (33.9)
4 (6.5)
44 (71)
17 (27.4)
1 (1.6)
21 (33.9)
22 (35.5)
19 (30.7)
51 (82.3)
11 (17.7)
37 (59.7)
8 (12.9)
7 (11.3)
10 (16.1)
43 (69.4)
19 (30.6)

Figure 2.1: Distribution of factors that influence the initiation and the choice of antimicrobials used by clinicians at the
University of Tennessee Veterinary Medical Center, 2017 (n = 62).
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Figure 2.2: Distribution of sources of information influencing the choice of antimicrobials used by clinicians at the University
of Tennessee Veterinary Medical Center, 2017 (n = 62).
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Figure 2.3: Self-reported antimicrobial prescription practices of clinicians at the University of Tennessee Veterinary Medical
Center, 2017 (n = 62).
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Figure 2.4: Self-reported antimicrobial prescription practices for surgical prophylaxis by clinicians at the University of
Tennessee Veterinary Medical Center, 2017 (n = 62).
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Clinicians’ opinions on AMU practices at UTVMC differed. One clinician (1.6%)
believed antimicrobials were prescribed based only on confirmed infections, 21 (33.9%) believed
antimicrobials were sometimes prescribed based on no documented evidence of infection.
Thirty-eight clinicians (61.3%) believed that antimicrobials were sometimes prescribed for
suspected (but not confirmed) infections, and two clinicians (3.2%) were not sure.
As per prescription rate at UTVMC, clinician’s opinions also differed. One clinician
(1.6%) believed antimicrobials were under-prescribed. While 29 (46.8%) and 32 (51.6%)
believed antimicrobials were optimally prescribed and over-prescribed, respectively. Overall,
two (3.2%) clinicians believed UTVMC had an AMS program, 51 clinicians (82.3%) were not
sure, while nine (14.5%) mentioned that none existed. Within the faculty cohort (n = 44), eight
(13.1%) believed there was no AMS program, 34 (55.7%) were not sure, and two (3.3%)
mentioned that one existed.
Of the 17 house officers, 16 (26.2%) were not sure if AMS program existed and one
individual (1.6%) believed none existed. The respondent who did not disclose the nature of their
clinical position was also not sure of the existence of AMS program at UTVMC. Of the nine
clinicians who believed no AMS program currently exists, seven (77.8%) mentioned that
development and implementation of AMS program in the hospital was necessary while the other
two (22.2%) clinicians mentioned the opposite.
Regarding the clinicians’ familiarity with Veterinarian Client Patient Relationship
(VCPR), three (4.8%) were not familiar at all. While nine clinicians (14.5%) were moderately
familiar with VCPR, 17 (27.4%) were very familiar, 33 (53.2%) were extremely familiar. A
comparison of the level of familiarity with the VCPR between faculty members and house
officers is shown in Figure 2.5.
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Figure 2.5: Self-reported level of familiarity with Veterinarian Client Patient Relationship by clinicians at the University of
Tennessee Veterinary Medical Center, 2017 (n = 62).
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Of the 62 respondents, 10 clinicians (16.1%) mentioned that they never utilized VCPR in
their antimicrobial prescription practice, three (4.8%) mentioned that they rarely used VCPR, and
four (6.5%) sometimes utilized VCPR. Ten clinicians (16.3%) often utilized VCPR, and 35
(56.5%) always utilized VCPR in their antimicrobial prescription practice. A comparison of the
use of VCPR in antimicrobial prescription practice of clinicians based on the nature of clinical
position is shown in Figure 2.6.
The extent to which the Doctor of Veterinary Medicine (or equivalent veterinary degree)
training adequately equipped clinicians with knowledge on rational use of antimicrobials varied.
For one clinician (1.6%), it was “not at all,” three (4.8%) mentioned “a little,” 22 (35.5%)
responded “somewhat,” 28 (45.2%) believed “quite a bit,” and eight (12.9%) said “very much.”
Similarly, the extent to which the present-day veterinary curriculum adequately trains students
on rational use of antimicrobials varied. One clinician felt that present-day veterinary medical
students do not receive any adequate training on rational use of antimicrobials, nine (14.8%)
stated the students received “a little,” 28 (45.9%) responded “somewhat,” 21 (34.4%) responded
“quite a bit,” and two (3.3%) responded “very much.” Seventeen (27.4%) clinicians had never
read the FDA / American Veterinary Medical Association (AVMA) guidelines for judicious use
of antimicrobials, 19 (30.7%) rarely did, 20 (32.3%) sometimes did, and six (9.7%) very often
read the guidelines.
In rating other veterinarians’ concerns about AMR, 18 clinicians (29.1%) believed other
veterinarians were slightly concerned about AMR, 36 (58.1%) believed that others were
moderately concerned, five (8.1%) believed that others were quite concerned, and three (4.8%)
believed others were very concerned.
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Figure 2.6: Self-reported use of Veterinarian Client Patient Relationship in antimicrobial prescription practice by clinicians at
the University of Tennessee Veterinary Medical Center, 2017 (n = 62).
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With respect to their clients’ concern about AMR, 27 clinicians (43.6%) believed their
clients were not concerned, 25 (40.3%) believed they were slightly concerned, eight (12.9%)
believed the clients were moderately concerned, and two (3.2%) believed they were quite
concerned. Twelve clinicians (19.4%) strongly disagreed with the statement “antimicrobial
classes commonly used in human medicine should not be used in veterinary medicine because
their use in veterinary medicine selects for AMR in microbes affecting humans.” Thirty-two
(51.6%) disagreed with this statement, 11 (17.7%) neither disagreed nor agreed, and seven
(11.3%) agreed with this statement. For the statement “antimicrobial drug use in veterinary
practice may lead to AMR in pathogens affecting humans,” one (1.6%) strongly disagreed, 8
(12.9%) disagreed, 17 (27.4%) neither disagreed nor agreed, 24 (38.7%) agreed, and 12 (19.4%)
strongly agreed. One respondent (1.6%) was not concerned about antimicrobial resistant
infections. Two (3.2%) were slightly concerned; 27 (43.6%) were moderately concerned.
Nineteen clinicians (30.7%) were quite concerned, and 13 (21%) were very concerned about
antimicrobial-resistant infections.

Preferential ordering of the medically important antimicrobial classes by
small animal clinicians
For these results on preferential ordering of the medically important antimicrobial classes
by small animal clinicians, a plot of the empirical cumulative logit function yielded
approximately parallel empirical cumulative logits which was indicative of an appropriate
proportional-odds model. Based on the frequency of prescriptions, the small animal clinicians
preferred the following medically important antimicrobial classes in an increasing order:
lincosamides, aminoglycosides, macrolides, sulfonamides, fluoroquinolones, tetracyclines, and
penicillins/cephalosporins (Table 2.2). Compared to the tetracycline, the lincosamides,
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aminoglycosides, macrolides, and sulfonamide classes were significantly less preferred classes
but there were no significant differences in the preference for fluoroquinolones, penicillins, and
cephalosporins by small animal clinicians (Table 2.2).
Table 2.2: Increasing order of preference of medically important antimicrobial classes
based on self-reported frequency of prescription by small animal clinicians at the
University of Tennessee Veterinary Medical Center, 2017 (n = 37).
Antimicrobial class†

Parameter
Standard
Odds ratio (95%
P value
estimate
error
CI)
Lincosamides
2.6468
0.4637
14.11 (5.69 – 35.01) <0.001
Aminoglycosides
2.6050
0.4522
13.53 (5.58 – 32.83) <0.001
Macrolides
1.8271
0.4518
6.22 (2.56 – 15.07)
<0.001
Sulfonamides
1.7709
0.4411
5.88 (2.48 – 13.95)
<0.001
Fluoroquinolones
0.1857
0.4374
1.20 (0.51 – 2.84)
0.671
Tetracyclines*
—
—
—
—
Penicillins
–0.3091
0.4768
0.73 (0.29 – 1.87)
0.517
Cephalosporins
–0.3086
0.4425
0.73 (0.31 – 1.75)
0.486
†
*Reference class. The least preferred class had the highest odds ratio because the probability of
disliking a class was modeled.

Univariable analyses
Number of years in clinical practice (clinical experience), year of graduation from
veterinary school, and nature of clinical position were the only explanatory demographic
variables that were significantly associated with the outcome variable (Table 2.3). Compared to
clinicians with more years in clinical practice, those with less were significantly less concerned
about AMR (OR = 0.95). In other words, that the estimated odds of being less concerned about
AMR decreased by 5% for every year in clinical practice. Similarly, compared to clinicians who
graduated from 1970–1999, those who graduated from 2000–2009 and 2010–2016 were 2.83 and
4.55 times less concerned about AMR, respectively. However, there was no significant
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difference observed between graduates of 2000–2009 and those of 2010–2016. House officers
were 3 times less concerned about AMR in comparison to faculty members.

Table 2.3: Univariable analyses for associations between various demographic predictors
and clinicians’ degree of concern about antimicrobial resistant infections at University of
Tennessee Veterinary Medical Center, 2017.
Variable
Gender
Number of years in
clinical practice
Nature of clinical
position
Year of graduation
from veterinary
school
Where veterinary
degree was obtained
Specialty board
certification

Category
Male vs *Female
1-year increase

OR (95% CI)
1.01 (0.37 – 2.74)
0.95 (0.91 – 0.99)

P Value
0.307
0.018

House officers vs *Faculty
members
††
Overall
2000 – 2009 vs *1970 – 1999
2010 – 2016 vs *1970 – 1999
2010 – 2016 vs *2000 – 2009
U.S. vs *Non-U.S.

3.19 (1.04 – 9.79)

0.043

─
2.83 (0.91 – 8.77)
4.55 (1.35 – 15. 38)
1.61 (0.49 – 5.25)
1.79 (0.54 – 5.94)

0.040
0.071
0.015
0.431
0.343

No vs *Yes

2.84 (0.98 – 8.19)

0.054

††

Overall
─
*
Primary patient load
Food animal vs Small animal
4.14 (0.82 – 21)
*
Equine vs Small animal
2.34 (0.55 – 9.97)
*
†
Food animal vs Others
1.36 (0.2 – 9.16)
*
Food animal vs Equine
1.77 (0.24 – 12.91)
Others† vs *Equine
1.31 (0.22 – 7.77)
†
*
Others vs Small animal
3.06 (0.77 – 11.88)
†
*
A combination of mixed animal and exotics. Reference category.
††
Overall = overall effect of predictor on outcome variable.

0.164
0.086
0.251
0.755
0.573
0.768
0.107

There was no significant correlation between proportion of total professional activity
dedicated to clinical practice (effort allocation to clinical practice) and frequency of prescription
of antimicrobials for therapeutic treatment of infectious diseases (r = 0.20211, P = 0.1152).
Likewise, there was no significant correlation between period of graduation from veterinary
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school and frequency of prescription of antimicrobials for therapeutic treatment of infectious
diseases (r = 0.1654, P = 0.1989). However, number of years in clinical practice and year of
graduation from veterinary school were highly correlated (r = 0.915, P < 0.001).

Multivariable analyses
In the multivariable cumulative logit model, year of graduation from veterinary school
was significantly associated (P = 0.025) with clinicians’ degree of concern about AMR, after
controlling for clinicians’ primary patient load which was a confounder in the model (Table 2.4).
The Score test for the Proportional Odds Assumption (P = 0.132), Deviance (P = 0.278) and
Pearson (P = 0.286) Goodness-of-Fit Statistics indicated that the model fit the data very well.
Compared to clinicians who obtained their veterinary degree from 1970–1999, those who
graduated from 2000–2009 and 2010–2016 were 3.96 (P = 0.034) and 5.39 (P = 0.01) times less
concerned about AMR, respectively.

Table 2.4: Cumulative logit model of multivariable analyses of factors associated with
clinicians’ degree of concern about antimicrobial resistant infections at the University of
Tennessee Veterinary Medical Center, 2017.
Variable
Year of graduation
from veterinary
school

Category
OR (95% CI)
2000 – 2009 vs *1970 – 1999
3.69 (1.104 – 12.33)
*
2010 – 2016 vs 1970 – 1999
5.39 (1.49 – 19. 51)
2010 – 2016 vs *2000 – 2009
1.46 (0.44 – 4.87)
*
Food animal vs Small animal
3.32 (0.64 – 17.25)
Primary patient load
Equine vs *Small animal
3.9 (0.83 – 18.36)
†
*
Others vs Food animal
1.14 (0.16 – 8.22)
*
Equine vs Food animal
1.18 (0.15 – 9.44)
Equine vs *Others†
1.03 (0.16 – 6.49)
†
*
Others vs Small animal
3.8 (0.91 – 15.80)
†
A combination of mixed animal and exotics; *Reference category.
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P Value
0.034
0.010
0.537
0.153
0.085
0.894
0.879
0.977
0.067

Discussion
In the present study, we have shown that controlling for UTVMC clinicians’ primary
patient load, clinicians’ concern about AMR decreased among those who graduated after 1999
compared to those that had been in clinical practice for longer. There are two possible
explanations for this finding. Firstly, clinicians who graduated from 1970-1999 could have been
more experienced and had received greater exposure and awareness about the risks associated
with AMR than those who graduated after 1999. Alternatively, the result perhaps reflects an
inadequate emphasis on the judicious use of antimicrobial drugs in the veterinary curriculum
over the recent years. The latter may be true because teaching of AMR and antimicrobial
pharmacology in most veterinary schools has been described as inadequate [3]. In fact, most
clinicians in the present study expressed less enthusiasm about the adequacy of training on
rational AMU practices received by present day veterinary students. Before a generalized
conclusion can be made from the observed results, further evaluation of the tested associations is
needed from other veterinary teaching hospitals as well as from primary care veterinary
hospitals. In the interim, educational interventions, such as an increased educational emphasis
about AMS approaches for veterinary students and continuing professional development for
practicing veterinarians aimed at promoting prudent AMU by veterinary clinicians at all levels of
clinical experience, would be helpful in modifying prescription behaviors and practices of
clinicians. Also, in this study, we found that many clinicians believed their clients were either not
concerned about AMR, or were slightly concerned, suggesting a need for more client education
on AMR.
The use of bacteriological culture and antimicrobial susceptibility test results, along with
other Good Stewardship Practices (GSP), is very important in the practice of evidence-based
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antimicrobial therapy [3, 18, 29]. Based on predisposition for choice of and source of
information for antimicrobial drugs, clinicians in the present study utilized evidence-based
approach in their prescription practices. Firstly, 47 clinicians (75.8%) reported results from
bacteriological culture and susceptibility tests to be an extremely important factor in deciding
their choice of antimicrobial. This is consistent with the findings of other studies, [7, 23] where
veterinarians rated bacteriologic culture and antimicrobial susceptibility among the most
important factors in clinical decision-making. Next, cultural measures of uncertainty avoidance
and wide power distance between the clinician and client/producer may influence antimicrobial
prescribing practices [30, 31]. Clinicians with high uncertainty avoidance would probably
prescribe antimicrobials in the event of undesirable clinical outcomes. Likewise, fear of litigation
by the client/producer could influence the clinician to yield to client’s requests on AMU.
However, these factors were not identified as major drivers in AMU practice in the present
study. Pressure from clients or producers to the clinician to prescribe antimicrobials was not at
all important to over 45% of the clinicians in the present study. Similarly, fear of litigation by the
client or producer was not an important factor. Evidently, power distance (the extent to which
power is distributed between the clinician and the client or producer based on their hierarchical
distance in the society) is narrow in the UTVMC. Thus, uncertainty avoidance may not be a very
influential factor in prescription decision-making in this hospital. Furthermore, aggressive
marketing by pharmaceutical companies is believed to influence clinicians’ information about
antimicrobials. In a survey of small animal veterinarians in the UK, 331 clinicians (70%) ranked
pharmaceutical companies as an important source of information on antimicrobial drugs [32].
However, among the 62 clinicians in the present study, 55% rated pharmaceutical company
representatives as “not at all important” but over 56% rated peer-reviewed literature as
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“extremely important” sources of information for antimicrobial products. A survey at another
U.S. veterinary teaching hospital identified peer-reviewed literature as an important source of
antimicrobial information utilized by most clinicians in determining their choice of antimicrobial
[23]. But, in a survey of all companion animal veterinarians in Australia, 260 clinicians (36%)
reported using peer-reviewed literature as a source of information on antimicrobials [33].
Possibly, compared to veterinarians in general care hospitals, those in referral hospitals rely more
on peer-reviewed literature for their sources of antimicrobial information. In summary, it is
reassuring that clinicians in the present study utilize evidence-based approach in their
prescription practices, an attitude that would improve success of an AMS program.
To promote judicious AMU practices, FDA and AVMA developed guidelines for
judicious antimicrobials by veterinary clinicians. However, the uptake of these AMU guidelines
among the clinicians at UTVMC appears low. Although a few clinicians were either not at all
familiar with or never used VCPR, these clinicians had clinical duties that did not directly
involve antimicrobial prescription. Nevertheless, this observation does not justify a non-judicious
AMU practice. Only six clinicians (9.7%) read very often the FDA/AVMA guidelines for
judicious use of antimicrobials while the rest either never read or infrequently read the
guidelines. Apparently, little awareness exists among these clinicians about the existing
guidelines for judicious use of antimicrobials. A recent survey of U.S. veterinarians [34] found
that 218 of 247 (88%) clinicians were unaware of the available guidelines for judicious AMU
practices. However, implementation of AMU guidelines led to a significant decrease in
antimicrobial prescription rates in some human pediatric emergency departments [35] and
compliance with AMU guidelines may have led to a reduction in overall AMU at a veterinary
teaching hospital [19]. Therefore, more awareness and compliance is needed about the available
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AMU guidelines for veterinary clinicians. Furthermore, only nine clinicians (14.52%) knew that
UTVMC does not have an AMS program currently. Others were either uncertain or believed that
an AMS program existed. These disparities might be due to variations in knowledge and
awareness among clinicians about what constitutes an AMS program, suggesting a need for more
training and awareness on AMS and GSP.
Antimicrobial stewardship programs involve multifaceted approaches that aim to sustain
the efficacy of antimicrobial drugs, while minimizing the emergence of AMR [18]. Clinician
preference for certain antimicrobials is justified in certain situations e.g. based on knowledge of
drug toxicity such as aminoglycoside toxicity; when the characteristics of the infecting bacteria
at a given infection site are known; when knowledge of the usual susceptibility profile of the
suspected pathogens is available; when the cost of treatment is an issue; and when observation of
AMU regulations is required [36]. Also, a clinician may prefer a certain antimicrobial when
based on his or her judgment, culture and susceptibility testing shows that it is the only treatment
option [37]. Frequent use of preferred antimicrobial classes will lead to prolonged exposure of
bacteria to these drugs and subsequently select for resistance. In the present study, β-lactams,
were the most preferred antimicrobial classes by small animal clinicians. Recent studies of
veterinary antimicrobial prescribing practices in the U.S. also showed that β-lactams are the most
commonly prescribed antimicrobials by veterinarians [38, 39]. The antimicrobial preference
ordering for food animal, equine and other clinicians was not reported because of the few
respondents in these categories which did not allow for meaningful analysis. Similarly, our study
did not evaluate the preference for specific drugs within an antimicrobial class. Future studies
could benefit from evaluating clinicians’ preference for specific drugs within antimicrobial
classes. Such scrutiny could provide additional details about prudent AMU. Implementation of
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AMS strategies [16], such as de-escalation (reduction in the spectrum of antimicrobials used
through the discontinuation of antimicrobials or switching to a narrow-spectrum antimicrobial)
and antimicrobial cycling (rotational use of two or more antimicrobial classes on a specified time
scale) could minimize likely buildup of AMR to the most preferred classes at this hospital.
Additionally, non-judicious AMU for surgical prophylaxis may exert selection pressure leading
to AMR. In routine surgical practice, antimicrobials may be given prophylactically: preoperatively, peri-operatively or post-operatively, often based on the judgment of the surgeon.
These AMU for surgical prophylaxis is especially important when surgeries are performed either
in suboptimal conditions, such as in farm animal practice, [40] or when the surgical procedure is
classified as contaminated [41]. Surgical prophylaxis is not recommended for neutering and
routine uncomplicated dental procedures [33]. In the present study, most clinicians used
antimicrobials for surgical prophylaxis in more than half of their surgical cases. Although we did
not ascertain the types of surgical cases for which antimicrobials were used, we contend that an
AMS program at this hospital would provide guidance on AMU for surgical prophylaxis. There
is a need to develop and implement an AMS program at UTVMC based on the findings of the
knowledge gaps or current AMU practice at this hospital. Through training, antimicrobial
prescribers are more likely to accept and implement AMS after benefits are evident; this
approach reduces their non-judicious AMU practices [3]. In the absence of an AMS program and
training programs, AMR challenge could be evident in this hospital. Also, it would be useful to
explore the AMU practices among other primary and tertiary veterinary hospitals in the U.S. A
nationwide survey would provide details on the feasibilities of reducing AMR burden at a
national scale.
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A 2004/2005 observational study of Norwegian general medical practitioners found that
antimicrobial prescribing rates of physicians significantly increased with increased number of
consultations [42]. Findings from this Norwegian study suggested that busy physicians may rely
on antimicrobials in presence of diagnostic uncertainty, as the consultation duration may be too
short to conduct a proper clinical investigation. At the design of this present study, we had
hypothesized that busy veterinary clinicians with less effort allocation to clinical practice and
more effort allocation to other non-clinical duties would perhaps play safe by prescribing broadspectrum antimicrobials as a timesaving strategy in the face of diagnostic uncertainties.
However, effort allocation to clinical practice was not significantly correlated with frequency of
prescription of antimicrobials at UTVMC. Possibly, the difference in these observations could be
from the nature of patients seen or the expertise level of the clinicians. We contend that the
findings of this study cannot be extrapolated to first opinion (primary care) veterinary practices
because clinicians in primary care may have different AMU practices than those in tertiary
hospitals that are mostly comprised of specialists in their fields. An evaluation of the association
between effort allocation and frequency of antimicrobial prescription at other veterinary schools
and in primary care veterinary hospitals would be useful in providing a better justification for
this disparity.
There is a growing perception among veterinarians that non-judicious AMU practices
occur in veterinary practice. In this study, 21 clinicians (33.9%) mentioned that antimicrobials
were sometimes prescribed based on no documented evidence of infection, while 38 (61.3%)
mentioned that antimicrobials were sometimes prescribed for suspected (but not confirmed)
infections. A recent retrospective study [22] from a veterinary school showed similar findings:
38% of antimicrobial prescription did not have documented evidence of infection, while 45% of
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antimicrobial prescriptions at that hospital were for suspected infections. In the present study, 32
clinicians (51.6%) believed that antimicrobials were over-prescribed. Clinicians in another U.S.
teaching hospital [23] also held a similar view that antimicrobials were overprescribed.
Therefore, it is necessary to conduct a targeted study evaluating actual prescription records in
these hospitals to validate or dispute the perceived non-judicious AMU practices.
Communicating the importance of the survey along with sending reminders to
respondents through diverse media has been suggested to improve response rates [43]. Response
rate in the present study was higher than other surveys among veterinarians in the U.S. and
elsewhere [23, 34, 38, 43, 44]. Attending departmental and weekly clinical rounds meetings
before the survey as well as sending out weekly email reminders to participants during the
survey duration could have contributed to the observed high response rate of 51.2%.
Although bias was not assessed, results of this study could have been influenced by
response and or non-response bias. Social desirability bias (which is a form of response bias) and
non-response bias can be issues in any survey [45]. Possibly, the clinicians provided answers that
they deemed socially acceptable (social desirability bias) rather than their true opinions,
perceptions and practices. Alternatively, the survey answers of the respondents could have
differed from those of non-respondents. Non-responder analysis was not performed because it
would breach the confidentiality and anonymity of the study. Furthermore, results of this study
may be more reflective of opinion and perceptions of small animal clinicians than other
clinicians because of the over representation of small animal clinicians in the study. However,
this observation is a true representation of the clinician demographics in this hospital and could
not have been improved by any other method.
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Conclusions
After controlling for UTVMC clinicians’ primary patient load, clinicians’ concern about
AMR decreased among those who graduated after 1999 compared to those that have been in
clinical practice for longer. Most clinicians utilize evidence-based approach in their choice of
antimicrobials but are unaware or underutilize the FDA/AVMA guidelines for judicious use of
antimicrobials. Some practices and perceptions are suggestive of non-judicious AMU practices.
Therefore, there is a critical need to increase awareness about judicious AMU practices among
clinicians, increase emphasis about AMR in the present veterinary curriculum, and implement
AMS program in this institution. Educational activities in combination with awareness
campaigns and the stewardship programs could be used to improve AMU practices of veterinary
clinicians at this hospital. Also, more client education on AMR is needed. Prospectively,
evaluation of AMU practices across other veterinary hospitals in the U.S is necessary to provide
details on the feasibility of reducing AMR burden at a national scale.
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CHAPTER 3
Drivers of antimicrobial use practices among Tennessee beef cattle
producers
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Abstract
Background
In recent years, there has been an increased awareness of antimicrobial resistance in both animals
and humans, which has triggered concerns over non-judicious antimicrobial use. In the United
States, antimicrobial use in food-producing animals for growth promotion or improved feed
efficiency is perceived as non-judicious. To facilitate judicious antimicrobial use, the United
States Food and Drug Administration implemented the Veterinary Feed Directive, effective from
January 1, 2017. Interventions, such as the VFD, designed to ensure the judicious use of
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antimicrobials among cattle producers may be more effective if the factors that inform and
influence producer AMU practices are addressed. The specific objectives of this study were to
determine the following among Tennessee beef cattle producers: (1) the most common drivers
for using antimicrobials, (2) the perceived alternatives to antimicrobials, (3) the knowledge and
perceptions regarding antimicrobial resistance, and (4) the preferred avenues for receiving
information on prudent antimicrobial use. A total of 5 focus group meetings with beef producers
were conducted in East, Middle, and West Tennessee. Each focus group was video recorded and
thematic analysis was performed using NVivo.

Results
The factors that producers considered to drive antimicrobial use were the type of cattle operation,
disease and animal welfare, economic factors, veterinarian consultation, producer’s experience
and peer support, Veterinary Feed Directive, and perceived drug efficacy. Vaccination, proper
nutrition, and other good management practices were considered alternatives to antimicrobial
use. To encourage vaccine use among small producers, participants suggested packaging
vaccines into smaller quantities. Antimicrobial resistance was perceived to be a problem
affecting animal and public health. Participants suggested additional education for cattle
producers on the prudent use of antimicrobials as a measure for improving antimicrobial use. The
veterinarian, producer associations and meetings, and county extension agents emerged as
trusted avenues for channeling information on prudent antimicrobial use to cattle producers.

Conclusions
Several factors drive antimicrobial use among cattle producers in Tennessee. Participants
generally perceived their antimicrobial use to be discreet and used only when necessary. More
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awareness of drivers for the development of antimicrobial resistance and continuing education on
prudent antimicrobial use is needed for Tennessee beef producers.

Keywords
Qualitative study, focus group discussions, antimicrobial use, antimicrobial resistance, veterinary
feed directive, Tennessee-beef cattle producers

Background
In recent years, there has been an increased awareness of antimicrobial resistance (AMR)
in both human and veterinary medicine. This increased awareness has triggered concerns over
non-judicious antimicrobial use (AMU) in animals, especially due to the perceived risk
associated with the zoonotic transfer of resistant pathogens from animals to humans [1].
Although there is currently no robust evidence concerning the impact of AMU in food animals
on AMR in human pathogens, some studies suggest evidence of AMR transmission from food
animals to humans, while other studies do not support such transmission [2-4]. This lack of
strong evidence has led to an on-going controversial debate on the public health impacts of AMU
in food animals [2, 5].
Recent studies have shown that indiscriminate use of antimicrobials for both therapeutic
and non-therapeutic purposes in animals leads to propagation and shedding of substantial
amounts of AMR microorganisms [6, 7]. Furthermore, antimicrobial treatment failure in swine
herds was found to be associated with the use of multiple antimicrobial drugs [8]. Despite the
controversies around the public health impacts of AMU in animals, it is necessary that judicious
practices are widely adopted by all sectors within the animal agriculture food production system
in order to prolong the efficacy of current antimicrobial agents [9].
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The World Health Organization (WHO) recommended complete restriction of AMU for
growth promotion and disease prevention in food-producing animals to preserve the efficacy of
medically important antimicrobials [10]. Judicious approaches to AMU in animals have been
supported and instituted in many countries based on the precautionary principle [6, 11]. The
precautionary principle is a guiding tenet of public health which recommends adoption of
preventive measures in the face of uncertainty and exploring various alternatives to potential
threats to public health [12].
In the U.S., AMU in food-producing animals for growth promotion or improved feed
efficiency is perceived as non-judicious and use for disease management has minimal veterinary
oversight due to lack of food animal veterinarians in some areas [13]. To facilitate the judicious
use of medically important antimicrobials in food producing animals, the FDA implemented the
Veterinary Feed Directive (VFD), effective from January 1, 2017, authorizing the use of
medically important antimicrobials in feed and water for therapeutic purposes under the
supervision of a licensed veterinarian. Interventions, such as the VFD, designed to ensure the
judicious use of antimicrobials among cattle producers may be more effective if the factors that
inform and influence producer AMU practices are addressed. Producers consistently base their
decisions and actions on a complex system of core values and knowledge. A review by Garfoth
suggested that producers do what makes sense to them in the circumstances of their farms,
families, and businesses [14]. Behavioral change communication can be effective in educating
the farming public about the dangers of non-judicious AMU if the producers’ knowledge,
attitudes, skills, and aspirations about AMU and AMR are considered [15].
Studies conducted on United Kingdom pig farmers and pig veterinary surgeons identified
economic factors, issues surrounding farming systems, management, agricultural factors, and
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external pressures as key drivers affecting AMU [1, 16]. Among New Zealand dairy producers,
veterinary advice and the producer’s personal on-farm experience were identified as primary
drivers of AMU [15]. However, prior to this study, the drivers of AMU by U.S. cattle producers
were not documented. A 2007 quantitative survey of Tennessee (TN) beef cattle producers found
that higher AMU was associated with herd size > 50, participation in beef quality assurance or
master beef producer certification programs, quarantining of newly purchased animals, use of
written instructions to treat disease, and observation of withdrawal times [17]. Nevertheless, this
2007 survey did not use qualitative methods to identify drivers of AMU among beef producers.
The purpose of this study was to identify and document the factors driving AMU,
alternatives, knowledge, and perceptions towards AMU among Tennessee beef cattle producers.
The specific objectives of this study were to determine the following: (1) the most common
drivers for using antimicrobials, (2) the perceived alternatives to antimicrobials, (3) the
knowledge and perceptions regarding AMR, and (4) the appropriate avenues for receiving
information on prudent AMU. These findings will optimize the efforts of targeted campaigns to
apply nationwide stewardship of AMU. These efforts could, in the long run, lead to responsible
AMU and the reduction in selection pressures from non-judicious use that drive AMR.

Materials and methods
Focus group design, structure, and procedure
We conducted a total of five beef producer focus groups in East TN, Middle TN, and
West TN in June 2017. Overall, 39 producers participated in the focus group discussions. These
regions were chosen based on the demographic density of the Tennessee beef cattle population
[18]. For recruitment, the leadership of the Tennessee Cattlemen’s Association (TCA) invited
members (via e-mail) with experience in different cattle production systems and from different
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geographical areas to represent a range of beef producers in TN. All the four authors attended
each focus group. Each focus group comprised of 5 - 9 producers (participants) recruited from a
purposive sampling technique and lasted approximately 90 minutes. An informed consent form
giving an overview of the study was provided to all participants, and a signed consent was
obtained before their participation in the focus group discussion. Participants could opt out of the
discussion at any time, and a meal was provided to each participant as an incentive.
A semi-structured interview guide which was modified after the first focus group was
utilized (see appendix 2). The modified interview guide (appendix 2B) consisted of 11 openended questions. To maintain anonymity, each participant was assigned an identity number,
which was used throughout the discussion. Participants announced these numbers before
speaking and were identified by these numbers for any follow-up questions. All the focus group
discussions were moderated by one of the researchers (EBS) with a background in the behavioral
sciences. As described previously, the moderator’s role and responsibility was to give guidance
to the discussion and to allow free discussion to develop, while ensuring that all areas in the topic
guide were addressed [19, 20]. Three members of the research team (JEE, MC, and CCO) took
hand written notes of any key points, provided clarifications to questions, and asked follow-up
questions when necessary. At the end of each focus group meeting and before the next focus
group discussion, the research team held a debriefing session to allow for discussion of emerging
themes and for comparison between focus groups [21]. Data saturation was reached during the
fifth focus group discussion. These video-recorded focus group discussions were held either at
local restaurants or at county extension centers. Recorded video from each focus group was
transcribed verbatim by a professional transcription service provider for thematic analysis.
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Data analysis
The transcribed discussions were analyzed using data analysis software (NVivo
qualitative data analysis Software; QSR International Pty Ltd. Version 11, 2017). A recursive
six-phase approach (familiarization with the data, generation of initial codes, search for themes,
review of themes, definition and naming of themes, and report production) to thematic analysis
was performed as described previously [22]. In a brief description of the recursive approach,
each member of the team read all transcripts from the focus groups to be familiarized with the
data. To visualize patterns in the data, the primary author (JEE) performed a cluster analysis (in
NVivo) by grouping focus groups that shared similar words. Jaccard’s coefficient, a statistic that
measures similarity between groups by determining the percent of word similarity between
groups, was used to assess the degree of similarity for each pair of focus groups. The primary
author (JEE) developed a master project with initial nodes identified through consensus at the
debriefing meetings and distributed the same to the other authors for individual coding. During
the thematic analysis, each author was at liberty to use either the already prescribed coding frame
in the master project (theoretical/deductive approach) or to create new nodes independent of the
prescribed coding frame (the inductive approach). Thus, each author either added nodes to the
master themes or created new themes. After the individual coding, the primary author (JEE)
imported the other team members’ coded data into the master project and checked if the themes
from the individual coding were related to the coded extracts and all the data transcripts.
To ascertain the degree of agreement in the data coding, inter-rater reliability testing was
performed in NVivo using percent agreement (JEE, MC, EBS, and CCO). The entire team met
twice to review and harmonize the results of the independent coding. Disagreements at the first
review and harmonization meeting related to definition and naming of themes were resolved at
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the second review and harmonization meeting. These themes were refined to identify sub-themes
and to ensure that each theme is meaningful and clear but distinct from other themes [16]. Subthemes that were linked by a common subject area or which related to an overall topic were
grouped together, given a unique theme title, and considered as major themes. A thematic map
was constructed to review the relationships between minor themes and major themes.

Results
Focus group participant characteristics
A total of 39 beef producers, 1 female and 38 male, from a wide range of beef cattle
production systems in Tennessee participated in the 5 focus groups. Participants’ perceived ages
ranged from late twenties to early seventies. The reported herd size per producer ranged from
approximately 20 to 225 cattle (Table 3.1).
The degree of similarity between focus group pairs (Jaccard’s similarity index) ranged
from 27% to 33%. This Jaccard’s similarity index showed there was diversity among participants
in the different focus groups. Percent agreement (in coding) between each pair of coders was >75
%.

Objective 1: Drivers of antimicrobial use practices
The major themes identified as drivers of AMU were: a) type of operation; b) disease and
animal welfare; c) economic factors; d) veterinarian consultation; e) producer’s experience and
peer support; f) VFD; e) perceived drug efficacy (Figure 3.1). A detailed presentation of these
factors accompanied by excerpts from the focus group transcripts is given below.
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Table 3.1: Focus group participant characteristics

Focus group

Geographic
region
(location)
Johnson
City, East
Tennessee

Number of
participants
(n)
9

Herd size
range

Gender of
Cattle operation type (number of participants)
participants

40 - 80

All male

2

Dickson
county,
middle
Tennessee

9

40 - 135

All male

3

McNairy
county, west
Tennessee

8

30 - 200

All male

4

Jefferson
county, East
Tennessee
Athens,
McMinn
county, East
Tennessee

8

20 - 200

All male

5

30 - 225

Male

1

5

Female
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Cow-calf operation (n = 2)
Cow-calf and backgrounding (n = 2)
Stocker (n = 2)
Backgrounding and finishing (n = 1)
Cow-calf and stocker operation (n = 2)
Cow-calf producer (n = 3)
Cow-calf producer and commercial stocker
(n = 1)
Seed stock producer (n = 1)
Stocker (n = 1)
Brood cow producer (n = 1)
Seed-stock and brood cow producer (n = 1)
Seed-stock and replacement bull, heifers (n =1)
Black angus operation (n = 1)
Angus seed-stock operation (n = 2)
Seed stock operation (n = 2)
Cow-calf operation (n = 2)
Cow-calf operation and angus seed stock (n = 1)
Cow-calf operation (n = 6)
Stocker (n = 1)
Cow-calf and backgrounding operation (n = 1)
Cow-calf (n = 2)
Cow-calf and backgrounding operation (n = 1
Brood cow and backgrounding operation (n = 1)
Cow-calf and backgrounding (n = 1)

Figure 3.1: A thematic map showing drivers of antimicrobial use among beef producers in Tennessee, 2017.
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1a. Type of cattle operation (management factors)
The type of operation was associated with the degree of AMU. Stocker cattle operations
use more antimicrobials due to stress and potential sickness associated with stocker operations
compared to cow-calf operations. Additionally, compared to producers with open herds, those
with closed herds require and use less antimicrobials in their operations.
…a lot of the cattle that we see not just in this county but surrounding counties, 85 to 90
percent of the cattle are mismanaged cattle. So, if it was left up to the mamma cow, cowcalf operators to take better care and management of their cattle, it would help No. 2 and
No. 9’s larger backgrounder or stocker operators, not just on antibiotic cost but health
and letting them turn cattle over faster to ship or do whatever… [No. 1, focus group 1].
…And with the stocker cattle, used a lot more antibiotics because the cattle required it
because of the stress and potential sickness and a lot of the diseases that we go through
the cattle…But with the cow-calf operation, unless it’s warranted by some medical
condition, they don’t get it… [No. 3, focus group 4].
1ai: Market demand by cattle buyers: Along with the routine use of antimicrobials associated
with a specific type of cattle operation, consumer requests encourage increased AMU. Some
buyers request that cattle breeders treat their cattle with antimicrobial drugs prior to shipping.
This prophylactic treatment is aimed at reducing the risk of infection during transit from the
breeder to the buyer.
…we bring in cattle – I would say quite weekly but almost biweekly from other places.
And we sell across the country and ship stuff out. Antibiotics is second nature to us. We
have to have that. A lot of people out in California we sell cattle to, they mainly buy
young calf and resell it. They want that calf to have draxxin before it gets on the truck,
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because they don’t know how long it’s gonna take to get them from our ranch in
Tennessee to California. They might stop at ten other ranches to water and this and that.
And they want a shot of draxxin just for those ten days so that calf don’t pick up anything
or get sick on day three and have a seven-day haul to get to where they’re going. I agree
with a closed herd, which with my operation, we can’t do that… [No. 8, focus group 3].
1b. Disease and animal welfare
In order to maintain the welfare of their cattle, producers tend to use antimicrobials for
disease management in their herds. The presence of early signs of disease was considered to
commence AMU because producers feel they have a responsibility to protect the lives of cattle
under their care.
…We use it as needed sometimes – foot problems. They can step on something, stab or a
thorn or something in their foot. And we use antibiotics for that. If a calf in the
wintertime acts like he’s getting pneumonia or something like that, we see the early signs
– whether it be a cow, calf or whatever, we give that… [No. 7, focus group 2].
…If I see early symptoms, I’ll treat early and try to head things off rather than let it get
full blown, otherwise, it’s grass and hay, protein and mineral… [No. 3, focus group 2].
…As far as what’s important when deciding to use the antibiotics, they key factor comes
down to economics and the animal welfare. I think cattlemen are very strong proponents
of animal welfare because if the animal is not being treated properly or is not healthy,
we’re not making money off of them. And that’s what we have to make sure of at the end
of the day… [No. 3, focus group 4].
1bi: Season: Antimicrobial use for disease management tends be influenced by season
(weather/climate). Wintertime use of antimicrobials was mentioned in focus group 1 for the
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management of interdigital phlegmon and focus group 2 in suspected cases of respiratory
disease. However, participants from focus group 4 stated that antimicrobials were mainly
required from spring through fall for the management of anaplasmosis and infectious bovine
keratoconjunctivitis.
…. Antibiotics depends on the weather. Spring or whether it’s fall …. have an issue
where you need some antibiotics… [No. 8, focus group 4].
…I do use some feed grain antibiotics when I have train wrecks … in September and
October. You are going to have some sick cows during what we call dead-cow month
October/November… Occasionally, there’s some feed through antibiotics that goes
through those wrecks… [No. 2, focus group 4].
1c. Economic factors
The need to obtain economical gain from a healthy herd was an important driver of AMU
among producers. The producers frequently stated that they use antimicrobials to maintain a
healthy and productive herd for sustainable economic gain. They were defensive and frequently
asserted that antimicrobials are only used when necessary and not indiscriminately, as perceived
by policy makers, consumers, and the public.
… I think it comes down once again to economics…that economic threshold... But as a
producer, you have to look at it from an economic standpoint is it worth it to give the
antibiotic? Is it worth it to pay the vet bill at this point? Or am I going to try something
that’s worked in the past?... [No. 3, focus group 4].
1d. Veterinarian consultation
Although access to emergency veterinary care was mentioned to be difficult in some
areas, a section of participants from areas with active food animal veterinarians (McMinn
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county, Jefferson county) considered veterinarian consultation an important influencer of AMU.
Producers with a good relationship with their veterinarians consulted them on AMU issues.
…. I just work close with my veterinarian. He goes off label or whatever you’re trying to
treat at the time. I just stay with that…. [No. 6, focus group 5].
…I’ll say consultation with a veterinarian is one factor… [No. 3, focus group 4].
However, for those with limited access to food animal veterinarians, veterinarian consultation
was not an influencer of AMU.
…We don’t have a veterinarian we regularly work with. What [we do] is just visual
appraisal if we have sick animals… [No. 7, focus group 4].

Some producers in East TN, Middle TN, and West TN decried the lack of food animal
veterinarians in their areas.
… [It is] more difficult [to access a food animal veterinarian] than it was a few years
ago. Most of them [veterinarians] going to be cat and dog vets. They won’t treat the
cattle... [No. 6, focus group 2].
1e. Producer’s experience and peer support
The participants frequently stated that they rely on their own experience, knowledge, and
judgment when deciding to use antimicrobials in their cattle and tapped into the AMU
experiences of their peers (other producers). However, in situations that are difficult to handle,
they consult the veterinarians. There was a shared belief among participants that peers are easy to
access given that some areas do not have food animal veterinarians.
…I think for most of us, we’re relying on our own experience and our own knowledge. If
it’s something that I’ve seen before and I know how to treat it, I’m going to treat it like I
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treated it before…whatever has been successful. If it happens to be something that I have
a question about, I can text one of the vets I was talking about… [No. 4, focus group 2].
…. experience and not necessarily my experience but experience of producers that’ve
done the same thing I’m doing a lot longer than I have. I find a lot of times they know –
nothing against the veterinarians, the producers deal with this every day. In a lot of
cases, they know more about it than the veterinarian does and will offer some more solid
advice of what to use, when to use it, that kind of thing but still consulting with the
veterinarian in doing the right thing… [No. 3, focus group 4].
…What I pick up on is when I start having wrecks, I just pick up the phone and call
somebody else who does the same thing…He’s doing the same thing I’m doing week in
and week out…You get on the phone. You start calling. Hey, what’s working? What
medicine are you using?... [No. 2, focus group 1].
1e. Veterinary Feed Directive
Throughout all the focus groups, it was common for participants to state that the
restriction of in-feed antimicrobial products at sub-therapeutic concentrations and for
prophylactic indications by way of the VFD has led to increased occurrence of disease in herds
and increased mortalities. Examples of those diseases are infectious bovine keratoconjunctivitis,
anaplasmosis, and interdigital phlegmon in calves.
…There is increase in injectable because we’re having a lot more pinkeye, a lot more
foot rot. Even in our weaned calves this year, we have foot rot we never had before,
never... [No. 3, focus group 5].
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1g. Perceived drug efficacy
Antimicrobials perceived to be more efficacious are often chosen in preference to those
perceived to be less efficacious. In the event of treatment failure, producers switch from
apparently less effective antimicrobial to a “more effective” one sometimes based on their own
observation or on the advice of a veterinarian or their peer group.
…And the medicines – I don’t know about anybody else, but I’ve used every medicine
that’s new and old and come out. And the truth of the matter is one week this might work.
The next week, this one don’t work. We have a veterinarian come through all the time
that wants you to switch. … Sometimes when you switch, it’s a disaster. I’ve used
everything that’s come out… To me it seems like the medicines aren’t strong enough, if
anything. They’re not working. We had Draxxin come out a few years ago. I mean, it
worked great. Now you just as well shoot farm water at them with a dart gun. That’s
what we found out. They just wouldn’t respond to it.… [No. 2, focus group 1].
1gi: Marketing pressure from veterinary pharmaceutical companies: Marketing from
drug companies tend to shape producers’ perception of antimicrobial efficacy, as well as
antimicrobial choice. Producers expressed the marketing techniques to be persuasive and
aggressive.
…I don’t know about anybody else here, but there’s nothing no worse than to look up a
driveway and see the Pfizer man coming up the driveway. If they’re like me, they go try to
hide because it’s gonna drive you crazy. Their product’s always the best and always this
and always that. Most of the time, we wanna get it done. We wanna feed. We wanna make
sure the cattle’s healthy... [No. 2, focus group 1].
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Objective 2: Alternatives to antimicrobials
The commonly mentioned alternatives to antimicrobials used by focus group participants
generally included proper animal nutrition, use of good management practices, use of vaccines,
and immunostimulants. The excerpts that support these alternatives are provided below.
2a. Proper animal nutrition
Maintaining cattle on good ration, good pasture, and clean fresh water were suggested as
prerequisites to a healthy productive animal. Adequate mineral and vitamin supplementation was
also considered important in raising healthy animals to abrogate the need antimicrobials.
…We use good minerals, good feed… [No. 5, focus group 5].
…You’ve got to keep your cattle in a good body score. They can’t be too fat, definitely
not too skinny. It’s just like No. 7 said, we have good grass, good mineral program and a
good vaccination program – not antibiotics, your viral vaccines… [No. 3, focus group 5].
2b. Good management practices
Good management practices, such as on-farm biosecurity/infection control programs,
vector control (tick control), rotational grazing, proper sanitation and hygiene, stress
management, provision of good cow comfort through proper housing, and routine deworming of
the herd, were suggested as preventive measures to limit AMU. Participants who maintained
closed herd operation types stated that a closed herd operation system helped them in preventing
disease introduction from other farms and minimized AMU on their farms. However, those with
open herds practice isolation of newly introduced animals from other farms to prevent disease
introduction and minimize the need for AMU.
…You do everything management wise to prevent the need for it [need for
antimicrobials], whether it be sanitation, nutrition, daily removal of stress from the
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animal’s life – in your case, trying to keep out infectors from them. We do everything
within our power management wise. And it’s a whole program, not just one step… [No.7,
focus group 3].
… We don’t have a closed herd. Definitely, [we] see the benefits to a closed herd… And
we’re doing that in picking new animals along the way. …We isolate a period of time and
vaccinate as soon as we get those animals to see if we’ll have any disease and sickness
and keep that from being a threat to rest of the herd… [No. 5, focus group 4].
2c. Vaccination and immunostimulants
Vaccination and use of immunostimulants, such as zelnate®, were frequently mentioned
as alternatives to AMU. Also, immunostimulants are used to boost the animals’ immune
response to infection.
…we use vaccines … [No. 5, focus group 5].
…we have good grass, good mineral program, and a good vaccination program – not
antibiotics, your viral vaccines… [No. 3, focus group 5].
…And to go along with vaccinations, the cattle have to be prepared to respond to those
vaccines. You can’t give vaccines to sick calves or calves that are not prepared to
respond and expect them to respond because it won’t work… [No. 4, focus group 2].
… We put ours on a good health protocol. They’re run through… twice a year for
vaccines, worming … You’ve got to have a healthy animal for your vaccines to work. If
you don’t have a healthy animal to start with, they’re not going to work… [No. 6, focus
group 2].
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Objective 3: Knowledge of AMR and perceptions regarding AMR
Generally, many participants were well informed regarding AMR and perceived it to be a
threat to both animal and public health. Participants suggested several measures for containing
AMR. A detailed presentation of participants’ knowledge of and perceptions regarding AMR is
given below.
3a. Knowledge of AMR
Although many participants had a fair understanding of AMR, it was clear from the
discussions that some were uninformed regarding AMR. Some participants associated AMR with
prolonged use of the same antimicrobials in the farm. A section of producers believed AMR in
cattle pathogens does not exist.
…Has anybody seen when you give them some antibiotic and they don’t respond? Most of
them respond. So, they’re not resistant to it… I think most people here are not convinced
that there is animal antibiotic resistance …. I do believe there’s human just because of
the abuse of antibiotics… [No. 3, focus group 5].
3b. Perceptions regarding AMR emergence
A section of participants perceived AMR emergence to be a problem challenging animal
and public health. It was voiced that AMR could be occurring in Tennessee cattle pathogens.
…Unless the medicines are changed, then my opinion the bugs or whatever you want to
use as a scientific name, are getting resistant because it’s not doing the same thing. I
can’t tell you that [because] I don’t know if they’re weakening the medicine… [No. 2,
focus group 1].
The role played by AMU in livestock on the emergence of AMR was generally disputed
by participants. Although some producers thought that other producers could be indiscriminately
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using antimicrobials and contributing to selection pressure associated with non-prudent use, the
focus group participants generally perceived their AMU practices to be prudent. Concerns about
over-use in cattle production were generally regarded as unfounded and not evidence-based.
…Use the same antibiotic for everything – some [cattle producers] do that. They’ve only
got one bottle, they’ll just give them a dose it… [Unidentified participant, focus group 5].
…As mentioned [we use antimicrobials only as needed], just as needed to treat animals
that – whether it’s his foot or respiratory illness or cow or calf needs, something like that
but only as needed and usually the least potent thing to do the job… [No. 4, focus group
2.
Participants frequently mentioned non-judicious use of antimicrobials in human health
(and not in livestock) as the key driver of AMR in pathogens affecting humans.
… There’s been misuse on the human side… [No. 7, focus group 4]. …the humans are
taking a lot more than the cattle are taking… [No. 2, focus group 2].
…I think they take in what has happened in the human side and try to say that’s
happening in the beef side, and it’s not. The human side, ya know, I got a sniffle. I go get
a shot. They give me a Z-Pack. And we don’t do the animals like that. They don’t get five
rounds of antibiotics a year like some people do… [No. 3, focus group 5].
3c. Proposed solutions to AMR
The focus group participants suggested a wide range of measures for containing AMR. A
brief description of measures suggested by the participants is given below.
3c. i Restricted use of medically important antimicrobials
Restriction of the use of medically important antimicrobials in food animals was strongly
supported and was perceived to be an important measure for prolonging the efficacy of
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medically/critically important antimicrobials. Participants suggested that medically important
antimicrobials should be reserved for use in humans.
…I’m pretty concerned about the superbugs you hear about in hospitals and the new
bugs that are out there that don’t respond to any antibiotic. I think it’s a pretty big
concern for all of us how we’re going to treat some of this in the future. I think there are
some common sense approaches we can take, especially some of the types of antibiotics
we use that are not necessarily used on the human side. I hope we can identify those and
not just restrict all antibiotics because I think there are some that are important to us that
aren’t used on the human side… [No. 7, focus group 4].
… I think avoiding medically important antibiotics for humans in animal production as
much as possible [is important]. [We should] use those antibiotics that are not used for
human medicine as much as we can … [No. 3, focus group 4].
3c. ii Use of sound research
More investment in research on AMR and AMU by federal agencies and development of
novel antimicrobial drugs by the pharmaceutical industry was suggested. Additionally, it was
suggested that scientific evidence of the link between AMU in livestock and development of
AMR in animal and human pathogens should be provided to producers. Such evidence whether
pictorial or in video format would trigger behavioral change towards maintenance and adoption
of prudent AMU by producers. It was suggested that wide consultations with producers before
enacting and implementing policies on AMU in animal production would be useful for wider
acceptance of such policies.
… As far as the results that they get from the research that they do on the certain
antibiotic, show the results. They say this does this. This does that. Where’s the proof?
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Show it to us. Show the farmer what it’s doing. Give us the proof. Let us know what it’s
doing. Show us pictures. Show us what to do… [Unidentified participant, focus group
5].
3c. iii Additional education of producers
Additional education of cattle producers on prudent AMU was frequently suggested by
participants to improve AMU in cattle production so that selection pressure from non-judicious
use can be reduced. Areas in which additional education for producers is needed include proper
management of cattle, farm-level biosecurity to prevent disease, use of antimicrobial
cycling/rotation in farms, and encouraging producers to always consult the veterinarians on
AMU.
… I believe education [on AMU] is the key to it all… [No. 6, focus group 3].
…Well, I think it would be a good thing to teach us on it [antimicrobial use]. And we’ll
use that [the acquired knowledge] for our background and start our program… [No. 8,
focus group 4].
3c. iv Promoting vaccination of animals
The need to promote vaccine use among producers for those diseases that are vaccinepreventable was frequently mentioned as a measure for reducing AMU and minimizing AMR
selection pressure. Packaging of vaccines into smaller quantities was suggested to cater for
producers with small herd sizes because the currently available livestock vaccines are mainly
packaged in large quantities. Such large quantities that may be ultimately wasted are perceived to
deter small scale producers from using vaccines.
… I think we could accomplish a lot with proper vaccination programs in the southeast.
In Tennessee, we have a lot of part-time producers that just don’t know or it’s not that
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important to them to have the proper vaccine protocols. And that’s what leads to the need
for all the antibiotics at the doctoring background… [ No. 7, focus group 4]
… there’s so many producers that …they’re not gonna break into a box that says ten
doses to vaccinate three calves. That’s throwing seven doses away. I’m just not gonna do
it. I don’t know if we can break this down into smaller doses or something just to get
these products[to] more smaller producer[s] … [No. 5, focus group 1].
3c. v Simplified antimicrobial labeling
The current antimicrobial labels and information on the antimicrobial package inserts
were perceived to be very technical for producers to comprehend. Thus, participants suggested
that antimicrobial drug labels and information in the antimicrobial package insert should be
written in non-technical language to make such information easy for producers to comprehend.
…. Sometimes you read those drug labels. I’m not a chemist or biochemist. But maybe get
the veterinary college to simulate the information down to a working level …. [No. 6,
focus group 5].
... I deal with people every day that try to read those labels and can’t understand them –
too many big words. I think if they would speak in plain language, say this is for shipping
fever, pneumonia, or what this specifically does. That would be a help for people… [No.
5, focus group 5].
3c.vi Miscellaneous measures
Other measures suggested for reducing AMU and containing AMR include the promotion
of infection control and biosecurity measures; discouragement of veterinary pharmaceutical
companies from aggressive marketing of antimicrobial products; training more food animal
veterinarians; training para-professionals, such as veterinary technicians; and incentivizing the
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producers through subsidies so as to encourage wider adoption of use of vaccines and
alternatives to antimicrobials.
…Start at the top with the drug producers…. I would ask them to not be marketing at
such an aggressive level as to prevention, cure, et cetera, et cetera … [No. 3, focus group
2].
…. encouraging people to use vaccines. I think the best encouragement is if you hit them
in the pocketbook. When everything’s bringing the same price, whether it’s vaccinated or
unvaccinated, there’s no motivation for producers to vaccinate. But if there’s some price
differentiation, people will spend the $5.00 to vaccinate. We have to make it justified
economically, once again… [No. 3, focus group 4].

Objective 4: Avenues for receiving information on prudent AMU
Avenues for reaching out to producers on prudent AMU vary by producer’s age as well
as the geographical region. Although no one medium for receiving information on prudent AMU
would work for all producers, the following were identified as viable avenues: email, farm
magazines, feed sales persons, peers/other producers, producer meetings, the veterinarian, county
extension agents, photographs, videos, and hard copies mailed to their mail boxes.
…I love Internet. But I also love hardcopy [as source of information] because [if] I get a
magazine, and I won’t read it. I’ll stick it back in the bookcase. Something might come
up, and I’ll read it through it and be an article from two years ago. And I can go back
and kinda research. I kinda like it both ways… [No. 4, focus group 3].
However, the veterinarian (for areas with food animal vets), producer associations/meetings, and
county extension agents were commonly mentioned as trusted avenues for channeling
information on prudent AMU to cattle producers.
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… if there’s information, I want it from a trusted source and not from somebody that I
don’t know or somebody just trying to sell something. I trust my vet and other producers
who have used products or may know more than I know about it.... [No. 4, focus group
2].

Discussion
A deep understanding of factors influencing producers’ decision-making, their beliefs,
attitudes, and perceptions is needed as a basis for building effective interventions [14]. Hence,
identifying producers’ current behavior towards AMU is a critical step towards achieving
success in policy interventions that promote judicious AMU among cattle producers. This
qualitative study provides a detailed understanding of drivers of AMU among beef cattle
producers in TN. Additionally, this study identified the producers’ alternatives to antimicrobials,
their perceptions regarding AMR, and the appropriate avenues for disseminating information on
prudent AMU to these producers. These findings should aid in shaping and optimizing
interventions that seek to promote and improve judicious AMU in TN and the entire US. The
impact of such interventions on AMU could then be validated when measuring AMU both
qualitatively and quantitatively.
Our study shows that the factors driving AMU among beef producers in TN are
numerous and in conformity with those identified in other studies elsewhere [1, 23]. Occurrence
of disease at farm level, cost-benefit analysis of the treatment of disease, producer’s expertise
and experience, and producers attitude towards risk, among other factors, have previously been
identified as drivers of AMU [23]. Previous European studies have demonstrated that economic
factors drive farmers’ AMU [1]. Among dairy cattle producers in New Zealand and dairy
producers in South Carolina, owner’s experience was an important driver of AMU [15, 24]. The
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OIE prudent use guidelines discourages the veterinary pharmaceutical industry from directly
advertising antimicrobials to food-animal producers [25]. In the present study, producers
perceived the veterinary antimicrobial marketing techniques to be persuasive and aggressive.
Aggressive marketing of antimicrobials is a known driver of AMU that has led to calls for
banning pharmaceutical industry and drug retailers from advertising antimicrobials [26]. Several
findings of our study are in keeping with findings of these previous studies.
The VFD was identified as a key factor that is driving increased use of injectable
antimicrobial agents by producers and decreased use of in-feed antimicrobials, since it became
effective on January 1, 2017. This is an important finding that needs to be further validated. It is
necessary to conduct a targeted country-wide evaluation of the impact of the VFD on the use of
injectable antimicrobials in the US. In Denmark, where the use of antimicrobials for growth
promotion (AGP) has been banned, the reported impacts of the ban are conflicting. In one study,
the ban reportedly led to a reduced total AMU and increased therapeutic use of antimicrobials
due to significant increase in health problems in Danish pigs [27]. However, in another study
[28] that evaluated changes in AMU and productivity in the Danish pig industry, long term swine
productivity was not affected by the ban on AGP use.
Optimal housing and hygiene practices, climate control, feed, and water quality are
known to be prerequisites for reduction of AMU in farm animals [29]. In the present study, there
was strong appreciation of good management practices and vaccination as alternative approaches
to reduce AMU. The WHO action plan to combat AMR has identified vaccination as an
alternative to AMU and part of the solution to AMR [30]. The producers’ suggestion for
promotion of vaccinations as an alternative to antimicrobials is in line with the WHO action plan
to combat AMR. Use of vaccines eliminates the need for antimicrobial therapy and indirectly

109

combats AMR, reducing AMU through indirect protection provided by herd immunity [31].
Countries, such as Denmark, have already taken steps to promote the use of vaccines and to
discourage use of antimicrobials, especially critically important antimicrobials (CIAs). Denmark,
since 2013, is applying differentiated taxes (0% on vaccines, 0.8% on narrow-spectrum
penicillins and other veterinary medicines, 5.5% on other veterinary antimicrobials, and 10.8%
on CIAs) on antimicrobials to promote the use of vaccines by farmers [23, 32]. The participants
in this study suggested that vaccines should be packaged in smaller quantities to encourage small
producers to use vaccines, and incentives should be provided to farmers to encourage the
adoption of alternatives to antimicrobials. Further evaluation of the potential benefits of these
suggestions would be useful in providing a better justification for their adoption.
A previous study suggested that farmers should be provided with clear evidence of the
consequences of non-judicious use of veterinary antimicrobials and the need to reduce AMU
[33]. Dissemination of existing knowledge to producers about best practices to reduce AMU
while at the same time not compromising animal health and production has been suggested to
convince producers of the feasibility of production with less AMU [33]. In the present study, the
participants suggested that producers should be provided with scientific evidence that shows how
the use of AMU in food animals contributes to AMR. Although many participants had a fair
understanding of AMR, others appeared not to be conversant with AMR, with some participants
stating that such resistance in cattle pathogens did not exist. These findings suggest a need for
more awareness among producers of what constitutes and drives the development of AMR. If
producers don’t believe there is AMR in veterinary pathogens, then they are likely to maintain
those practices that would select for resistance.
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The WHO has suggested restriction of critically important antimicrobials for use in food
animals [34]. In this study, some participants were positive about restriction of medically
important antimicrobials for use only in humans and suggested that such restriction will be
significant in preserving the efficacy of medically important antimicrobials. With more
awareness, cattle producers are likely to embrace such AMU restrictions as recommended by
WHO.
The participants in this study called for more sound research and development of new
antimicrobials. This suggestion echoes well with calls by various actors for industry to develop
novel antimicrobials [30, 35]. The participants suggested antimicrobial drug labelling should be
made easy for producers to comprehend and should be written in non-technical language. This is
an important suggestion that needs to be considered by pharmaceutical companies. In the day-today running of farms, it is the farmers themselves and their farm staff who make ultimate
diagnostic and antimicrobial treatment decisions for their animals, sometimes under
veterinarians’ guidance [15]. The authors contend that simplified drug labels (with non-technical
language) might actually reduce the complexity that would cause inaccurate dosage
determination by producers. Accurate dosage determination is important for prudent use.
In a UK study, farmers perceived themselves as prudent antimicrobial users [1]. In our
study, participants generally perceived their use of antimicrobials to be prudent (responsible and
within sound reason) and concerns about antimicrobial misuse/over-use in cattle production to be
unfounded and not evidence-based. Such perceptions could likely hinder behavioral change
towards prudent AMU. Behavioral change communication to educate the farming public about
the dangers of uncontrolled AMU would likely be a challenge, since most producers perceive
their practices to prudent. Researchers in Europe found that when producers do not see the need
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to change behavior, long-established on-farm practices are difficult to change [36]. Possibly,
quantification of on-farm AMU and benchmarking (comparing a farm’s AMU practices against
the practices in one or more peer farms with the objective of identifying the best AMU practices
for improved use) best practices could cause producers to critically reflect on their current AMU
practices. Nevertheless, campaign efforts targeting behavioral change on AMU among TN
producers should focus on encouraging producers to continue benchmarking AMU practices
from peers.
In the present study, the veterinarian (for areas with food animal vets), producer
associations/meetings, and county extension agents emerged as trusted avenues for channeling
information on prudent AMU to cattle producers. In the Netherlands, administration of
veterinary antimicrobials restricted to veterinarians only and farmers are only permitted to
administer antimicrobials to their animals in specified cases without the physical intervention of
the veterinarian [37]. However in the U.S., most antimicrobial treatments in farms are
administered by non-technical farm personnel (producers and farm employees) [38, 39]. In the
present study, veterinarian’s prescription was an important driver of AMU only in areas with
active food animal veterinarians and training of more food animal veterinarians was suggested
due to the shortage of food animal veterinarians in the U.S. Some producers in East TN (Johnson
City focus group) and Middle TN (Dickson County focus group) decried the lack of food animal
veterinarians in their areas. This lack of food animal veterinarians in some counties in Tennessee
could be a key barrier to judicious use of antimicrobials. Also, training of veterinary nurse
practitioners and para-veterinarians was suggested to fill the gap of lacking food animal
veterinarians. More access to food animal veterinarians could play a key role in stimulating
change towards prudent AMU among producers. Although encouraging behavioral change
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among producers is necessary intervention for promoting prudent AMU and managing AMR, the
lack of food animal veterinarians in some counties make it difficult to implement this
intervention. Training of food animal para-professionals and licensed veterinary technicians
might be worth exploring (although it might emerge as a contentious issue in the veterinary
community).
In human medicine, integration of behavioral change messages into routine health care
has been suggested as a measure for improving AMU practices [21]. Because the veterinarians,
producer associations/meetings, and county extension agents are the trusted avenues for reaching
out to producers, targeted behavioral change messages towards prudent AMU could be
integrated into routine farm visits and veterinary/agricultural extension programs. The use of
behavioral techniques such as motivational interviewing informed by assessing producers’
readiness for change could be useful [40]. Producer meetings/associations could be used to
identify AMU training needs and raise more awareness about AMR and prudent AMU among
producers. European researchers suggested that AMU behavioral change among producers can
be realized if farmers are offered a sense of ownership of the recommendations for judicious
AMU [41]. It would be beneficial to conduct studies exploring objectified, reproducible, and
transparent methods for quantifying on-farm AMU in the U.S., since such measures could create
awareness and stimulate behavioral change towards prudent AMU.
Like any other focus group study, our findings may have been biased by the presence of
dominant participants, such that the results may reflect the opinions of the dominant participants,
rather than that of the group. However, such bias was minimized by having a moderator in the
research team with a behavioral/social science background, skilled in moderating such meetings.
Selection bias resulting from purposive sampling may also inevitably be an issue. However,
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purposive sampling of participants allowed for inclusion of beef producers with experience in
different beef cattle production systems and from different geographical areas to represent a
range of beef cattle producers in TN. Cluster analysis of the focus groups (Jaccard’s similarity
index, ranging from 27% to 33%) suggested that there was great diversity of opinions among
participants in the different focus groups. The issue of AMU in farm animals is emotive given
the current debate in the media that is shaping the public/consumer perceptions of AMU in food
producing animals. Because producers are aware of concerns about non-judicious AMU in
animal production, social desirability bias could also be an issue in this study. The producers
might have given socially desirable responses. To assess how the factors identified in this study
represent the opinions of all beef producers in the state, a quantitative study built on preliminary
findings of this study was conducted and findings presented in a separate paper.

Conclusions
This study provides insight into the several factors that drive the use of antimicrobials
among cattle producers in TN. Participants generally perceived their use of antimicrobials to be
discreet. However, what the producers perceive as prudent AMU may not necessarily be prudent
use. As a result of this study, campaign efforts targeting behavioral change on AMU among
producers should focus on encouraging producers to continue benchmarking AMU practices
from peers. Benchmarking best practices could perhaps cause producers to critically reflect on
their current AMU practices. To reduce the burden of AMR, more awareness of what constitutes
and drives the development of AMR, and additional education on prudent use of antimicrobials
is needed for beef producers. Training on prudent AMU is likely to be well received by
producers if the information comes from their veterinarians, county extension officers, or trusted
fellow producers. The trainings should utilize published evidence of the consequences of non114

judicious use of veterinary antimicrobials and the need to improve judicious AMU in livestock.
Perhaps such training may cause reflection on current practices and would trigger acceptance of
messages that aim at behavioral change towards prudent AMU.
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CHAPTER 4
Drivers of antimicrobial use practices among Tennessee dairy cattle
producers
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Abstract
Non-judicious antimicrobial use (AMU) and inadequate antimicrobial stewardship are
known modifiable factors driving the occurrence of antimicrobial resistance (AMR). A mixed
methods approach using a combination of focus groups and survey questionnaires was used to
explore the AMU practices of Tennessee (TN) dairy cattle producers. Specifically, the objectives
of the study were to determine the following: (1) the most common drivers for using
antimicrobials, (2) perceived alternatives to antimicrobials, (3) knowledge of and perceptions
regarding AMR, (4) and the appropriate avenues for receiving information on prudent AMU.
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Two focus groups were conducted, one in July 2017 and the other in March 2018. The
questionnaire was simultaneously made available to participants both in print form and online
from January 26, 2018 through May 11, 2018. Twenty-three dairy producers participated in the
focus groups and 45 responded to the survey. Eight (18.6%) producers never used bacterial
culture and sensitivity testing (C/S) to select antimicrobials, more than half (25 producers
(58.1%)) sometimes used C/S, four (9.3%) used C/S about half the time, five (11.6%) most of
the time, and one (2.3%) always used C/S. The most common drivers for using antimicrobials
were disease and animal welfare, pathogen surveillance, economic factors, veterinarian
recommendation, producer’s experience and judgment, drug attributes, and the Veterinary Feed
Directive. Good management practices, vaccination, use of immunomodulatory products, and
use of appropriate technology for early disease detection were considered alternatives to AMU.
Four (9.1%) dairy producers were very concerned about AMR, 27 (61.4%) moderately
concerned, and 10 (22.7%) were not concerned about AMR. The veterinarian was considered to
be a trusted source of information on prudent AMU. Use of C/S test results for antimicrobial
selection is widespread among TN dairy producers. More awareness about C/S and continuing
training on prudent AMU is needed.

Key words
Mixed methods study, antimicrobial use, antimicrobial resistance

Introduction
Antimicrobial resistance (AMR) is now recognized as a major global health problem [1,
2]. Non-judicious antimicrobial use (AMU) and inadequate antimicrobial stewardship (AMS) are
known modifiable factors driving the occurrence of AMR [3]. The public health threat of AMR
has led to increased societal pressure to limit AMU in food animals [4].
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To prevent potential public health consequences of AMR, many countries have instituted
measures to reduce and minimize AMU in food animals [3]. These measures are based on the
precautionary principle, since there is currently no robust evidence on the public health impacts
of AMU in food animals on AMR in human pathogens [3]. The precautionary principle of public
health recommends the adoption of preventive measures in the face of uncertainty and exploring
various alternatives to potential threats to public health [5]. Recent systematic reviews showed
that although some primary studies suggested evidence of AMR transmission from and between
food animals and humans, a large proportion did not provide evidence supporting such
transmission [6-8]. Recent studies have shown that indiscriminate use of antimicrobials for both
therapeutic and non-therapeutic purposes in animals leads to propagation and shedding of
substantial amounts of AMR microorganisms [3, 9].
The World Health Organization (WHO) recommends complete restriction of AMU in
food animals for growth promotion and for disease prevention, as well as a reduction in the
overall use of medically important antimicrobials in food animals [1]. Beginning January 1,
2017, the United States Food and Drug Administration (FDA) implemented the Veterinary Feed
Directive (VFD), aimed at facilitating the judicious use of medically important antimicrobials in
food producing animals. The VFD authorizes the use of medically important antimicrobials in
feed and water for therapeutic purposes, under the supervision of a licensed veterinarian. For
policy interventions such as the VFD to be effective, factors that inform and influence or drive
producer behavior in relation to AMU need to be addressed because producers consistently base
their decisions and actions on a complex system of core values and knowledge.
Previous studies among dairy farmers identified veterinary advice, the producer’s
personal on-farm experience, disease occurrence, animal welfare, and the drug withdrawal period
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as primary factors driving choice and use of antimicrobials [10-12]. To date, however, there has
been very limited investigation into the drivers of AMU practices of cattle producers in the
United States. No previous study to our knowledge has explored the drivers of AMU among
Tennessee (TN) dairy cattle producers.
In this study, our aim was to use a combination of focus groups and survey questionnaires
to explore the AMU practices of TN dairy cattle producers. Specifically, the objectives of the
study were to determine the following: (1) the most common drivers for using antimicrobials, (2)
perceived alternatives to antimicrobials, (3) knowledge of and perceptions regarding AMR, and
(4) the appropriate avenues and formats for receiving information on prudent AMU. These
findings should optimize the efforts under which targeted campaigns for nationwide AMS are
applied in US dairy production.

Materials and methods
Study design
This was a mixed methods study using a combination of focus groups and survey
questionnaires. To aid in the triangulation between the qualitative and quantitative data,
preliminary findings from one focus group were used in the development of the survey
questionnaire. The University of Tennessee Institutional Review Board for the Protection of
Human Subjects in Research reviewed and approved both the qualitative (Protocol number: UTK
IRB-17-03702-XP) and the quantitative (Protocol number: UTK IRB-17- 03884-XP) parts of
this study.
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Qualitative methodology
Focus group design, structure, and procedure
We conducted two dairy producer focus groups in middle TN and east TN in July 2017
and March 2018, respectively. The middle TN focus group (focus group 1) was conducted with
dairy producers attending an annual dairy producer meeting. Fourteen people attended this
annual dairy producer meeting (12 of whom actively participated in the discussions). Participants
in the east TN focus group (focus group 2) were recruited from dairy producers attending a
master dairy training meeting. Of the approximately 35 producers who attended this master dairy
training session, 11 volunteered to participate. Each focus group meeting lasted approximately
60 minutes. Each participant was given an informed consent form with an overview of the study
and a signed consent was obtained before participating in the focus group discussion.
Participants could opt out of the focus groups at any time. A meal was provided to all invited
participants irrespective of their active participation.
We used a semi-structured interview guide consisting of 11 open-ended questions
designed to address the study objectives (See Appendix 2B). We assigned each participant an
identity number to maintain anonymity. These identity numbers were used throughout the
discussion and participants announced these numbers before speaking. The two focus groups
were moderated by one of the authors (EBS). Three members of the research team (JEE, MC,
and CCO) took hand written notes of any key points, provided clarifications to questions, and
asked follow-up questions when necessary. Each focus group discussion was video-recorded and
later transcribed verbatim by a professional transcription service provider for thematic analysis.
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Data analysis
We analyzed the transcripts using a data analysis software (NVivo qualitative data
analysis Software; QSR International Pty Ltd. Version 12, 2017). Thematic analysis was
performed using a recursive six-phase approach (familiarization with the data, generation of
initial codes, search for themes, review of themes, definition and naming of themes, and report
production) as described previously [13]. To familiarize themselves with the data, each member
of the team (JEE, MC, EBS, and CCO) read both transcripts. The percent of word similarity
between the 2 focus groups was assessed using Jaccard’s coefficient. A master project with the
two transcripts uploaded was developed by the primary author (JEE) and distributed to the other
authors for individual coding. An inductive approach was used to develop a coding frame (each
author created independent nodes). Upon completion of the individual coding, the primary author
(JEE) imported the other team members’ coded data into the master project and examined if the
themes from the individual coding were related to the coded extracts in all the data transcripts.
The degree of agreement in the data coding among the coders (JEE, MC, EBS, and CCO) was
determined in NVivo using percent agreement. Results of the independent coding was reviewed
and harmonized by the research team.

Quantitative methodology
Study design and administration of survey
A survey questionnaire consisting of a section for dairy producers and another for beef
producers was developed and evaluated by two professionals with expertise in AMU to ensure
all critical issues were identified and covered (See file S2 in the supplementary materials for the
survey questionnaire). Dairy producers completed only the dairy section of the questionnaire.
Preliminary findings from focus group 1 were used in the development of the questionnaire. The
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56 survey questions targeted the producer’s demographics and their AMU practices, factors
driving producer’s choice of antimicrobials, and perceptions, opinions, and concerns about AMU
and AMR in cattle production.
The targeted producer demographic information included age, sex (male versus female), level of
education, herd size, whether raised on a livestock farm or not, and number of years in cattle
farming. This demographic information was our explanatory variables of interest. Our main
outcome of interest was the producers’ degree of concern about antimicrobial resistant infections
in cattle. Also, the association between level of education and producer’s perception of
antimicrobial label instructions was of interest. Three-point scales and ordinal Likert scales were
used to capture participant responses to questions related to AMU practices, factors driving
choice of antimicrobials, and perceptions, opinions and concerns about AMU and AMR in cattle
production.
The questionnaire was simultaneously made available to participants both in print form
and online. Participants who completed the print survey were requested not to complete the
online survey and vice versa in the informed consent statement. The on-line version of the survey
was housed in a survey software (Qualtrics software, Provo, UT) and was adapted for computer,
tablets, and cell phone responses. The anonymize function in the Qualtrics software was
optimized, so responses were not attached to any personal identifiers. During an annual dairy
producer meeting in January 2018, producers were notified about the online survey option in
order to increase the response rate. Subsequently, an email invitation to take the survey was sent
out to all the 87 dairy producers on the University of Tennessee Animal Science department
email list. The printed questionnaire was distributed to producers attending dairy producer
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meetings and master dairy training meetings across TN. Completed printed questionnaires were
returned to the investigators or mailed to the last author.
Both the printed survey and online survey remained open from January 26, 2018,
through May 11, 2018. Participation in the survey was voluntary and the survey targeted all dairy
producers in the state (the estimated number of dairy producers in TN as of 2017 was 300) [14].
To further increase the response rate, follow-up email reminders were sent to non-respondents of
the online survey every two weeks. All participants were invited to participate in a $10 gift card
raffle taken at the end of the survey and the winners were randomly selected. Eligibility to
participate in the raffle was not contingent upon survey completion.
Statistical analysis
A commercial statistical software (SAS, version 9.4, SAS Institute Inc, Cary, NC) was
used to complete descriptive and univariable inferential analyses. Descriptive statistics
(frequencies and proportions) were used to summarize the data. Responses on the Likert scales
were visualized using stacked bar charts created in another commercial software (Tableau
software, version 8.2, Seattle, WA). No corrections were made to missing data.
Univariable analyses (ordinal models with PROC LOGISTIC) were performed to test for
associations between the captured demographic information and producers’ degree of concern
about antimicrobial resistant infections in cattle (our primary outcome of interest). Model fit was
assessed using the score test for the proportional odds assumption, deviance, and Pearson
goodness-of-fit statistics. Also, binary logistic regression was used to test the association
between level of education and producer’s perception of antimicrobial label instructions. For the
univariable analysis, level of education was reclassified into two categories, high
school/vocational or ≥ college, while herd size was reclassified into ≤ 150 or ≥ 150 dairy cattle.
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The 95% confidence intervals were used to test significant associations. Values of P < 0.05 were
considered statistically significant. Multivariable analyses were not performed because
meaningful multivariable analysis was deemed to be untenable based on findings from the
univariable analyses.

Results
Focus group participant characteristics
A total of 23 dairy producers actively participated in the two focus groups. Focus group 1
had one female and 11 male participants, while focus group 2 had two females and nine male
participants. The reported milking herd size per producer ranged from approximately 40 to 1,100
dairy cattle. There was no participant that self-identified as an organic dairy producer.
The responses from the 2 focus groups were 31.2% similar (Jaccard’s similarity index =
0.312). This Jaccard’s similarity index provided evidence that there was diversity among
participants. Percent agreement (in coding) between each pair of coders was > 80%.

Survey participant characteristics and self-reported AMU practices
Of the estimated 300 dairy cattle producers in the state, a total of 45 participated in the
survey. Overall, the estimated survey response rate was 15%. Majority of respondents provided
complete responses for most questions, except for a few cases where some respondents left some
questions unanswered. Of the 45 dairy participants, 40 completed the print survey, while only
five completed the online version. Thirty-nine (39) provided their gender: 31 males and seven
females. One of these respondents preferred not to report their gender. The demographic
information of the survey respondents is presented in Table 4.1. Majority of the participants
mentioned that they kept up-to-date written records on antimicrobial purchases and did not
practice extra-label AMU (Table 4.2).
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Table 4.1. Demographics of Tennessee dairy producers surveyed concerning antimicrobial
use practices, 2017
Variable
Gender
Female
Male
Preferred not to report gender
Age group (years)
20 – 29
30 – 39
40 – 49
50 – 59
60 – 69
Education level
High school
Vocational
College
Professional
Years in dairy cattle production
<5
6 – 10
16 – 20
21 – 25
26 – 30
> 30
Herd size
1 – 49
50 – 99
100 – 149
150 – 199
200 – 299
300 – 399
400 – 499
500+
Raised on a cattle farm
Yes
No

Number (%) of respondents
n = 39
7 (18.)
31 (79.5)
1 (2.6)
n = 37
2 (5.4)
6 (16.2)
8 (21.6)
13 (35.1)
8 (21.6)
n = 37
16 (43.2)
2 (5.4)
18 (48.7)
1 (2.7)
n = 38
1 (2.6)
6 (15.8)
1 (2.6)
4 (10.5)
4 (10.5)
22 (57.9)
n = 37
2 (5.4)
8 (21.6)
7 (18.9)
5 (13.5)
7 (18.9)
3 (8.1)
1 (2.7)
4 (10.8)
n = 39
2 (5.1)
37 (94.9)
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Table 4.2: Survey results showing the practices of Tennessee dairy producers related to
antimicrobial use, 2018
Number of participants
(percentage)

Practice

Farm keeps up-to-date written records of
antimicrobial drug purchases (n = 40)
Farm keeps written records of medicated feeds
purchased in the framework of VFD (n = 40)
Farm keeps up-to-date written records of
antimicrobial drugs used to treat animals (n = 40)
Cattle on the farm are sometimes treated with
antimicrobials at dosages higher than the label
provision (n = 40)
Farm practices extra-label AMU (n = 38)
Farm has written protocols for treating sick
animals with antimicrobials (n = 38)

Yes
23 (57.5)

Not sure
5 (12.5)

No
12 (30)

20 (50)

3 (7.5)

17 (42.5)

28 (70)

4 (10)

8 (20)

9 (22.5)

1 (2.5)

30 (75)

7 (18.4)
17 (44.7)

2 (5.3)
3 (7.9)

29 (76.3)
18 (47.4)

Objective 1: Drivers of AMU practices
For producers who responded to the survey questionnaire, the rating of the level of
importance of factors influencing Tennessee dairy producers’ choice of antimicrobials before
(Figure 4.1) and after (Figure 4.2) the VFD-final rule became effective on January 1, 2017,
were not significantly different. Noticeably, of the 42 producers who rated the level of
importance of factors influencing their antimicrobial choice before the VFD, clinical signs and
symptoms of disease were rated very important by 54.8% and extremely important by 16.7%.
Drug withdrawal times were rated as an extremely important influencer of producers’ choice of
antimicrobials by 26.2% of the 42 respondents (before the VFD became effective), and culture
and susceptibility tests were rated extremely important by 21.4% of respondents (Figure 4.1).
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Figure 4.1: Level of importance of factors influencing Tennessee dairy producers’ (n = 42) choice of antimicrobials before the
veterinary feed directive-final rule became effective on January 1, 2017.
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Figure 4.2: Level of importance of factors influencing Tennessee dairy producers’ (n = 36) choice of antimicrobials after the
Veterinary Feed Directive-final rule became effective on January 1, 2017.
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Clinical signs and symptoms of disease were rated extremely important influencer of
producers’ choice of antimicrobials by 25% of the 36 respondents (after the VFD became
effective), veterinarian’s prescription was rated extremely important by 33.3% of the 36
respondents, and culture and susceptibility tests were rated extremely important by 33.3% of
respondents (Figure 4.2). Figures 1 and 2 provide details of how questionnaire respondents rated
the level of importance of factors influencing producers’ choice of antimicrobials before and
after the VFD-final rule became effective on January 1, 2017.
The major themes identified as drivers of AMU in the focus groups were: a) disease and
animal welfare; b) pathogen surveillance; c) economic factors; d) veterinarian recommendation;
e) producer’s experience, and judgment; f) drug attributes; and g) the VFD. A detailed
presentation of these themes from the focus groups and other survey findings salient to this
objective are given below.
1a. Disease and animal welfare
The decision to use antimicrobials by dairy farmers was influenced by the presence of
early signs of disease, such as high rectal temperatures, droopy ears, and teary eyes. Mastitis was
commonly mentioned as the reason for using antimicrobials. Producers believed it was their duty
to ensure the welfare of their cattle through treatment with antimicrobials.
… if she’s running a temperature, we try to get drugs in her pretty quick. … [No. 8, focus
group 2].
… We treat all of our sick cows with antibiotics. We like to use some tetracycline in our
calves to combat lots of things … [No. 3, focus group 2].
Among survey respondents, mastitis (n = 21), respiratory infections/pneumonia (n = 4),
and lameness/hoof problems (n = 2) were mentioned as the most common diseases/conditions for
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which antimicrobials were used. Other diseases/conditions mentioned by survey respondents
included enteric problems/scours (n = 1) and infectious bovine keratoconjunctivitis (n = 1). The
most commonly used antimicrobial drugs mentioned by the survey participants belonged to
cephalosporins (n = 13), tetracyclines (n = 7), penicillins (n = 3), and amphenicols (n = 1)
antimicrobial classes. Ceftiofur (n = 10), cephapirin (n = 3), long acting oxytetracycline
preparations (n = 5), and florfenicol (n = 1) were the most commonly mentioned individual
antimicrobials used. These individual antimicrobials were often mentioned using their
proprietary names.
1b. Pathogen surveillance
A section of focus group respondents self-reported that they used culture and sensitivity
test results for on-farm pathogen surveillance. This use of culture and sensitivity testing
influenced AMU in some dairy farms and reportedly led to reduced AMU.
…We recently started plating mastitis cows. That’s been a big deal whether or not
because before we would just treat anybody who got mastitis. And now we actually not
100 percent know the bug. But we know what group it’s in. So that’s kind of cut down on
our antibiotic use as far as mastitis goes… [No.12, focus group 1].
…I’ve sent cultures[samples] off to university. Nine times out of ten, it’s a form of e-coli.
And he’ll [the veterinarian] give you the drugs to take care of it… Once that’s stopped to
kill that bacteria, these drugs [do] not work no more… [No.4, focus group 2]
On the other hand, eight producers (18.2%) who completed the questionnaire reported
they never used bacterial cultures to determine cause of disease in their farms, more than half of
the survey participants (26 (59.1%)) reported that they sometimes used bacterial cultures to
determine causes of disease in their farms, 10 (9.1%) reportedly used bacterial cultures for
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disease detection half of the time, and six (13.6%) used bacterial cultures for disease detection
most of the time. Regarding the use of bacterial culture and sensitivity testing (C/S) in selection
of antimicrobials, eight (18.6%) participants reported that they never used C/S, more than half
(25 (58.1%)) reported that they sometimes used C/S to select antimicrobials, four (9.3%) used
C/S about half of the time, five (11.6%) most of the time, and one (2.33%) always used C/S.
1c. Economic factors
In the focus groups, the economic value of the animal was commonly mentioned to be an
important driver of AMU. Animals perceived to be worth treating with antimicrobials were
treated, while those perceived not worth treatment were culled and replaced by healthy stock.
… We started looking at cattle a lot closer. If she’s actually worth the treatment? Or is
it better just to [inaudible] and ship them down the road? I have kind of stressed that
real hard amongst the employees. Before you treat, come to us; let’s see is she worth
it?... [No.5, focus group 1].
… Really, the history of the cow. If that cow is worth putting antibiotics in, calling the
vet or whatever – we’ve sent some to slaughter because of her history. She’s just not
[worth treating] – and her genetics, too – she’s carrying a good heifer cow or whatever,
we look at that also… [No.9, focus group 2].
Among survey questionnaire respondents, four (10%) strongly agreed with the statement
“profitability of your operation is an important factor influencing your decision to use antibiotics
on your cattle,” 20 (50%) agreed with this statement, 10 (25%) neither disagreed nor agreed, four
(10%) disagreed, and two producers (5%) strongly disagreed.
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1ci. Lactation stage and the dry period: The stage of lactation (early lactation or late
lactation) as well as the dry period influenced AMU practices of dairy producers.
…I mean, stage of lactation is probably first [determinant of antimicrobial use] ...
[No.10, focus group 1].
… [Animals are treated with antimicrobials] depending on dry cow or freshing cow or
just depending on what stage of lactation they’ve come through… [No.6, focus group 2].
Some focus group participants reported using blanket dry cow therapy (intramammary
antimicrobials are administered to all quarters of all cows in the farm at the end of lactation) at
their farms to minimize the economic losses associated with intramammary infections, while
others indicated that they do not use blanket dry cow therapy, but rather utilized selective dry
cow therapy (cows receive antimicrobial treatment at the end of lactation only based on
evaluation of the infection status of the cow or quarter. Only cows infected in one or more
quarters are treated with intramammary antimicrobials in all quarters at dry off). In focus group
2, cessation of blanket dry cow therapy was associated with an increase in somatic cell counts.
…One thing that hasn’t been mentioned is dry cow therapy, which is pretty much blanket
treatment at our farms. [No.12, focus group 1].
…I was told by someone else to not [do] blanket dry treatment because I’m seasonal. So,
I have to do [selective dry cow] treatment… [No.6, focus group 1].
…This is the first year that I didn’t do that [blanket dry cow therapy]. And I’ve had more
somatic cell count problems than I’ve ever had… [No.6, focus group 2].
1d. Veterinarian recommendation
For some producers with access to a veterinarian, veterinary recommendations influenced
their AMU. However, others mentioned that the veterinarians they consulted had limited
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knowledge of dairy cattle restrictions. Cost was an additional barrier to seeking veterinary
assistance.
…. We follow veterinarian recommendations as well.…. [No. 5, focus group 1].
… We have access to a group of veterinarians about an hour, 45 minutes away. They
deal mainly with beef cattle on the large animal side. They know very little about dairy
produce restrictions and that sort of thing. Like somebody said earlier, they ask me what
we should use? When you get the bill, it kind of hurts your feelings.... [No.13, focus
group 1].
1e. Producer’s experience and judgment
Most producers mentioned that they relied on their own experience, knowledge, and
judgment when deciding to use antimicrobials in their cattle. This helped them reduce costs, such
as veterinary fees, and helped them handle emergency cases in the event the veterinarian
delayed. Furthermore, because producers are used to working with cattle on a daily basis, some
dairy farmers believed they knew more about food animal issues compared to some veterinarians
not used to working with food animals.
… Our vet lives over an hour away. So, if you have something that’s an emergency, you
still have to wait for him. In my experience, what happened with us was I just learned to
do everything myself. So, they sort of worked their self out of a job. … [No. 12, focus
group 1].

1f. Drug attributes
Perceived efficacy of the antimicrobial medicines, cost of antimicrobials, and the
antimicrobial drug withdrawal times were mentioned as key factors influencing choice of
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antimicrobial drugs. Drugs perceived to be highly efficacious were preferred, while drugs with
short withdrawal times were also preferred. It was mentioned that because some antimicrobials
are very expensive, producers preferred highly efficacious products to avoid the additional costs
of repeat treatments associated with treatment failure.
… Most important is an antibiotic that we use actually take care of the problem with one
– not necessarily the same dose but one round of antibiotics. The problem’s gone, and it
doesn’t return. If you go one round of antibiotics and the cow is fine and she’s
straightened up, and then two weeks later, she’s got to get it again, that’s not a good
result from your antibiotics. We want one round to make sure it’s all done; that
problem’s over with… [No.6, focus group 1].
Among questionnaire respondents, fifteen (37.5%) agreed with the statement “Aggressive
marketing of antibiotics by pharmaceutical companies greatly influences producers' use of
antibiotics,” 19 (47.5%) neither disagreed nor agreed with this statement, five (12.5%) disagreed,
and one (2.5%) strongly disagreed with this statement. However, in the focus group discussions,
marketing pressure from veterinary pharmaceutical company representatives was not identified
as a driver of AMU.
1g. The VFD
The VFD was believed to be driving the increase in the therapeutic use of antimicrobials,
especially in calves, because it has restricted access to in-feed antimicrobials for disease
prevention. Producers gave an example of Aureo S 700®, an in-feed antimicrobial preparation
that was previously easily accessible to producers and now is restricted to use by or on the order
of a licensed veterinarian. This restricted access to in-feed antimicrobials by federal law was
reported to be leading to increased use of injectable antimicrobials by producers.
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…We used it [aureomycin S 700] during winter stress times when it would get really
cold. We would use it as a preventative thing. So, now [with the VFD] we doctor with
something else once they get sick rather than preventing it. Using that prevents having to
use something stronger. If you put something there and prevent pneumonia, that’s better
than having it come back with whatever, you know, LA-200 or whatever else you’re going
to use… [No. 13, focus group 1].
For the questionnaire respondents, seven (17.5%) strongly agreed with the statement “The VFD
would lead to increased use of injectable antibiotics by producers,” 11 (27.5%) agreed with this
statement, 18 (45%) neither disagreed nor agreed, and four producers (10%) disagreed.

Objective 2: Alternatives to antimicrobials
Most of the dairy producers’ alternatives to antimicrobials were geared towards mastitis
prevention and control. The focus group participants considered: a) good management practices;
b) use of vaccines, and immunostimulants; and c) early disease detection as their alternatives to
antimicrobials. The excerpts that support these perceived alternatives are provided below.
2a. Good management practices
The husbandry practices considered alternatives to AMU included proper animal
nutrition, proper housing, and infection control measures. Specifically, good milking parlor
management, clean cow facilities, and good udder health management were reported to be
alternatives to AMU. Examples of good udder health management practices mentioned include
the use of teat dips, teat sprays, and teat sealants.
…I agree with managing your facilities properly. All your milking equipment and
housing and whatever plays a big part in it… [No.13, focus group 1].
…we use teat sealant[s]… [No.9, focus group 2].
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2b. Vaccines and use of immunomodulatory products
Vaccinations and use of immunomodulatory products, such as pegbovigrastim
(Imrestor®), were frequently mentioned as an alternative to antimicrobials. It was mentioned that
immunomodulatory products are used in fresh cows to minimize AMU.
… Well, I started using it [Imrestor®] temporarily just because it’s supposed to help
these cows, you know, fresh cows and keep the drug use down.… [No.11, focus group 1].
2c. Use of appropriate technology for early disease detection
Early disease detection using appropriate technology, such as rumination monitors, was
considered important in minimizing and reducing AMU.
… we have a monitoring system that monitors rumination as well as activity. So, when
her rumination goes down, you know something’s wrong. And maybe you can prevent it
or treat it before it gets bad… [No.12, focus group 1].
Additional training for dairy producers on infection prevention and control was supported by
many survey respondents. Two participants (5.1%) strongly agreed that infection prevention and
control measures (farm-level biosecurity and vaccination) would reduce AMU in dairy
operations, 17 respondents (43.6%) agreed, 17 (43.6%) neither disagreed nor agreed, and three
(7.7%) strongly disagreed.

Objective 3: Knowledge of AMR, and perceptions regarding AMR
Many focus group participants as well as survey participants were familiar with AMR.
The salient findings for our third objective are presented below in detail under the themes: a)
knowledge of AMR; b) perceptions regarding AMR emergence; and c) proposed solutions to
AMR.
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3a. Knowledge of AMR
Some focus group participants demonstrated their knowledge of AMR and believed there
was “some amount” of AMR occurring in food animal pathogens. Also, the repeated treatment
of animals with antimicrobials was mentioned in the discussions.
…As far as antibiotic resistance, there is some out there. I don’t think it’s gone
completely from food animals… [No.5, focus group 1].
…There’d be 25-30 percent chance of a repeat [treatment of animals with
antimicrobials] … [No.6, focus group 1].
The extent to which survey questionnaire respondents were familiar with AMR varied among the
43 respondents to this question. One producer (2.3%) reported to be extremely familiar with
AMR, 12 (27.9%) very familiar, 21 (48.8%) moderately familiar, six (14%) slightly familiar, and
three (7%) were not familiar at all. In rating their degree of concern about AMR, four (9.1%)
reported they were very concerned about AMR, 27 (61.4%) moderately concerned, 10 (22.7%)
reported that they were not concerned about AMR, and three producers (6.8%) did not rate their
degree of concern about AMR because they were unfamiliar with the meaning of AMR.
One dairy producer (2.5%) strongly agreed with the statement “Some antibiotics you use on your
cattle have become ineffective (there is resistance to antibiotics used in cattle),” 17 (42.5%)
agreed with this statement, 16 (40%) neither disagreed nor agreed, five (12.5%) disagreed, and
one (2.5%) strongly disagreed. For the statement “Antibiotic drugs work less effectively than in
the past,” one (2.5%) strongly agreed, 10 (25%) agreed, 20 (50%) neither disagreed nor agreed, 7
(17.5%) disagreed, and two (5%) strongly disagreed. Producer’s gender (male vs female; P =
0.699), herd size (P = 0.447), education level (P = 0.524, age (P = 0.508), and number of years in
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cattle farming (P = 0.535), were not significantly associated with producer’s degree of concern
about AMR. Based on these findings, no meaningful multivariable analyses could be performed.
3b. Perceptions regarding AMR emergence
Participants attributed the emergence and occurrence of AMR to the over-use and
prolonged use of the same antimicrobials without rotating and the lack of new antimicrobials.
The problem of AMR in human pathogens was attributed to antimicrobial over-use in humans
and not in livestock.
… [Antimicrobial resistance bites you] eventually if you overuse and use the same thing
[antimicrobial] too long. It’s the same as pesticides. They only work for so long.
Hopefully you can get enough variety to where you can switch from one to another and
maintain both… [No.11, focus group 2].
…As humans, we do a lot of stuff that probably amplifies that. Everybody’s antibacterial
nowadays. You can’t sneeze without being doused in it almost… [No.5, focus group 1].
Some participants believed that the human health risks associated with AMU in food animals are
not evidence-based and generally perceived their AMU practices to be prudent.
…We realize that there’s some amount of resistance to antibiotics. But a lot of the
population that has these fears of resistance that aren’t science based. And they’re the
ones that tend to drive regulation with non-science-based opinions on antibiotic
resistance. If something is science based and real, hey, I’m all for doing it. Because some
people in town think that antibiotics in cows cause them to have resistance and there’s no
science behind it, I think that’s a real problem… [No. 6, focus group 1].
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The producers believed the public was misinformed about how and why antimicrobials are used
in food animals, and the producers associated the misinformation with a lack of consumer
education and milk marketing with buzzwords such as “antibiotic free.”
…I think part of the problem with the public is our milk marketing. This jug of milk says
antibiotic and hormone free and this one does not. So, they assume that that one has
antibiotics in it, which falls into antibiotics in milk and all this antibiotic resistance and
stuff like that when no milk has antibiotics in it. But they just don’t know that. They’re
just not educated… [No. 12, focus group 1].

3c. Proposed solutions to AMR
The participants suggested: i) improving antimicrobial drug labels; ii) additional producer
training on prudent AMU; and iii) development of diagnostic tools for rapid on-farm detection of
AMR and on-farm antimicrobial sensitivity testing as measures for improving AMU and
containing AMR. A brief description of the suggested measures is given below.
3c. i Improving antimicrobial drug labels
It was suggested that the dosage rates indicated on antimicrobial drug labels need to be
changed to reflect the appropriate dosage rates because current antimicrobial drug labels may not
reflect the appropriate drug dosage rates.
… The [antimicrobial] labels need to be labeled for appropriate doses instead of what
appropriate doses were 40 years ago. All that information needs to be there on the label,
so we know what the appropriate dose is, what the appropriate withdrawal is and what
the appropriate bug or disease it’s going to take care of in a very concise, easy to read,
easy to understand label. That would be a most important change… [No.6, focus group
1].
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Also, producers perceived the current antimicrobial labels and information on the antimicrobial
package inserts to be very technical and difficult to comprehend and suggested that antimicrobial
drug labels and package inserts should be written in non-technical language to make such
information easier for producers to understand. To cater to non-English speaking farm
employees (Hispanic/Latino farm workers), it was suggested that antimicrobial drug labels be
written in both English and Spanish.
Among survey questionnaire respondents, 13 (33.3%) found antimicrobial labels difficult
to understand and interpret, whereas 26 (66.7%) found these labels easy to understand and
interpret. Education level was not significantly associated with producer’s perception of
difficulty to comprehend antimicrobial label instructions (OR = 2.24; 95% CI = 0.563, 8.91; P =
0.253). Of the 39 survey participants who responded to the question on the preferred language
for antimicrobial label instructions, only three (8%) preferred these labels to be in both English
and Spanish, whereas 36 (92%) preferred antimicrobial drug labels to be in English.
3c. ii Additional training on prudent AMU
Participants suggested that more training for dairy producers on prudent AMU was
needed for improving AMU in cattle production. However, continuing professional education for
medical practitioners on prudent AMU was suggested in order to reduce non-judicious AMU in
humans.
…I’d like to know more information about it [antimicrobial use]. I’d like to be able to
treat the animal one time and get it taken care of. It requires some advanced training.
And it’s hard to get that sometimes.… [No. 5, focus group 2].
…I have a statement about the human side of it. They need to educate doctors that
prescribe all of these liquid antibiotics to children for earaches and everything else when
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they’re not earaches and different things. And I think that’s what causes resistance in
humans… [unidentified participant, focus group 2].
Additional training for dairy producers on prudent AMU practices was supported by many
survey respondents. Four producers (10%) strongly agreed that producers required additional
training on prudent AMU, 10 (25%) agreed, 15 (37.5%) neither disagreed nor agreed, nine
(22.5%) disagreed, and two (5%) strongly disagreed.

3c.iii Development of diagnostic tools for rapid on-farm detection of AMR and on-farm
antimicrobial sensitivity testing.
It was suggested in the focus groups that producers should be able to test cows on-farm
for AMR and antimicrobial susceptibility. Such on-farm diagnostics would properly orient
antimicrobial therapy and guide the implementation of appropriate on-farm isolation measures.
… [We should be] able to test the cows on the farm – your own antibiotic and your own
somatic cell. We had a product that we were getting from RapiDEC for somatic cells. For
some reason they took it off the market… Products like that can help us on the farm…
[No. 1, focus group 1].

Objective 4: Avenues for receiving information on AMU
In the focus groups, participants identified the following as viable avenues for receiving
information on prudent AMU: the veterinarian, email, dairy publications, and producer meetings.
The producers considered the veterinarian (for areas with food animal vets) to be a trusted source
of information on prudent AMU.
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…Our vet has a meeting once a year where he will bring in sponsors that will be reps of
his companies mail list. It’s generally whenever we have a question, we call and ask.
He’s our source of information… [No. 3, focus group 2].
Regarding avenues/formats for receiving information on prudent AMU, no single
medium was most preferred by survey questionnaire respondents. The most commonly
mentioned avenues for receiving information on prudent AMU included brochures (n = 8),
educational seminars (n = 6), and a producers’ handbook on prudent AMU (n = 4). These
formats for receiving information were chosen individually or in combination with others, such
as AMU flowcharts for the barn, videos on prudent AMU, and laminated posters.

Discussion
The Jaccard’s similarity index and the survey participant demographics showed that there
was diversity of opinions among participants in the present study. Our study utilizes the strength
of a mixed methods research design (a combination of qualitative and quantitative methods) to
extend the knowledge of AMU in dairy production by highlighting the diversity and complexity
of factors driving AMU among dairy producers in TN. Additionally, we identified the dairy
producers’ alternatives to antimicrobials, their perceptions regarding AMR, and the appropriate
avenues and formats for disseminating information on prudent AMU to these producers.
Gussmann et al, suggested that campaign efforts that target improvements in AMU among
farmers need to take into account farmers’ usual AMU practices in order to motivate farmers to
adopt control measures that facilitate prudent AMU [4]. Therefore, our findings should aid in
optimizing the efforts under which targeted campaigns for nationwide AMS are applied in US
dairy production.
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A previous survey by the U.S Department of Agriculture (USDA) found that producers
on almost all the sampled dairy operations (99.7%) reported having at least one case of mastitis
during 2013 and antimicrobials were administered to mastitic cows on 96.9% of dairy operations
[15]. In the present study, mastitis was the most commonly mentioned disease for which
antimicrobials were used. This is not surprising because mastitis is known to be the most
frequent disease of dairy cows [16]. To minimize AMU, TN dairy producers should be
encouraged to strengthen their herd health measures for mastitis prevention and control.
Use of written protocols for treating sick animals with antimicrobials could reduce
treatment errors, since most of antimicrobial treatments in farms are often administered by nontechnical farm personnel (the farmer or farm employees) [17, 18]. In the present study, many
questionnaire respondents mentioned that their farms did not have written protocols for treating
sick animals with antimicrobials. This finding suggests a need for TN veterinarians and dairy
extension agents to emphasize and encourage the development and use of written AMU
protocols.
In the present study, a section of the focus group participants self-reported their use of
C/S test results for on-farm pathogen surveillance. Similarly, many producers who completed the
questionnaire self-reported their use of C/S to determine the causes of disease in their farms and
to select antimicrobials for farm use. In addition, more than half of the survey questionnaire
respondents rated C/S as either a very important or extremely important factor influencing their
choice of antimicrobials, before or after the VFD-final rule became effective on January 1, 2017.
These findings generally suggest that, although not universally practiced, use of C/S test results
for on-farm pathogen surveillance and for antimicrobial selection is a widespread and common
practice among TN dairy farmers. Producers not utilizing C/S could be constrained by either cost
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or lack of awareness about the benefits of C/S. These findings are also in contrast to those of a
previous New Zealand study, where C/S testing is perceived to be not useful because it did not
influence what antimicrobial the veterinarian prescribed and, hence, is not widely used by dairy
producers [10]. Possibly, use C/S test results is widespread and common among TN dairy
producers because its economic value is appreciated by many producers.
Our findings show that profitability of the dairy operation (economic gain) was a key
factor influencing the decisions of many producers to use antibiotics. In their dairies, cows
perceived to be economically less valuable were culled, rather than treated. Additionally, the
focus groups identified the lactation stage as a factor driving AMU by dairy producers. This
association between lactation stage and AMU could be due to high milk yield at peak lactation
and changes in immune function at early lactation. The pregnancy status of the cow (in-calf or
open) during the lactation period may also be a factor that producers consider when deciding to
use antimicrobials. It is possible that these producers treat high milk yielding cows with
antimicrobials in case of udder health problems to maintain high economic performance. A
Danish study found that high milk yield was associated with a higher probability of both
lactational and dry-off antimicrobial treatment of dairy cows [4]. High milk production is a
known risk factor for occurrence and recurrence of clinical mastitis, whose occurrence drives
AMU [4, 19, 20]. Changes in immune function and non-specific host defense mechanisms is
reported to be associated with high incidence of clinical mastitis in early lactation [19]. To
minimize the economic losses associated with intramammary infections, a section of focus group
participants mentioned using dry cow therapy as a blanket antimicrobial treatment at their farms
to control the risk of new intramammary infections during the dry period. This practice of
blanket dry cow therapy is concerning and suggests a need for veterinarians and dairy extension
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agents to encourage TN dairy producers to avoid blanket dry cow therapy and adopt selective dry
cow therapy to minimize unnecessary AMU. Although still a common practice in the US,
blanket dry cow therapy is now illegal in several European countries to avoid selection for AMR
[4, 21, 22]. Similarly, previous studies have shown that blanket dry cow therapy may not be an
optimal approach to dry cow therapy when compared to selective dry cow therapy, and dry cow
therapy does not compromise animal welfare and productivity and is economically more
beneficial compared to blanket dry cow therapy [22-25]. A policy shift towards banning blanket
dry cow therapy in TN and the entire US may be worth exploring.
Our findings showed that veterinarian recommendations and peer recommendations
generally influence AMU practices of dairy producers. Additionally, we identified the
veterinarian, producer meetings, and educational seminars (along with other avenues) to be
viable ways for reaching out to producers. Similar to other research [12], our findings suggest
that veterinarians and peers could act as agents of change towards prudent AMU among dairy
producers. Policy interventions towards prudent AMU should channel AMU-related behavioral
change messages to dairy producers through veterinarians (where possible) and other producers
(peers) using the identified avenues/formats. Furthermore, targeted behavioral change messages
towards prudent AMU practices should be integrated into routine veterinary farm visits and
master dairy training programs. Behavioral techniques, such as motivational interviewing
informed by assessing producers’ readiness for change, could be used [26]. Producer
meetings/associations and educational seminars for producers should be used to identify AMU
training needs and raise more awareness about AMR and prudent AMU among dairy producers.
The VFD was mentioned to have limited access to preventive in-feed antimicrobials (e.g.
Aureo S 700®), and as a result, is believed to be driving increased use of injectable antimicrobial
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agents. Aureo S 700® contains 3 antimicrobials (aureomycin, chlortetracycline, and
sulfamethazine) and is indicated for the use of weight gain maintenance and the management of
stressful conditions in calves. We did not ascertain, in the present study, if the increased use of
injectable antimicrobial agents was for prophylactic and/or therapeutic purposes. We suggest a
nation-wide investigation of the impact of the VFD on the use of injectable antimicrobials among
US dairy producers be conducted.
A previous study conducted in the United States showed that AMU among plain
(members of Amish or Mennonite religious communities) dairy farmers is minimal due to the
more frequent use of natural remedies for mastitis treatment [27]. In contrast to the plain dairy
farmers who frequently use natural therapies, our focus group participants considered good
management practices, use of vaccines, and immunostimulants, and early disease detection as
their alternatives to antimicrobials. There was no mention of alternative forms of treatment, such
as phytotherapy, aromatherapy, homeopathy, and use of essential oils and other forms of natural
therapy. Also, this finding is in contrast to findings from a 2015 study conducted in France,
where some farmers use alternative treatments, such as aromatherapy, phytotherapy, and
homeopathy, for the management of mastitis [28]. First, the differences observed could be
reflective of cultural differences between TN dairy farmers and plain/French dairy farmers.
Second, it is possible that the natural therapies used elsewhere for mastitis are not popular among
TN dairy producers because of the current lack of scientific evidence for their efficacy.
Although 12 survey participants reported to be very familiar with AMR, a considerably
large number (21) were moderately familiar, while others were either slightly familiar or not
familiar at all. Similarly, it is concerning that 10 (22.73%) reported they were not concerned
about AMR, and 3 producers (6.82%) did not rate their degree of concern about AMR because

154

they were not familiar with what AMR meant. These findings suggest a need for more
sensitization of producers on AMR and AMU.
Researchers in Australia suggested that veterinary antimicrobial drug labels need regular
updating to reflect the appropriate dosage rates for treatment of common veterinary pathogens
[29]. To improve AMU, our focus group participants suggested that antimicrobial dosage rates
indicated on certain antimicrobial drug labels need to be changed to reflect the appropriate
dosage rates. A targeted study evaluating the appropriateness of dosage rates indicated on drug
labels for currently used veterinary antimicrobials in the US is necessary to validate or dispute
this finding. A previous study conducted in South Carolina reported that the dairy industry often
relies on Hispanic labor, and the language barrier was a challenge when dealing with nonEnglish speaking farm employees [12]. In the present study, a section of focus group participants
suggested that antimicrobial drug labels should be in both English and Spanish to cater for nonEnglish speaking farm employees (Hispanic/Latino farm workers), and only three (7.69% [3/39])
producers who responded to the questionnaire preferred antimicrobial drug labels to be in both
English and Spanish. Possibly, these three questionnaire respondents who preferred antimicrobial
drug labels to be in both English and Spanish utilize Hispanic labor in their dairy farms.
Additionally, a section of focus group participants and many dairy producers (33.33%, (13/39))
who completed the questionnaire perceived the current antimicrobial labels and information on
the antimicrobial package inserts to be very technical and difficult to comprehend. Our findings
showed that producers’ education levels were not significantly associated with producers’
perceptions of difficulty to comprehend antimicrobial label instructions, perhaps due to the few
survey respondents. There is need to conduct a country-wide investigation of this perception that
current antimicrobial labels and information on the antimicrobial package inserts are very
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technical and difficult for producers to comprehend. Friedman et al, based on their South
Carolina study, recommend that all farm health resources and interventions should be bilingual
(in English and Spanish) and in an easy-to-understand language to cater to the growing
population of Hispanic/Latino farm employees [12]. As suggested by the producers during the
focus group discussions, we contend that there is a need for US veterinary pharmaceutical
companies to consider labeling antimicrobial drugs in both English and Spanish and in nontechnical language for easier comprehension.
Social desirability bias can be an issue in both focus groups and survey studies. Our focus
groups and survey participants could have given socially desirable responses, thus introducing
bias to our findings. However, socially desirable responses, if any, could be very minimal, since
both focus groups and survey respondents were assured that the data collected was anonymized
and participation was voluntary. Additionally, the survey questionnaire (both paper and online)
was self-administered. Thus, participants are likely to have given their true opinions, perceptions,
and practices. It is common for studies utilizing focus groups to be biased by the presence of
dominant participants. However, in the present study, such bias could be very minimal, if any,
because our focus groups were moderated by one of the authors (EBS) with a background in the
behavioral/social sciences and wide experience in moderating such meetings.

Conclusions
Use of culture and sensitivity test results for on-farm pathogen surveillance and for
antimicrobial selection is a widespread and common practice among TN dairy farmers. There is
need for more awareness about C/S to encourage producers not utilizing it to adopt its use.
Blanket dry cow therapy is still commonly practiced by some dairy producers in TN. There is
need to popularize/promote selective dry cow therapy and its associated benefits among dairy
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producers in the state. Tennessee dairy producers currently practicing blanket dry cow therapy
should be encouraged to adopt selective dry cow therapy and abandon the practice of blanket dry
cow therapy. An investigation of the impact of the VFD on the use of injectable antimicrobials
among US dairy producers should be conducted. Continuing training on prudent AMU is needed
for TN dairy producers.
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CHAPTER 5
A survey of antimicrobial use practices of Tennessee beef producers,
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Abstract
Inappropriate antimicrobial use (AMU) is a key modifiable factor that leads to the
development of antimicrobial resistance (AMR). The objectives of this study were to determine
the following among Tennessee beef cattle producers: (1) the opinions on factors driving AMU
(2) opinions on alternatives to antimicrobials, (3) the knowledge and perceptions regarding AMU
and AMR, and (4) the preferred avenues for receiving information on prudent AMU. A survey
questionnaire was made available to participants both in print and online from January 26, 2018
through May 11, 2018. The survey questions targeted the producers’ demographics and their
AMU practices; factors driving producer’s choice of antimicrobials; perceptions, opinions and
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concerns about AMU and AMR in cattle production. Ordinal logistic regression was used to test
for associations between the captured demographic information and producers’ degree of
concern about AMR. Overall, 231 beef producers responded to the survey. More than 60% of the
participants mentioned that they kept up-to-date written records on antimicrobial purchases and
AMU, whereas 87% did not practice extra-label AMU. Clinical signs were rated as an extremely
important influencer of producers’ use of antimicrobials by 97 of the 212 respondents and 104 of
the 205 respondents before and after the Veterinary Feed Directive became effective,
respectively. Controlling for type of cattle operation, age was significantly associated with the
producer’s degree of concern about AMR (P = 0.022). The commonly mentioned avenues for
receiving information on prudent AMU included: brochures, educational seminars, and
producers’ handbook on prudent AMU. There is a need to promote the use of written
antimicrobial treatment protocols among beef producers in Tennessee. Continued training for
beef producers on infection prevention and control and prudent AMU is needed.

Introduction
Antimicrobial drugs have been described as a common pool resource with the potential to
be depleted over time due to the emergence of antimicrobial resistance (AMR) [1]. In beef
production, antimicrobials are important to maintain or improve animal health and increase
productivity [2]. Although the development of AMR is a complex multifactorial process [3],
inappropriate antimicrobial use (AMU) is a key modifiable factor leading to its development, [4]
and as such, AMR is now referred to as a tragedy of the commons [1, 5, 6]. Globally, the use of
vaccines as well as other infection prevention and control approaches are viewed as promising
alternatives to antimicrobials [7-9]. To facilitate prudent AMU in animal production, an
emphasis on the agricultural education of cattle producers on prudent AMU practices is critical
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[10]. Furthermore, the whole-of-society approach to antimicrobial effectiveness [6] and One
Health approaches to optimization of AMU [11] have been suggested as measures for prolonging
the therapeutic life of available antimicrobial drugs.
To facilitate judicious AMU, a collective action towards promoting the prudent use of
antimicrobials is being advocated on a global scale [12]. In the United States, the Food and Drug
Administration (FDA) has taken steps to implement its policy on the judicious use of medically
important antimicrobial drugs in animals through the Veterinary Feed Directive (VFD), which
became effective on January 1, 2017 [13]. Researchers [14] have suggested that utilizing
approaches appealing to farmers’ internal motivators would increase the success of policy
interventions, such as the VFD, that aim to improve AMU. Therefore, understanding current
AMU practices of producers and factors that inform and influence those practices is critical for
the success of interventions to improve AMU in beef production.
In Ontario, Canada, a 1999-2002 study found that oxytetracycline, penicillin, macrolides,
florfenicol, and spectinomycin were the most commonly used antimicrobials by beef producers
[15]. A previous study conducted in 60 cow-calf operations in Tennessee (TN) found that
chlortetracycline was the most commonly used antimicrobial in the late 1980s for disease
prevention [16]. Additionally, a previous 2007-2008 survey evaluating the producers’ attitudes
and practices related to AMU in TN cattle found that approximately 34% of the surveyed
population reported using bacterial culture to determine the cause of disease, and 21.5% used
culture and susceptibility test results to guide their choice of antimicrobials [17]. However, that
2007-2008 survey did not utilize focus group findings in the development of the questionnaire.
Data on AMU in beef cattle in the United States is generally scarce. A 2014 systematic review
[18] examined the relationship between AMU in food animals and the emergence and spread of
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foodborne AMR-Campylobacter and expressed the need for a robust data collection system in
the United States that would help identify factors contributing to the persistence of AMR.
This present study is built on the preliminary findings of a previous qualitative study with
the aim of exploring how much the results of the qualitative study holds true for the larger
population of beef producers in the state. Therefore, our general aim was to assess the changes in
AMU practices and drivers of AMU in TN beef cattle production. This present study, therefore,
contributes to the wider knowledge of AMU by providing insights into the current practices,
perceptions, and opinions of TN beef producers regarding AMU and AMR. Specifically, the
objectives were to determine the following among Tennessee beef cattle producers: (1) the
opinions on factors driving AMU among beef producers, (2) opinions on alternatives to
antimicrobials, (3) the knowledge and perceptions regarding AMU and AMR, and (4) the
preferred avenues for receiving information on prudent AMU.

Materials and Methods
Study design and administration of survey
A questionnaire consisting of a section for beef producers and a section for dairy
producers was developed and evaluated by two professionals with expertise in AMU to ensure
all critical issues were identified and covered (see appendix 3 for the survey questionnaire).
Participants whose primary cattle production was beef, were required to complete the beef
producer section of the questionnaire. The data obtained from five beef focus groups previously
conducted by the authors was used to develop the questionnaire. The University of Tennessee
Knoxville, Institutional Review Board for the Protection of Human Subjects in Research
approved the study (Protocol number: UTK IRB-17- 03884-XP). The 56 survey questions
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targeted the producers’ demographics and their AMU practices, factors driving producer’s choice
of antimicrobials, and perceptions, opinions, and concerns about AMU and AMR in cattle
production.
The targeted producer demographic information included age, sex (male versus female), level of
education, herd size, whether the producer raised on a livestock farm, and number of years in
cattle farming. These demographic data were our explanatory variables of interest. Our main
outcome of interest was the producers’ degree of concern about antimicrobial resistant infections
in cattle. Also, the association between levels of education and producers’ perception of
antimicrobial label instructions was of interest. Three-point scales and ordinal Likert scales were
used to capture participant responses to questions related to AMU practices, factors driving
choice of antimicrobials, and perceptions, opinions and concerns about AMU and AMR in beef
cattle production.
With an assumed TN beef producer population size of 20,000 and a 50% response
distribution, 377 participants were determined to be the appropriate sample size for this study at
95% confidence level and a margin of error of 5%. The survey questionnaire was made available
to participants both in print and online. Producers who completed the print questionnaire were
requested not to complete the online survey and vice versa in the informed consent statement.
Qualtrics software (Provo, UT) housed the on-line version of the survey, which was adapted for
computer, tablet, and cell phone responses. Participant responses were de-identified using the
anonymize function in Qualtrics such that no personal information was collected. During the
Tennessee Cattle Men’s Association (TCA) annual meeting in January 2018, beef producers
were notified about the online survey option to increase the response rate. Subsequently, all
2,712 producers on the TCA mailing list received an email invitation to take the survey.
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Additionally, an anonymous survey link and QR code for the online survey were provided to the
TCA vice president for distribution to producers willing to take the survey. To further increase
the response rate, follow-up email reminders were sent to non-respondents of the on-line survey
every two weeks.
The printed questionnaire was distributed to producers attending the TCA annual meeting
and producer extension meetings across the state. Completed printed questionnaires were
returned to the investigators or mailed to the last author. Both the printed and online survey
remained open from January 26, 2018, through May 11, 2018. Participation in the survey was
voluntary. All participants were invited to participate in a $10 gift card raffle taken at the end of
the survey and the winners were randomly selected. Eligibility to participate in the raffle was not
contingent upon survey completion.

Statistical analysis
A commercial statistical software (SAS, version 9.4, SAS Institute Inc, Cary, NC) was
used to perform descriptive and inferential analyses. Descriptive statistics (frequencies and
proportions) were used to summarize the data. Another commercial software (Tableau software,
version 8.2, Seattle, WA) was used to create stacked bar charts for responses on the Likert scales.
Missing data was treated as such.
Univariable and multivariable analyses were performed using ordinal logistic regression
to test for associations between the captured demographic information and the producers’ degree
of concern about AMR. For the univariable analyses, herd size was reclassified into three
categories 0 – 49, 50 – 99, and > 100 beef cattle, and age was reclassified into <30, 30-39, 40-49,
50-59, 60-69, and ≥70 using the quantile classification method. In assessing the producers’
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degree of concern about AMR, a multivariable ordinal logistic regression model was manually
fitted using backwards elimination method and the probability of being less concerned was
modeled. In the model building, the Score Test for the Proportional Odds Assumption was used
to evaluate the proportional-odds assumption and the model fit was assessed using the standard
Pearson Goodness-of-Fit Statistic. Briefly, potential predictors at a P ≤ 0.20 from the univariable
analyses were included in the multivariable model building. Possible effects of confounding
were evaluated by comparing a change in parameter estimates with and without the suspected
variables [19, 20]. A predictor variable that caused a ≥ 20% change in another parameter
estimate upon removal from the model was considered a confounder and was retained in the final
model regardless of its statistical significance [21]. In the final model, two-way interactions (type
of cattle operation and age) were assessed based on plausibility and standard multiple pairwise
comparisons were obtained.

Results
Participant characteristics and self-reported AMU practices
A total of 231 beef producers participated in the survey:103 completed the print survey
while 128 completed the online version. Of the 231 participants, 200 provided their gender: 35
females and 163 males. Two of these respondents preferred not to report their gender. Complete
responses were provided for most questions, with the exception of a few cases where the
respondents left some questions unanswered. The demographic information of the respondents is
presented in Table 5.1. More than 60% of the participants mentioned that they kept up-to-date
written records on antimicrobial purchases and AMU, whereas 87% did not practice extra-label
AMU (Table 5.2).
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Table 5.1: Demographics of beef producers on survey to identify antimicrobial use
practices, 2018
Variable
Gender
Female
Male
Preferred not to report gender
Age group (years)
< 30
30 – 39
40 – 49
50 – 59
60 – 69
>70
Education level
< College
≥ College
Years in cattle production
<5
6 – 10
11 – 15
16 – 20
21 – 25
26 – 30
>30
Beef cattle operation type
Cow-calf production
Backgrounding-stocking
Seed-stock operation
Multiple operation type and others
Herd size
1 – 49
50 - 99
100 – 149
150 - 199
200 - 299
300 - 399
400 - 499
500+
Raised on a cattle farm
Yes
No

Number (%) of respondents
n = 200
35 (17.5)
163 (81.5)
2 (1.0)
N = 200
12 (6.0)
29 (14.5)
41 (20.5)
44 (22.0)
46 (23.0)
28 (14.0)
N=202
47 (23.3)
155 (76.7)
N = 202
23 (11.4)
19 (9.4)
17 (8.4)
24 (11.9)
24 (11.9)
21 (10.4)
74 (36.6)
N = 230
171 (74.4)
9 (3.9)
6 (2.6)
44 (19.1)
n = 202
84 (41.6)
54 (26.7)
28 (13.9)
12 (5.9)
13 (6.4)
5 (2.5)
1 (0.5)
5 (2.5)
n = 202
138 (68.3)
64 (31.7)
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Table 5.2: Practices of Tennessee dairy producers related to antimicrobial use, 2018

Practice
Farm kept up-to-date written records of antimicrobial drug
purchases (n = 208)

Farm kept written records of medicated feeds purchased in
the framework of VFD (n = 201)

Farm kept up-to-date written records of antimicrobial drugs
used to treat animals (n = 209)

Cattle in the farm were sometimes treated with antimicrobials
at dosages higher than the label provision (n = 204)

Farm practiced extra-label AMU (n = 201)

Farm had written protocols for treating sick animals with
antimicrobials (n = 199)

Backgrounding-stocking (n = 9)
Cow-calf production (n = 154)
Multiple operation type, others
(n = 39)
Seed stock operation (n = 6)
Backgrounding-stocking (n = 9)
Cow-calf production (n = 148)
Multiple operation type, others
(n = 38)
Seed stock operation (n = 6)
Backgrounding-stocking (n = 9)
Cow-calf production (n = 155)
Multiple operation type, others
(n = 39)
Seed stock operation (n = 6)
Backgrounding-stocking (n = 8)
Cow-calf production (n = 151)
Multiple operation type, others
(n = 39)
Seed stock operation
Backgrounding-stocking (n = 8)
Cow-calf production (n = 149)
Multiple operation type, others
(n = 38)
Seed stock operation (n = 6)
Backgrounding-stocking (n = 8)
Cow-calf production (n = 147)
Multiple operation type, others
(n = 38)
Seed stock operation (n = 6)
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Number of participants (frequency
percentage)
Yes
Not sure
No
9 (4.3)
0 (0)
0 (0)
90 (43.3)
17 (8.2)
47 (22.6)
26 (12.5)
4 (1.9)
9 (4.3)
6 (2.9)
9 (4.5)
69 (34.3)
25 (12.4)

0 (0)
0 (0)
21 (10.5)
2 (1)

0 (0)
0 (0)
58 (28.9)
11 (5.5)

6 (3.0)
9 (4.3)
102 (48.8)
28 (13.4)

0 (0)
0 (0)
11 (5.3)
3 (1.4)

0 (0)
0 (0)
42 (20.1)
8 (3.8)

6 (2.9)
0 (0)
9 (4.4)
6 (2.9)

0 (0)
0 (0)
9 (4.4)
1 (0.5)

0 (0)
8 (3.9)
133 (65.2)
32 (15.7)

0 (0)
0 (0)
12 (6.0)
7 (3.5)

0 (0)
0 (0)
12 (6.0)
1 (0.5)

6 (2.9)
8 (4.0)
125 (62.2)
30 (14.9)

0 (0)
2 (1.0)
22 (11.1)
9 (4.5)

0 (0)
0 (0)
6 (3.0)
4 (2.0)

6 (3.0)
6 (3.0)
119 (59.8)
25 (12.6)

3 (1.5)

0 (0)

3 (1.5)

Objective 1: Opinions on factors driving antimicrobial use
Profitability of the beef operation (economic gain) was a key factor influencing the
decisions of many producers to use antimicrobials in their farms. Forty-six (22.6%) participants
strongly agreed with the statement “profitability of your operation is an important factor
influencing your decision to use antibiotics on your cattle.” Ninety-five (46.6 %) agreed, 36
(17.6%) neither disagreed nor agreed with this statement, 20 (9.8%) disagreed, and seven
producers (3.4%) strongly disagreed. Seventeen respondents (8.3%) strongly agreed with the
statement “aggressive marketing of antibiotics by pharmaceutical companies greatly influences
producers' use of antibiotics.” Eight four (41%) respondents agreed, 71 (34.6%) neither
disagreed nor agreed with this statement, 26 (12.7%) disagreed, and seven (3.4%) strongly
disagreed with this statement.
The rating of the level of importance of factors influencing Tennessee dairy producers’
choice of antimicrobials before (Figure 5.1) and after (Figure 5.2) the VFD final rule became
effective on January 1, 2017, were not significantly different. Noticeably, antimicrobial efficacy
was rated as an extremely important influencer of producers’ choice of antimicrobials by 54% of
the 213 respondents (before the VFD became effective), concerns for animal welfare were rated
as extremely important by 48.8% of the 213 respondents, and concerns for food security were
rated as extremely important by 47.4% of the 213 respondents, while culture and susceptibility
(C/S) tests were rated as extremely important by 13.6% respondents (Figure 5.1). Antimicrobial
efficacy was rated as extremely important by 53.1% of the 207 respondents (after the VFD
became effective), concerns for animal welfare were rated as extremely important by 47.8%, and
concerns for food security were rated as extremely important by 51.7% of the 207 respondents
(Figure 5.2).
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Figure 5.1: Level of importance of factors influencing Tennessee beef producers’ (n = 213) choice of antimicrobials before the
veterinary feed directive-final rule became effective on January 1, 2017.
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Figure 5.2: Level of importance of factors influencing Tennessee beef producers’ (n = 207) choice of antimicrobials after the
Veterinary Feed Directive-final rule became effective on January 1, 2017.
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Clinical signs and symptoms of disease were rated as a very important influencer of
producers’ choice of antimicrobials by more than 40% of respondents and as an extremely
important influencer by more than 20% before and after the VFD became effective (Figures 5.1
& 5.2). Respiratory infections/pneumonia (n = 19) and lameness/hoof problems (n = 16) were
mentioned as the most common diseases/conditions for which antimicrobials were used. Other
diseases/conditions mentioned included: enteric problems/scours (n = 2) and infectious bovine
keratoconjunctivitis (n = 7). The most commonly used antimicrobial drugs for disease
management by the participants belonged to tetracyclines (n = 81), penicillins (n = 9),
cephalosporins (n = 4), amphenicols (n = 12), fluoroquinolones (n = 1), macrolides (n = 13), and
sulfonamides (n =2) antimicrobial classes. Ceftiofur (n = 10), cephapirin (n = 3), long acting
oxytetracycline preparations (n = 60), tulathromycin (n = 10), tylosin (n = 2), tildipirosin (n = 1)
and florfenicol (n = 12) were the most commonly mentioned individual antimicrobials used.
Producers mostly mentioned these individual antimicrobials using their proprietary names.
One hundred and twenty-eight (56.6%) participants reported they never used bacterial
culture to determine disease cause on their farms; 75 (33.2%) participants reported they
sometimes used bacterial culture to determine causes of disease on their farms. Seven (3.1%)
respondents reportedly used bacterial culture for disease detection half the time, nine (4%) used
bacterial culture for disease detection most of the time, and seven (3.1%) always used bacterial
culture for disease detection. Regarding the use of bacterial C/S testing in selecting
antimicrobials, 133 (59.4%) participants reported they never used C/S, 61 participants (27.2%)
reported that they sometimes used C/S to select antimicrobials, seven (3.1%) about half the time,
13 (5.8%) most of the time, 10 (4.5%) always used C/S. Regarding who makes the laboratory
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requests for bacterial culture testing for the farm, 67 of the 91 producers (73.6%) mentioned the
veterinarian, 20 (22%) mentioned the producer, and four (4.4%) mentioned the manager.

Objective 2: Opinions on alternatives to antimicrobials
Additional training of beef producers on infection prevention and control was supported
by many survey respondents. Thirty-three participants (16%) strongly agreed that infection
prevention and control measures (farm-level biosecurity and vaccination) would reduce AMU in
beef operations. One hundred and nineteen (57.8%) respondents agreed, 38 (18.5%) neither
disagreed nor agreed, 15 (7.3%) disagreed, and one (0.5%) strongly disagreed.

Objective 3: Knowledge of and perceptions regarding AMU & AMR
Of the 231 producers, 58 (25.1%) believed there was over-use of antimicrobials in beef
production, 92 (39.8%) believed there was no over-use, and 81 (35.1%) were not sure. Regarding
the beef production system(s) where antimicrobials were most used, 97 (42%) believed
antimicrobials were most used in feedlot operations, 63 (27.3%) in back-grounding stocking, 17
(7.4%) in cow-calf production, five (2.2%) in backgrounding-stocking and feedlot operations,
one (0.4%) in seed-stock operation, and 48 (20.8%) were not sure.
The extent to which survey participants were familiar with AMR varied among the 226
respondents. Twenty-five producers (11.1%) reported being extremely familiar with AMR, 59
(26.1%) were very familiar, 97 (42.9%) moderately familiar, 37 (16.4%) slightly familiar, eight
(3.5%) not familiar at all. In rating their degree of concern about AMR, of the 228 producers
who completed the question on degree of concern about AMR, 50 (21.9%) reported that they
were very concerned about AMR, 133 (58.3%) moderately concerned, and 36 (15.8%) reported
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they were not concerned about AMR. Nine producers (4%) did not rate their degree of concern
about AMR because they were not familiar with what antimicrobial resistance meant.
Twelve producers (5.8%) strongly agreed with the statement “some antibiotics you use
on your cattle have become ineffective (there is resistance to antibiotics used in cattle).” Fiftyfour (26.2%) respondents agreed, 84 (40.8%) neither disagreed nor agreed, 48 (23.3%)
disagreed, and eight producers (3.9%) strongly disagreed with this statement. For the statement
“antibiotic drugs work less effectively than in the past,” eight (3.9%) participants strongly
agreed, 43 (21%) agreed, 105 (51.2%) neither disagreed nor agreed, 39 (19%) disagreed, and 10
(4.9%) strongly disagreed.
Additional training of beef producers on prudent AMU was supported by the majority of
survey respondents. Twenty-two producers (10.7%) strongly agreed that producers required
additional training on prudent AMU. One hundred and twenty-nine (62.9%) respondents agreed,
37 (18.1%) neither disagreed nor agreed, 15 (7.3%) disagreed, and two (1%) strongly disagreed.
Of the 200 participants who completed the question on antimicrobial drug labels, 149
respondents (74.5%) found antimicrobial drug label instructions easy to understand and interpret
while 51 (25.50%) believed antimicrobial drug label instructions were difficult to understand and
interpret. All of the 201 survey participants (100%) who responded to the question on the
preferred language for antimicrobial label instructions preferred antimicrobial drug labels to be
in English. Education level was not significantly associated with producers’ perceptions of
difficulty to comprehend antimicrobial label instructions (College/professional vs high
school/vocational OR = 1.19; 95% CI = 0.57, 2.5; P = 0.641).
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Simple associations between demographic variables and producers’ degree of
concern about AMR
Producer’s gender (male vs female; P = 0.856), being raised on a cattle farm (P = 0.472),
herd size (P = 0.431), education level (P = 0.319), number of years in cattle farming (P = 0.273),
and operation type (P = 0.19) were not significantly associated with producer’s degree of
concern about AMR (Table 5.3). Age was significantly associated with producer’s degree of
concern about AMR (P = 0.048).

Multivariable analyses
In the multivariable ordinal logistic regression model, producers’ age was significantly
associated (P = 0.022) with their degree of concern about AMR, after controlling for type of
cattle operation (Table 5.4). For this model, the Score Test for the Proportional Odds
Assumption (χ2(8.03) = 8; P = 0.431) indicated that the proportional-odds assumption was met,
and the standard Pearson Goodness-of-Fit statistic (P = 0.109) showed that the model fit the data
very well. Compared to producers in the 40 – 49, 50 – 59, 60 – 69 and > 70 age groups, those in
the 30 – 39-year age group were significantly less concerned about AMR (Table 5.4). Similarly,
compared to cow-calf producers and producers with multiple or other types of cattle operations,
seed-stock operators were significantly less concerned about AMR.
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Table 5.3: Univariable analyses for associations between various demographic predictors
and Tennessee beef producers’ degree of concern about antimicrobial resistant infections,
2018.
Variable
Gender
Raised on a cattle
farm
Herd size

Education level
Age

Category
Male vs Female
Yes vs No

OR (95% CI)
1.07 (0.51 – 2.23)
1.25 (0.69 – 2.26)

P Value
0.856
0.472

†

─
1.57 (0.79 – 3.12)
1.23 (0.6 – 2. 54)
1.27 (0.66 – 2.45)
1.4 (0.72 – 2.72)

0.431
0.199
0.571
0.47
0.319

─
2.71 (1.03 – 7.11)
4.2 (1.63 – 10.83)
3.53 (1.38 – 9.03)
4.1 (1.42 – 11.87)
1.74 (0.44 – 6.88)
1.55 (0.66 – 3.67)
1.3 (0.55 – 3.07)
1.5 (0.56 – 4.07)
1.56 (0.41 – 5.92)
1.19 (0.52 – 2.3)
1.02 (0.4 – 2.66)
2.41 (0.65 – 9.02)
1.16 (0.45 – 3.01)
2.03 (0.55 – 7.55)
2.36 (0.58 – 9.6)

0.048
0.043
0.003
0.009
0.009
0.43
0.319
0.545
0.411
0.517
0.678
0.961
0.191
0.758
0.292
0.232

Overall
50 – 99 vs 0 – 49
50 – 99 vs ≥100
≥100 vs 0 – 49
High school/vocational vs
college/professional
†
Overall
30 – 39 vs 40 – 49
30 – 39 vs 50 – 59
30 – 39 vs 60 - 69
30 – 39 vs > 70
30 – 39 vs < 30
40 – 49 vs 50 – 59
40 – 49 vs 60 – 69
40 – 49 vs > 70
<30 vs 40 – 49
60 – 69 vs 50 – 59
> 70 vs 50 – 59
<30 vs 50 – 59
60 – 69 vs > 70
< 30 vs 60 – 69
<30 vs >70
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Table 5.3: Continued
Variable
Number of years in
cattle farming

Cattle operation type

†

Category
†
Overall
6 – 10 vs <5
6 – 10 vs 11 – 15
6 – 10 vs 16 – 20
6 – 10 vs 21 – 25
6 – 10 vs 26 – 30
6 – 10 vs >30
11 – 15 vs <5
11 – 15 vs 16 – 20
11 – 15 vs 21 – 25
11 – 15 vs 26 – 30
11 – 15 vs >30
16 – 20 vs <5
16 – 20 vs 21 – 25
16 – 20 vs 26 – 30
16 – 20 vs >30
21 – 25 vs <5
21 – 25 vs 26 – 30
21 – 25 vs >30
26 – 30 vs <5
26 – 30 vs >30
>30 vs <5
†
Overall
Seed-stock vs Backgroundingstocking
Backgrounding-stocking vs
Multiple operation and others
Backgrounding-stocking vs
Cow-calf
Seed-stock vs Multiple operation
and others
Seed-stock vs Cow-calf
Cow-calf vs Multiple operation
and others

Overall = overall effect of predictor on outcome variable
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OR (95% CI)
─
2.2 (0.63 – 7.67)
3.64 (0.98 – 13.53)
1.4 (0.41 – 4.74)
0.81 (0.24 – 2.75)
1.62 (0.46 – 5.62)
1.92 (0.69 – 5.35)
0.6 (0.17 – 2.11)
0.38 (0.11 – 1.32)
0.22 (0.06 – 0.78)
0.44 (0.13 – 1.56)
0.53 (0.19 – 1.48)
1.57 (0.49 – 5.08)
0.58 (0.18 – 1.83)
1.16 (0.36 – 3.73)
1.37 (0.54 – 3.48)
2.73 (0.83 – 8.95)
2.01 (0.61 – 6.55)
2.38 (0.92 – 6.16)
1.36 (0.41 – 4.5)
1.19 (0.54 – 3.11)
1.15 (0.44 – 2.99)
─
4.41 (0.55 – 35.56)

P Value
0.273
0.216
0.054
0.591
0.729
0.452
0.213
0.43
0.129
0.019
0.205
0.224
0.447
0.35
0.809
0.505
0.097
0.23
0.073
0.612
0.725
0.779
0.19
0.164

1.5 (0.33 – 6.74)

0.601

1.22 (0.3 – 4.97)

0.783

6.59 (1.19 – 36.38)

0.031

5.37 (1.07 – 27.02)
1.23 (0.6 – 2.49)

0.042
0.573

Table 5.4: Ordinal logistic regression model of multivariable analyses of factors associated
with Tennessee beef producers’ degree of concern about antimicrobial resistant infections,
2018.
Variable
Age

Category
†
Overall
30 – 39 vs 40 – 49
30 – 39 vs 50 – 59
30 – 39 vs 60 - 69
30 – 39 vs > 70
30 – 39 vs < 30
40 – 49 vs 50 – 59
40 – 49 vs 60 – 69
40 – 49 vs > 70
<30 vs 40 – 49
60 – 69 vs 50 – 59
50 – 59 vs > 70
<30 vs 50 – 59
60 – 69 vs > 70
< 30 vs 60 – 69
<30 vs >70
†
Overall
Cattle operation type Seed-stock vs Backgroundingstocking
Backgrounding-stocking vs
Multiple operation and others
Backgrounding-stocking vs
Cow-calf
Seed-stock vs Multiple operation
and others
Seed-stock vs Cow-calf
operators
Cow-calf vs Multiple operation
and others
†
Overall = overall effect of predictor on outcome variable
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OR (95% CI)
─
3.18 (1.19 – 8.54)
4.54 (1.73 – 11.88)
3.72 (1.43 – 9.65)
5.53 (1.85 – 16.52)
1.76 (0.44 – 7.04)
1.43 (0.59 – 3.43)
1.17 (0.49 – 2.8)
1.74 (0.64 – 4.71)
1.81 (0.47 – 7.03)
1.22 (0.53 – 2.83)
1.22 (0.46 – 3.23)
2.59 (0.68 – 9.88)
1.49 (0.56 – 3.93)
2.12 (0.56 – 8)
3.15 (0.75 – 13.2)
─
7.4 (0.85 – 64.59)

P Value
0.022
0.022
0.002
0.007
0.002
0.427
0.429
0.728
0.278
0.389
0.644
0.691
0.165
0.423
0.268
0.117
0.071
0.07

1.49 (0.32 – 6.89)

0.612

1.14 (0.27 – 4.72)

0.86

11.02 (1.85 – 65.51)

0.008

8.42 (1.56 – 45.37)

0.013

1.31 (0.63 – 2.72)

0.471

Objective 4: Avenues for receiving information on prudent AMU
Regarding avenues for receiving information on prudent AMU, no single medium was
most preferred by all producers. The most commonly mentioned avenues for receiving
information on prudent AMU included brochures (n = 19), educational seminars (n = 71), and a
producers’ handbook on prudent AMU (n = 37). These formats for receiving information were
chosen individually or in combination with others, such as videos on prudent AMU and
laminated posters. Of the 202 participants who answered the question on the preferred language
for receiving information on prudent AMU, 200 (99%) preferred to receive AMU information in
English.

Discussion
The findings of the study provide insight into the AMU practices of TN beef producers
and identify opportunities for improving AMU among these producers at a time when AMU in
food animals is under public scrutiny. Results of this study suggests that extra-label AMU among
TN beef producers could be very low. Written AMU protocols could reduce treatment errors
since most of antimicrobial treatments in farms are often administered by non-technical farm
personnel (the farmer or farm employees) [22, 23]. In the present study, a majority of the farms
did not utilize written protocols for treating sick animals with antimicrobials, suggesting a need
for veterinarians and TN beef extension agents to emphasize and encourage the development and
use of written AMU protocols.
Although a large proportion of producers in the present study were either extremely
familiar or moderately familiar with AMR, many were either slightly familiar or not familiar at
all with AMR, suggesting a need for more education on AMR and AMU. Moreover, producers in
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the 30 – 39 age group were significantly less concerned about AMR when compared to those in
the 40 – 49, 50 – 59, 60 – 69, and > 70 age groups. Also, seed-stock operators were significantly
less concerned about AMR when compared to cow-calf producers and those with multiple or
other types of cattle operations. Possibly this result may reflect a lack of awareness of the
consequences of AMR among producers in the 30 – 39 year age group and among seed-stock
operators. Perhaps, producers in the 30 - 39 years age-group rarely participate in educational
programs related to AMR when compared to those in other age groups and, as such, could be
less informed about AMR and its consequences. It is important to note that the number of seedstock operators in the survey was small (n = 6). Therefore, this finding may not be generalized to
all seed-stock operators in the state.
In the present study, 63% of the surveyed producers kept written records of antimicrobial
drug purchases and 69.4% kept written records of antimicrobial drugs used to treat animals,
whereas in the 2007/2008 survey of TN beef producers, 39.4% of the surveyed producers kept
records of antimicrobial purchases and 32.2% kept records of AMU [17]. The findings of the
present study suggest there was an increase in the number of TN beef producers keeping records
on antimicrobial purchases and AMU over the last 10 years. This increase in record keeping
could reflect an increased awareness of the importance of farm record keeping among beef
producers. Similarly, compared to the 2007/2008 survey findings where 13.5% of producers
treated their cattle with antimicrobials at dosages higher than the label instructed, the findings of
this present study found that only 7.3% of the surveyed producers mentioned that they
sometimes treated their cattle with antimicrobials at dosages higher than the label provision. This
finding suggests that producers’ practice of treating animals with antimicrobials at higher
dosages contrary to the label indication may have dropped by half (50%) over the past 10 years.
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This drop could be due to the producers’ recognition of the importance of adhering to label
instructions or due to the improvement in producers’ knowledge of AMU.
In the present study, 56.6% of the participants reported they never used bacterial culture
to determine disease cause on their farms and 59.4% of the participants mentioned they never
used C/S in selecting antimicrobials. Many producers rated C/S as an either not at all important,
slightly important, or moderately important factor influencing their choice of antimicrobials,
before or after the VFD final rule became effective on January 1, 2017. These findings generally
suggest that, although reportedly practiced in some beef farms, the use of bacterial culture to
determine disease cause and the use of C/S tests for antimicrobial selection is currently not
widely practiced on TN beef farms. A 2007-2008 survey [17] found that 34% of producers used
bacterial culture to determine disease cause and 31.5% of the surveyed beef producers reported
using C/S to choose antimicrobials. Compared to the 2007/2008 survey, the findings reported in
the present study suggest that there has not been any significant change (increase) in the use of
C/S test results among TN beef producers over the last 10 years. Possibly, many producers have
not adopted the use of C/S due to cost implications or lack of awareness about the benefits of
C/S. Again, veterinarians and TN beef extension agents should create more awareness regarding
the benefits of C/S among TN beef producers.
A previous review [24] identified farmers’ belief that AMU will improve profitability as
a barrier to sustainable AMU because it hinders the reduction of AMU. In the present study, 69%
of the producers agreed that profitability of the beef operation (economic gain) was a key factor
influencing the decisions of many producers to use antimicrobials in their farms. This finding is
not surprising given that the risk of disease transmission may exert significant economic pressure
on producers to use antimicrobials for infectious disease management and prevention [2].
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However, producers need to be informed that profitability can be realized with minimal or no
AMU, if appropriate infection prevention and control measures are implemented on the farm.
It is a common practice in many countries for pharmaceutical company representatives to
directly market antimicrobials to farmers. The marketing of antimicrobials directly to food
animal producers is discouraged by the World Organization for Animal health [25]. Our findings
show that many producers (41%) believed the aggressive marketing of antibiotics by
pharmaceutical companies greatly influenced producers' AMU, although 16.1% did not believe
pharmaceutical companies influenced AMU, and over 50% of the respondents rated
pharmaceutical company representatives as either not at all important or slightly important both
before and after the VFD was effected. Many producers (25.5%) in the present study believed
that antimicrobial drug label instructions were difficult to understand and interpret. Although this
finding may not be generalized to the entire United States beef producer population, it suggests
that veterinary pharmaceutical companies should consider labeling antimicrobial drugs in nontechnical, easy-to-understand language for increased comprehension among producers. A
countrywide investigation of the perceptions among beef producers about current antimicrobial
labels and information on the antimicrobial package inserts may prove useful.
In the present study, no single medium/avenue for receiving AMU information was most
preferred by all producers. This finding confirms the findings of previous studies, where farmers
differed in their preference for receiving information on management and infection/disease
prevention and control [14]. Previous scholars have suggested that veterinarians should act as
the main information source for farmers on AMU because they are perceived as trust worthy
social referents for farmers [26]. In the present study, over 60% of producers rated a
veterinarian’s prescription as either very important or extremely important in their antimicrobial
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choice, suggesting that veterinarians could act as agents of change towards prudent AMU among
beef producers. It could be beneficial for policy interventions towards prudent AMU to channel
AMU-related behavioral change messages to beef producers through veterinarians, where
possible. Furthermore, targeted behavioral change messages towards prudent AMU should be
integrated into routine veterinary farm visits and beef extension training programs. Behavioral
techniques, such as motivational interviewing informed by assessing producers’ readiness for
change, could be used [27]. Additionally, these behavioral change messages could be packaged
for beef producers in the form of brochures, a producer’s handbook on prudent AMU or prudent
AMU videos. Educational seminars should be used to identify AMU training needs and raise
more awareness about AMR and prudent AMU among beef producers. However, scholars in
Europe suggested that providing a sense of ownership of the recommendations for judicious
AMU can be useful in causing behavioral change among producers [26]. Exploring appropriate
methods for quantifying on-farm AMU in the U.S., may be invaluable since such measures could
cause behavioral change towards prudent AMU.
Although previous studies have shown that peers influence farmers decision making [14],
our findings suggest that peer recommendations could be a less important factor influencing
choice of antimicrobials for many TN beef producers. Additionally, personal experience with
specific AMU practices have been found to influence farmers attitudes towards antimicrobial
treatment [26]. In the present study, over 40% of respondents rated their farming experience as
very important, both before and after the VFD became effective, and over 18% rated it extremely
important in their antimicrobial choice. Personal experience was rated as a more important factor
influencing choice of antimicrobials when compared to peer recommendations, suggesting that
there could be limited sharing of experiences among beef producers in TN, perhaps due to
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limited social interactions among the beef producers. Use of peers as agents of change towards
prudent AMU in TN beef production may be less valuable. A study investigating the possible
reasons why peer recommendations could be less useful to TN beef producers would be
beneficial.
The strength of the present study was that preliminary findings from our previous
qualitative study were used in developing the survey questionnaire, and the survey was
anonymous, voluntary, and self-administered. Nevertheless, it is possible that the results of this
study could have been influenced by social desirability bias, which is a form of response bias in
which respondents provide socially desirable answers to survey questions [28]. Socially
desirability bias, if any, could be minimal. Additionally, selection bias could be minimal because
the demographic characteristics of late respondents and their responses to survey questions were
similar when compared with early respondents [29], suggesting the survey answers of the
respondents could be similar to those of non-respondents.

Conclusions
The proportion of TN beef producers keeping farm records on antimicrobial purchases
and AMU may have increased over the last 10 years. The proportion of beef producers treating
cattle with antimicrobials at dosages higher than the label indication may have reduced by 50%
over the last 10 years. Culture and sensitivity tests for antimicrobial selection are currently not
widely used in TN beef farms, perhaps due to cost implications. Peer recommendations could be
a less important factor influencing the choice of antimicrobials among TN beef producers. There
is need to promote the use of written antimicrobial treatment protocols among TN beef
producers. Continued training for beef producers on infection prevention and control, and
prudent AMU is needed.
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Abstract
Background
To prevent potential public health consequences of AMR, many countries have instituted
measures to reduce and minimize AMU in food animals. Since January 1, 2017, the United
States Food and Drug Administration (FDA) has implemented the Veterinary Feed Directive
(VFD) aimed at facilitating judicious use of medically important antimicrobials in food
producing animals. The objective of this study was to identify the common perceptions of
Tennessee cattle producers regarding the VFD.
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Materials and Methods
We used a combination of focus groups and survey questionnaires to explore Tennessee (TN)
cattle producers’ perceptions regarding the VFD. Preliminary findings from 7 focus groups of 62
producers were used in the development of the survey questionnaire sent both online and in-print
to rest of cattle producers in TN.

Results
The beef focus group participants perceived the VFD: to be a top-down policy; to have led to
unregulated access to in-feed antimicrobials; a regulation that has limited the producers’ ability
to prevent disease and leading to economic losses; to negatively affect small producers; and to be
affected by challenges related to prescription writing and disposal of un-used medicines. The
dairy focus group participants perceived the VFD as unnecessary and burdensome, to have
affected small producers, and introduced additional costs. Twenty-eight beef producers (12.3%)
believed the VFD is a very useful policy, 97 (42.5%) believed the VFD is somewhat useful, 32
(14.0%) took a neutral stand (neither not useful nor beneficial), and 27 (11.8%) believed the
VFD is not useful. Among the dairy producers, one (2.3%) mentioned the VFD is a very useful
policy, 10 (22.7%) mentioned the VFD is somewhat useful, 16 (36.4%) took a neutral stand
(neither not useful nor beneficial), nine (20.4%) mentioned that VFD is not useful. Thirty-five
beef producers (15.4%) were not familiar at all with the VFD while 48 (21.1%) were slightly
familiar. Among dairy producers, six (13.6%) were not familiar at all with the VFD, whereas 11
(25%) were slightly familiar.
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Conclusions
Many cattle producers were either not familiar or were slightly familiar with the VFD and
perceived it as not useful. Therefore, more awareness regarding the VFD and its benefits is
needed among both beef and dairy producers in TN.

Key words
Mixed methods study, Qualitative, Quantitative, Focus group discussions, Antimicrobial use,
Antimicrobial resistance, Veterinary Feed Directive, Tennessee-dairy cattle producers

Background
Antimicrobial resistance (AMR) is a major global public health problem [1, 2] that has
triggered global concerns over non-judicious antimicrobial use (AMU) in food animals [3]. Nonjudicious AMU and inadequate antimicrobial stewardship (AMS) are known modifiable factors
driving the occurrence of AMR [4]. To prevent potential public health consequences of AMR,
many countries have instituted measures to reduce and minimize AMU in food animals [4] and
have restricted AMU for growth promotion and disease prevention [5]. In Europe, the primary
goal of banning the use of antimicrobial growth promoters was to reduce AMR traits in the
microbial flora of food-producing animals [6]. Restrictions on the use of medically important
antimicrobials in food-producing animals is a major strategy for addressing AMR [7]. The World
Health Organization (WHO) recommends complete restriction of AMU in food animals for
growth promotion and for disease prevention, and also recommends reduction in the overall use
of medically important antimicrobials in food animals [1].
Antimicrobial use restrictions generally aim at mitigating AMR in humans and animals,
are often administered through national-level policy [8]. These restrictions are based on the
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precautionary principle of public health, because there is currently no robust evidence of the
public health impacts of AMU in food animals on antimicrobial resistance (AMR) in human
pathogens [4]. Evidence from recent systematic reviews showed that although a large proportion
of primary studies did not provide evidence supporting AMR transmission from and between
food animals and humans, some primary studies suggested evidence for such transmission [911]. Recent studies have shown that indiscriminate AMU for both therapeutic and nontherapeutic purposes in animals leads to propagation and shedding of substantial amounts of
AMR microorganisms [4, 12].
Beginning January 1, 2017, the United States Food and Drug Administration (FDA)
implemented the Veterinary Feed Directive (VFD). The VFD is aimed at ensuring judicious use
of medically important antimicrobials in food-producing animals [13]. The VFD authorizes the
use of medically important antimicrobials in feed and water for therapeutic purposes, under the
supervision of a licensed veterinarian. A previous review that evaluated evidence on unintended
consequences of AMU restrictions in food animals recommended that more research should be
conducted to evaluate, document, and report the unintended consequences of interventions
targeting AMR reduction [7]. Since implementation, and prior to this present study, U.S. cattle
producers’ experiences with the VFD, to the best of our knowledge, had not been studied. No
previous study to our knowledge had comprehensively explored the perceptions of Tennessee
(TN) cattle producers regarding the VFD. Specifically, the objective of the study was to identify
the common perceptions of TN cattle producers regarding the VFD. The findings reported here
could inform VFD awareness campaigns and could help in the improvement of the VFD and the
development of VFD-related policies.

198

Materials and methods
Study design
A mixed methods design using a combination of focus groups and survey questionnaires
was utilized. To develop a robust questionnaire that captured our objective, focus group
discussions with cattle producers were first conducted to gather opinions about the VFD.
Preliminary findings from the focus group discussions were used in the development of the
survey questionnaire that was administered to the rest of the cattle producers in TN. The
University of Tennessee Knoxville, Institutional Review Board for the Protection of Human
Subjects in Research reviewed and approved both the qualitative (Protocol number: UTK IRB17-03702-XP) and the quantitative (Protocol number: UTK IRB-17- 03884-XP) parts of this
study. Informed consent was obtained from each producer before participation in the study.

Qualitative methodology
Focus group design, structure, and procedure
In total, seven focus group discussions with 62 cattle producers were conducted. Of the
seven focus groups, five involved beef producers and two were dairy producer groups. The fivebeef producer focus groups were conducted in East TN, Middle TN, and West TN in June 2017
and had a total of 39 participants. For recruitment of beef producers, the leadership of the
Tennessee Cattlemen’s Association (TCA) invited members (via e-mail) with experience in
different cattle production systems and from different geographical areas to represent a range of
beef producers in TN. Each beef focus group comprised of 5 - 9 producers and lasted
approximately 90 minutes. The two dairy producer focus groups were conducted in Middle TN
and East TN in July 2017 and March 2018 respectively. The middle TN dairy focus group (dairy
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focus group 1) was conducted with dairy producers attending an annual dairy producer meeting
while participants in the east TN focus group (dairy focus group 2) were recruited from dairy
producers attending a master dairy training meeting. Dairy focus group 1 was held in a local
restaurant while the second one was conducted at a county extension center. Prior to the dairy
producer meetings, the University of Tennessee Institute of Agriculture extension agents notified
and requested eligible producers to participate in our focus group meetings. Each focus group
meeting lasted approximately 60 minutes. The first dairy focus group comprised 12 producers
(participants) while the second one had 11 participants. In both the beef and dairy focus groups,
each participant was given an informed consent form with an overview of the study and a signed
consent was obtained before participation at the focus group discussion. Participants could opt
out of the focus groups at any time. All invited participants were provided with a meal
irrespective of their active participation.
A semi-structured interview guide which was modified after the very first focus group
was utilized (see appendix 2). The modified interview guide (appendix 2B) consisted of 11 openended questions. We assigned each participant an identity number for confidentiality and to
maintain anonymity. These identity numbers were used throughout the discussion and
participants announced these numbers before speaking. All the seven focus groups were
moderated by one of the authors (EBS) and all the four authors attended each focus group. Three
members of the research team (JE, MC and CO) took hand written notes of key points, provided
clarifications to questions, and asked follow-up questions were necessary. Debriefing meetings
were held at the end of each focus group meeting and before the next focus group discussion as
previously described [14]. In the beef focus groups, data saturation was reached during the fifth
focus group discussion. However, data saturation was not reached in the dairy focus groups. For
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thematic analysis, each focus group discussion was video-recorded and later transcribed verbatim
by a professional transcription service provider.
Data analysis
The beef and dairy transcripts were analyzed separately using a software (NVivo
qualitative data analysis Software; QSR International Pty Ltd. Version 12, 2017). Thematic
analysis was performed using a recursive six-phase approach (familiarization with the data,
generation of initial codes, search for themes, review of themes, definition and naming of
themes, and report production) as described previously [15]. For data familiarization, each
member of the team (JEE, MC, ES and CCO) read all transcripts. The percent of word similarity
between the focus groups was assessed using Jaccard’s coefficient. Two separate master projects
(beef and dairy) with the transcripts uploaded were developed by the primary author (JEE) and
distributed to the other authors for individual coding. For the beef master project, the initial
nodes were identified through consensus at the debriefing meetings held after each focus group
and each author was at liberty to use either the already prescribed coding frame in the master
project (theoretical/deductive approach) or to create new nodes independent of the prescribed
coding frame (the inductive approach) during the thematic analysis. For the dairy master project,
an inductive approach was used to develop a coding frame (each author created independent
nodes). Upon completion of the individual coding, the primary author (JEE) imported the other
team members’ coded data into the master project and examined if the themes from the
individual coding were related to the coded extracts and all the data transcripts. The degree of
agreement in the data coding among the coders (JEE, MC, EBS and CCO) was determined in
NVivo using percent agreement. Results harmonization meetings were held by the research team
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to define and name/re-name themes. The identified themes were refined to identify sub-themes
and to ensure that each theme is meaningful, clear and distinct.

Quantitative methodology
Study design and administration of survey
This survey targeted both beef and dairy cattle producers and was part of the broader
survey of drivers of AMU practices among cattle producers in TN. First, a questionnaire was
developed and evaluated by two professionals with expertise in AMU to ensure all critical issues
were identified and covered (see appendix 3 for the survey questionnaire). Preliminary results
obtained from the five beef focus groups and dairy focus group one was used to develop the
questionnaire. The questionnaire captured the producer’s demographics and had five questions
on producers’ perceptions regarding the VFD. The captured producer demographic information
included age, sex (male versus female), level of education, herd size, whether raised on a
livestock farm or not, and number of years in cattle farming. A three and a four-point scale as
well as ordinal Likert scales were used to capture participant responses to questions on
perceptions regarding the VFD.
For beef participants, the sample size required for this survey was determined to be 377
participants at 95% confidence level, a margin of error of 5%, 50% response distribution, and an
assumed TN beef producer population size of 20,000. The survey targeted all dairy producers in
the state (the estimated number of dairy producers in TN as of 2017 was 300) [16]. The survey
questionnaire was made available to participants both in print form and online. Producers who
completed the print questionnaire were requested in the informed consent statement not to
complete the online survey and vice versa. The on-line version of the survey was housed in a
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survey software (Qualtrics software, Provo, UT) and was adapted for computer, tablets, and cell
phone responses. Participant responses were de-identified using the anonymize function in
Qualtrics such that no personal information was collected. Beef producers were notified about
the online survey option during the TCA annual meeting in January 2018. Subsequently, all
2,712 producers on the TCA mailing list received an email invitation to take the survey.
Additionally, an anonymous survey link and QR code for the online survey were provided to the
TCA vice president for distribution to producers willing to take the survey. Dairy producers were
also notified about the online survey option during an annual dairy producer meeting in January
2018. Subsequently, an email invitation to take the survey was sent out to all the 87 dairy
producers on the University of Tennessee Animal Science department email list. To further
increase the response rate, follow-up email reminders were sent to both beef and dairy on-line
survey non-respondents every two weeks.
The printed questionnaire was distributed to beef producers attending the TCA annual
meeting, and producer extension meetings across the state and to dairy producers attending dairy
extension meetings such as the master dairy training sessions. Completed printed questionnaires
were returned to the investigators. The survey (both the printed and online) remained open from
January 26, 2018, through May 11, 2018. Participation in the survey was voluntary. All
participants were invited to participate in a $10 gift card raffle taken at the end of the survey. The
winners were randomly selected and eligibility to participate in the raffle was not contingent
upon survey completion.
Statistical analysis
A commercial statistical software (SAS, version 9.4, SAS Institute Inc, Cary, NC) was
used to complete descriptive analyses. Descriptive statistics (frequencies and proportions) were
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used to summarize the data. Stacked bar charts created in another commercial software (Tableau
software, version 8.2, Seattle, WA) were used to visualize responses captured on the Likert scale.

Results
Perceptions of beef producers regarding the VFD: Qualitative results
Focus group participant characteristics
Of the 39 beef producers who participated in the five focus group discussions, one was
female and 38 were male. Participants’ perceived ages ranged from late twenties to early
seventies and the reported herd size per producer ranged from approximately 20 to 225 cattle
(Table 6.1). Jaccard’s similarity index showed there was diversity among participants in the
different focus groups (Jaccard’s similarity index ranged from 27% to 33%). Percent
agreement (in coding) between each pair of coders was >75 %.
Table 6.1: Beef focus group participant characteristics (n = 39)
Focus group

1
2

3
4
5

Geographic
region
(location)
Johnson City,
East Tennessee
Dickson county,
middle
Tennessee
McNairy county,
west Tennessee
Jefferson county,
East Tennessee
Athens, McMinn
county, East
Tennessee

Number of
participants (n)

Herd size range

Gender of
participants

9

40 - 80

All male

9

40 - 135

All male

8

30 - 200

All male

8

20 - 200

All male

5

30 - 225

4 males, 1
female
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Perceptions regarding the VFD
Although a section of participants stated that they were unaffected by the VFD, the VFD
was commonly perceived to have negatively impacted production (Figure 6.1). Broadly, the
producers described the VFD: to be a top-down policy; to have led to unregulated access to infeed antimicrobials; a regulation that has limited the producers’ ability to prevent disease and
leading to economic losses; to negatively affect small producers; and to be affected by challenges
related to prescription writing and disposal of un-used VFD feed. Below, we give a detailed
description and excerpts of the participants’ perceptions about the VFD.
Top-down policy
The participants described the VFD as government over-reach that has created additional
costs to producers and introduced additional difficulties to producers. Others perceived the VFD
as red tape, and a policy that is ineffective. The VFD was also perceived to be a waste of time
and money, not only for the producer and the veterinarian, but also for the government.
…I’m idea on the Veterinary Feed Directive is it did come from the top-down. It was
implemented before the education process really even started. And building the plane
while you’re flying it doesn’t work. It normally results in a crash… [No. 3 focus group
4].
…I’d think they (government) jumped the gun with this VFD deal ... I think they’re taking
things way far more than what – it’s run good for years and years…. [Unidentified
participant, focus group 5].
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Figure 6.1: A thematic map showing relationship between major and minor themes for the perceptions of Tennessee beef
cattle producers regarding the Veterinary Feed Directive (VFD)
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The producers also frequently stated that the VFD adds to management by introducing additional
labor associated with the work of getting the cattle up to give them an injectable, especially when
the cattle may be a long distance away from the working/handling facilities. Additionally, the
VFD was seen to have complicated farm record keeping.
… [VFD is] Additional hardship and burden on a business already……I think extra cost
is all I can see, less profit…. [No. 5, focus group 4].
Unregulated access to in-feed antimicrobials
Un-regulated access to antimicrobials was mentioned as a likely un-intended
consequence/outcome of the VFD. A section of participants in the west Tennessee focus group
mentioned that the VFD would drive some producers to look for alternative sources of in-feed
antimicrobials. These alternative sources would mostly be illegal and un-traceable.
…But you’re gonna cause little things to go kind of illegal to get the job done… [No. 4,
focus group 3].…There’s gonna be people that are gonna do things to circumvent law
that’s not right… [No. 1, focus group 3]. …That’s when the black market’s gonna
[supply in-feed antimicrobials] … [No. 2, focus group 3].
Limited producers’ ability to prevent disease
The VFD limiting producers’ ability to prevent disease was frequently expressed in all
the focus groups. The producers expressed concern that the VFD has disabled disease prevention
in their operations and is leading to economic loss and that the VFD is affecting the economic
performance of the animals and setting up producers to financial losses. The VFD was
commonly mentioned to have negatively affected calf health, led to reduced productivity and
negatively affected animal welfare.
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… the VFD has removed an ounce of prevention…They’ve set us up for financial loss…
[No. 7, focus group 3].
…It’s [VFD] a loss of money. When we have this in our feed system, our cow[s] were
getting treated. …When we have these ingredients [antimicrobials] in our minerals and
in our feed, most of the time it helps a lot to keep the pinkeye down, the sore foot down. If
they’ve got a sore foot, they’re not going to want to walk to the water trough and to the
feed trough. They’re not gaining weight. We’re not making money… [No. 2, focus group
1].
The producers also mentioned that, because of the VFD, the lack of access to in-feed
antimicrobials for prophylactic purposes would lead to smaller birth weight of calves, and lead to
increased culling of calves due to disease.
…You’d think the public would want to see a healthy calf going to market or a sick calf
going to market. That’s what it’s going to be. There’re going to be more and more sick
calves slaughtered… [No. 3, focus group 5].
VFD negatively affects small producers
There was a consensus among all the focus group participants that the VFD has negatively
affected the small producers by introducing additional costs of involving a veterinarian and the
costs of setting up facilities for handling cattle and therefore, affecting the profit margins of
small producers. It was clear from the discussions that small scale beef producers rarely involved
veterinarians in their operations.
… To get the Veterinary Feed Directive, it’s going to require you to have that call. And
that small producer – where’s the profit margin at? If you spread that veterinarian client
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relationship over 100-150 cows, you’re alright. And you have that connection. But if
you have nine, that one farm call may have cost you your profit… [No. 4, focus group 5].
…My impression and my opinion is the Feed Directive is particularly impacting
negatively the small stocker operation, which is me… If I feed according to script – which
we’re probably not going to do anymore – I have to feed 11 pounds per head per day for
five days, stop. These calves won’t be eating 11 pounds a week for the first week. [No. 2,
focus group 2].
…. A lot of these smaller producers don’t have the facilities to get these animals up. And
they might [have] five or ten head of cattle. And if they don’t have that measure in the
feed, they don’t have a way of treating them at all. …And their production, if they’ve only
got five head of animal[s] and they lose one, that’s 25 percent of their whole herd or 20
percent. That affects their production greatly… [No. 5, focus group 5].
VFD prescription-related challenges
Some focus group participants commonly expressed concern that some veterinarians did
not know how to write VFD prescriptions.
… And it’s been a nightmare. We get prescriptions that aren’t worth the paper they’re
written on. I mean, the vets don’t understand how to write them. And lots of times I have
to send an example. They’ll say send me an example of how it should read. I mean,
there’s just not been a lot of education on the proper way to write them… [No. 6, focus
group 1].
…Even the vets that we deal with didn’t know how to write a VFD. It didn’t have all the
items on there that needed to be for us to legally sell the items. If the vets didn’t know
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how to do it, it’s for sure that the everyday producer didn’t know how it worked. People
would come in with the VFD from their vet that wouldn’t even tell what product to give
them or what level or quantity to give them. It’s a real struggle, and it still is. We still
get those things after months of this that these people don’t know… [No. 5, focus group
5].
On the other hand, some producers mentioned that some veterinarians were unwilling to write
VFD prescriptions. While others mentioned that in their areas, there are not enough veterinarians
to write VFD prescriptions. That even when it is possible to get a VFD prescription, the
prescription may be delayed thus limiting their ability to manage disease in their farms. One
focus group participant in the McNairy county focus group (West-Tennessee) stated that disposal
of un-used in-feed antimicrobials was a challenge because the garbage collectors considered unused VFD medicines medical waste that is not supposed to be placed in garbage.
…Some vets won’t write them. They’re just not going to fool with it. It’s just not worth
their time …. [No. 6, focus group 1].
…I mean, I called the vets. They weren’t around for our program, not in Tennessee. No,
sir. I got one, but I never used it. I sent $75.00 to another state and got. A vet in this
area would not write one, period… [No. 2, focus group 1].

Perceptions of beef producers regarding the VFD: Quantitative results
A total of 231 beef producers participated in the survey. Of the 231 participants, 103
completed the hard copy survey while 128 completed the online version. Of the 231 participants,
200 provided their gender: 35 females and 163 males. Two of these respondents preferred not to
report their gender. Complete responses were provided for most questions with the exception of
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a few cases where the respondents left some questions unanswered. The demographic
information of the respondents is presented in Table 6.2.
Table 6.2: Demographics of beef producers on survey of the perceptions of Tennessee beef
producers regarding the veterinary feed directive, 2017
Variable
Gender
Female
Male
Preferred not to report gender
Age group (years)
< 30
30 – 39
40 – 49
50 – 59
60 – 69
>70
Education level
< College
≥ College
Years in cattle production
<5
6 – 10
11 – 15
16 – 20
21 – 25
26 – 30
>30
Beef cattle operation type
Cow-calf production
Backgrounding-stocking
Seed-stock operation
Multiple operation type and others
Herd size
1 – 49
50 - 99
100 – 149
150 - 199
200 - 299
300 - 399
400 - 499
500+
Raised on a cattle farm
Yes
No

Number (%) of respondents
n = 200
35 (17.5)
163 (81.5)
2 (1.0)
N = 200
12 (6.0)
29 (14.5)
41 (20.5)
44 (22.0)
46 (23.0)
28 (14.0)
N=202
47 (23.3)
155 (76.7)
N = 202
23 (11.4)
19 (9.4)
17 (8.4)
24 (11.9)
24 (11.9)
21 (10.4)
74 (36.6)
N = 230
171 (74.4)
9 (3.9)
6 (2.6)
44 (19.1)
n = 202
84 (41.6)
54 (26.7)
28 (13.9)
12 (5.9)
13 (6.4)
5 (2.5)
1 (0.5)
5 (2.5)
n = 202
138 (68.3)
64 (31.7)
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Perceptions regarding VFD
Regarding the beef producers’ familiarity with the VFD, 35 (15.4%) were not familiar at
all, 48 (21.1%) were slightly familiar with VFD, 75 (32.9%) were moderately familiar, 55
(24.1%) were very familiar, and 15 (6.6%) mentioned extremely familiar. A large proportion
(36.4%) of respondents were either not at all familiar or slightly familiar with the VFD. Twentyeight beef producers (12.3%) believed the VFD is a very useful policy, 97 (42.5%) believed the
VFD is somewhat useful, 32 (14%) took a neutral stand (neither not useful nor beneficial), 27
(11.8%) believed the VFD is not useful. Forty-four producers (19.3%) did not give their opinion
on the usefulness of VFD because they were not familiar with the VFD. Of the 227 producers
who responded to the question on whether they were aware of the VFD before its
implementation, 128 respondents (56.4%) mentioned that they were aware of the VFD before its
implementation, eighty-six (37.9%) mentioned they were not aware of VFD before its
implementation, while 13 (5.7%) were not sure.
The beef producer responses as to whether the VFD influenced producers to seek
veterinary services varied. Forty-five participants (20.2%) mentioned that the VFD has caused
them to seek veterinarian services more frequently, 137 (61.4%) reported VFD has not
influenced them to seek veterinarian services, 10 (4.5%) reported VFD has reduced their use of
veterinarian services, and 31 (13.9%) did not specify how the VFD influenced their use of
veterinary services. More perceptions of survey participants regarding the VFD are provided in
Figure 6.2.
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Figure 6.2: Tennessee beef producers’ perceptions (n = 209) regarding the Veterinary Feed Directive, 2018
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Perceptions of dairy producers regarding the VFD: Qualitative results
Focus group participant characteristics
A total of 23 dairy producers participated in the 2 focus groups. Dairy focus group 1 had
one female, and 11 male participants while the second one had 2 females and 9 male participants.
The reported milking herd size per producer ranged from approximately 40 to 1100 dairy cattle.
The responses from the 2 focus groups were 31.2% similar (Jaccard’s similarity index =
0.312). This Jaccard’s similarity index provided evidence that there was diversity among
participants. Percent agreement (in coding) between each pair of coders was > 80 %.

The VFD perceptions
The general perceptions from the dairy producer focus groups were that the VFD is an
unnecessary and burdensome policy that has affected small producers and introduced additional
costs that cannot be passed along to consumers.
…It’s just more cost. I think it’s $25.00 for the veterinarian – I mean, that $25.00 aingt
[is not] going to make or break nobody. But it’s still $25.00. That’s just something else
you gotta deal with. And who gets that?... [No.6, dairy focus group 2].
…There’s no problem with it [VFD] in one sense if I could pass my additional cost along.
…You made my cost of production go up. I can’t do a thing about it. I cannot pass that
along to the milk processor. I cannot do anything to recoup that cost. I’ve got to bear it
all myself… [No.9, dairy focus group 2].
That the VFD has limited producers’ access to essential antimicrobial medicines
necessary for preventive care and subsequently leading to increased disease occurrence
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especially among calves, increased animal deaths and reduced productivity, and increased use of
injectable antimicrobials.
…Like on the foot bath for your dairy cows, it’s hard to get the tetracycline now unless
you do whatever. That’s our biggest problem because if you don’t keep those warts
under control, then you’ve got sore feet. And you’ve got cold cow. That is our biggest
problem… [No.8, dairy focus group 2].
… we used to use aureomycin 700. And it was a preventative type thing and a useful
thing that we can’t use now. It’s just too much hassle to get it. I couldn’t say that it was
that harmful. … [No.1, dairy focus group 1].
…We had to do what we could to get the downtime to try to save our animals. We lost
some, and we saved some… [No.7, dairy focus group 2]
However, some producers mentioned that they did not have difficulty accessing these medicines
because they have a good veterinarian-client-patient relationship with their veterinarians.
…Some heifer feeds and other feeds, we go through our vet to get – prescription or
whatever you want to call it – even in the beef cattle – mainly Aureomycin that we use in
some different feeds. If you have a working relationship with your vet and your vet
knows what he’s doing, you don’t have any problems if you’ll do what he says. If you go
haphazardly, you’re going to have problems… [No.9, dairy focus group 2].

Perceptions of dairy producers regarding the VFD: Quantitative results
A total of 45 producers participated in the dairy section of the survey. Complete
responses were provided in most questions except for a few cases where some respondents left
some questions unanswered. Of the 45 dairy participants, 40 completed the hard copy survey
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while only five completed the online version. Thirty-nine (39) provided their gender: 31 males
and seven females. One respondent preferred not to report his/her gender. The demographic
information of the survey respondents is presented in Table 6.3.
Table 6.3: Demographics of dairy producers on survey to identify common perceptions of
Tennessee dairy producers regarding the veterinary feed directive, 2018
Variable
Gender
Female
Male
Preferred not to report gender
Age group (years)
20 – 29
30 – 39
40 – 49
50 – 59
60 – 69
Education level
High school
Vocational
College
Professional
Years in dairy cattle production
<5
6 – 10
16 – 20
21 – 25
26 – 30
> 30
Herd size
1 – 49
50 – 99
100 – 149
150 – 199
200 – 299
300 – 399
400 – 499
500+
Raised on a cattle farm
Yes
No

Number (%) of respondents
n = 39
7 (18.)
31 (79.5)
1 (2.6)
n = 37
2 (5.4)
6 (16.2)
8 (21.6)
13 (35.1)
8 (21.6)
n = 37
16 (43.2)
2 (5.4)
18 (48.7)
1 (2.7)
n = 38
1 (2.6)
6 (15.8)
1 (2.6)
4 (10.5)
4 (10.5)
22 (57.9)
n = 37
2 (5.4)
8 (21.6)
7 (18.9)
5 (13.5)
7 (18.9)
3 (8.1)
1 (2.7)
4 (10.8)
n = 39
2 (5.1)
37 (94.9)
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Perceptions regarding VFD
Regarding the dairy producers’ familiarity with the VFD, 6 (13.6%) were not familiar at
all, 11 (25%) were slightly familiar with VFD, 18 (40.9%) were moderately familiar, and 9
(20.5%) were very familiar. A substantial proportion (38.6%) of respondents were either not at
all familiar or slightly familiar with the VFD. One dairy producer (2.3%) believed the VFD is a
very useful policy, 10 (22.7%) believed the VFD is somewhat useful, 16 (36.4%) took a neutral
stand (neither not useful nor beneficial), nine (20.4%) mentioned that the VFD is not useful.
Eight producers (18.2%) did not give their opinion on the usefulness of VFD because they were
not familiar with it.
The dairy producer responses as to whether the VFD influenced producers to seek
veterinary services varied. Thirteen participants (30.9%) reported that the VFD had caused them
to seek veterinarian services more frequently, 23 (54.8%) reported VFD had not influenced them
to seek veterinarian services, four (9.5%) reported VFD had reduced their use of veterinarian
services, two (4.8%) stated that VFD had not influenced their use of veterinary services in any
way. More perceptions of survey participants regarding the VFD are provided in Figure 6.3.
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Figure 6.3: Tennessee dairy producers’ perceptions (n = 41) regarding the Veterinary Feed Directive, 2018
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Discussion
The present study identified the perceptions of TN cattle producers regarding the VFD
and presents the first published perceptions among cattle producers in TN since the VFD final
rule became effective on January 1, 2017. In the present study, the VFD was generally perceived
by most producers to have negatively affected them. This finding is similar to the that of a 2015
survey of U.S. beef producers, that was conducted prior to the VFD becoming effective on
January 1, 2017 where 70% of the surveyed population expressed a negative attitude towards the
VFD [17]. Many participants in the present study were either not familiar or slightly familiar
with the VFD suggesting a need for more producer awareness regarding the VFD. Producers’
negative perceptions regarding the VFD may reflect the challenges and frustrations experienced
by the producers since its implementation.
In the present study, the producers were concerned that the VFD had and would lead to
increased occurrence of disease in herds and increased mortalities, has limited their ability to
prevent disease, would lead to smaller birth weight of calves, and lead to increased culling of
calves due to disease. A previous review study provided evidence from mostly Europe showing
that the unintended consequences from national-level restrictions on AMU on food-producing
animals is temporary and minor [8, 18]. Tennessee producers’ concerns regarding the VFD may
be justified and warrant more research on other states. A nationwide evaluation of these
perceptions may be useful. Although the intended consequence of the VFD is to ensure judicious
AMU and mitigate AMR, its negative effects on animal health, welfare, and production could
definitely be unintended.
According to the FDA [19], disposal of VFD feed that is no longer needed/left over
should be in a manner that is in accordance with state or local requirements for medicated feeds.
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In the present study, a beef focus group participant mentioned that disposal of un-used in-feed
antimicrobials had become a challenge because the garbage collectors considered un-used VFD
medicines or medical waste that is not supposed to be placed in regular garbage. Similarly,
although more than half of the survey questionnaire respondents (both beef and dairy) either
agreed or strongly agreed that they were aware of how to properly dispose any un-used VFD
feed, a considerably large number (14.5% beef and 9% dairy) either strongly disagreed or
disagreed. These findings suggest that (1) for many TN cattle producers, disposal of un-used
VFD feed is problematic, (2) there is a need for more awareness among producers of the FDA
guidance on disposal of un-used/expired VFD feed. To ensure proper disposal, veterinarians and
beef/dairy extension agents should conduct routine producer awareness regarding the Tennessee
requirements (or local area requirements) for disposal of medicated feeds.
In the present study, the producers mentioned that the VFD’s limiting of access to infeed antimicrobials has affected the economic performance of their herds and would lead to
smaller birth weight of calves. Although this concern warrants more research in the U.S. context,
it has been suggested that growth response to in-feed antimicrobials is small in optimized
production systems [20]. Additionally, changes in antimicrobial consumption following the
implementation of policies to discontinue AMU for growth promotion in Denmark did not have a
negative impact on swine productivity [21]. Researchers in Europe suggested that coercive
instruments such as regulations and fines may result in unintended consequences such as illegal
AMU practices among producers [22]. In the present study, some focus group participants
mentioned that the VFD “would” lead to un-regulated access to in-feed antimicrobials through
the black market. Also, more than 12% of beef participants and more than 9% of dairy producers
either agreed or strongly agreed with the statement “the VFD has created more black-market

220

access to in-feed antimicrobials by producers”. Because black market access is possible if there
is public demand [23], the farmers assertion that the VFD has created un-regulated access to infeed antimicrobials through the black market needs to be studied further across the nation so that
appropriate interventions to curtail un-regulated access are designed and instituted.
In the present study 37.8% of the beef producers and 43.9 % of dairy producers who
completed the survey questionnaire either agreed or strongly agreed that the VFD would lead to
increased use of injectable antimicrobials by producers. This perception suggests that there might
be a compensatory increase in the use of injectable antimicrobials for therapeutic and
prophylactic purposes from the time the VFD became effective. It would be beneficial to further
investigate the perceived increase in injectable AMU. Improved veterinary oversight, linking
antimicrobial surveillance to remedial action on excessive AMU, implementation of mandatory
AMU reduction targets, and improvements in animal health are suggested as measures for
containing compensatory increases in AMU following restricted use [7]. However, for Tennessee
and the U.S. in general, increased campaigns for improved animal health may be the only
feasible option for avoiding any compensatory increase in AMU due to the VFD. This is because
in TN and the U.S. in general, there is currently: (1) shortage of food animal veterinarians in
some areas, (2) lack of data on antimicrobial consumption in cattle farms (which data would be
an indicator of the appropriateness of AMU), and (3) absence of mandatory AMU reduction
targets.
The strengths for this present study were that: (1) there was diversity of opinions among
participants as shown by Jaccard’s similarity index and the survey participant demographics, (2)
a mixed methods research design was utilized, (3) both focus group and survey respondents were
assured that the data collected was anonymized and participation was voluntary, and (4) the
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survey questionnaire (both print and online) was self-administered. Additionally, the focus group
discussions were moderated by one of the authors (EBS) with a background in the
behavioral/social sciences and wide experience in moderating such meetings. Nevertheless, the
focus group and survey participants could have given socially desirable responses, thus
introducing bias to our findings. However, such bias, if any, could be very minimal. Participants
are likely to have given their true perceptions regarding the VFD.

Conclusions
The findings of this study could inform future VFD policy review processes. Many cattle
producers were either not familiar or slightly familiar with the VFD and perceived it as not
useful. Disposal of VFD feed, as required of the VFD rule, could be problematic for many TN
producers. More awareness regarding the VFD is needed among both beef and dairy producers in
TN. For antimicrobial stewardship purposes, campaigns targeting improved animal health in
cattle farms should be stepped up to contain the unintended compensatory increase in injectable
AMU due to the VFD. A nationwide survey of the perceptions of cattle producers regarding the
VFD should be conducted to inform future policy making and implementation.

Declarations
Consent for publication
The authors declare that the manuscript does not contain any personally identifiable
information and all personal data were anonymized.

222

Availability of data and material
The open-ended focus group interview guide and the survey questionnaire are available
in the appendices section of this dissertation. All data (focus group transcripts) pertaining to the
manuscript can be obtained from the corresponding author of this manuscript upon reasonable
request.

Competing interests
The investigators declare that they have no competing interests.

Funding
This study received major funding from the National Institute of Food and Agriculture
(NIFA) & a matching fund from The University of Tennessee, Center of Excellence in Livestock
Diseases and Human Health (COE). The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of this manuscript.

Authors Contributions
The primary author (JEE) participated in designing and executing the study, performed
both the qualitative and quantitative data analysis, and prepared the manuscript draft. MC, EBS
and CCO participated in study design and execution, performed qualitative data analysis and
edited the manuscript. All authors read and approved the final manuscript.

Acknowledgements
We are grateful to the cattle producers for participating in this study. We extend our
special thanks to Drs. Lew Strickland and Brian Whitlock for evaluating and validating the
223

survey questionnaire. We thank Mr. Charles Hord (Vice President of Tennessee Cattlemen’s
Association) for helping with mobilization of beef focus group participants and administration of
survey questionnaires, and Dr. Lew Strickland of the University of Tennessee Institute of
Agriculture, Department of Animal Science for helping us with data collection from beef
producers. We thank Drs. Liz Eckelkamp and Peter D. Krawczel of the Department of Animal
Science at the University of Tennessee and Mr. Stan Butt of the Tennessee Dairy Producers
Association for helping with participant mobilization and organizing the dairy focus groups. We
thank Mr. Geoff Trivette for processing the recordings for transcription.

224

References
1.

Aidara-Kane A, Angulo FJ, Conly JM, Minato Y, Silbergeld EK, McEwen SA, Collignon
PJ: World Health Organization (WHO) guidelines on use of medically important
antimicrobials in food-producing animals. Antimicrob Resist Infect Control 2018, 7:7.

2.

Robinson T, Bu D, Carrique-Mas J, Fèvre E, Gilbert M, Grace D, Hay S, Jiwakanon J,
Kakkar M, Kariuki S: Antibiotic resistance is the quintessential One Health issue.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2016, 110(7):377380.

3.

Coyne LA, Pinchbeck GL, Williams NJ, Smith RF, Dawson S, Pearson RB, Latham SM:
Understanding antimicrobial use and prescribing behaviours by pig veterinary
surgeons and farmers: a qualitative study. The Veterinary record 2014, 175(23):593.

4.

Marshall BM, Levy SB: Food Animals and Antimicrobials: Impacts on Human
Health. Clinical microbiology reviews 2011, 24(4):718-733.

5.

Maron DF, Smith TJS, Nachman KE: Restrictions on antimicrobial use in food animal
production: an international regulatory and economic survey. Globalization and
Health 2013, 9(1):48.

6.

Cogliani C, Goossens H, Greko C: Restricting antimicrobial use in food animals:
lessons from Europe. Microbe 2011, 6(6):274.

7.

McEwen SA, Angulo FJ, Collignon PJ, Conly JM: Unintended consequences
associated with national-level restrictions on antimicrobial use in food-producing
animals. The Lancet Planetary health 2018, 2(7):e279-e282.

8.

McEwen SA, Angulo FJ, Collignon PJ, Conly J: Potential unintended consequences
associated with restrictions on antimicrobial use in food-producing animals. 2017
225

Mar. In: WHO Guidelines on Use of Medically Important Antimicrobials in FoodProducing Animals. Geneva: World Health Organization; 2017 23 Available from:
https://wwwncbinlmnihgov/books/NBK487949/?report=classic Accessed September 18,
2018.
9.

Muloi D, Ward MJ, Pedersen AB, Fèvre EM, Woolhouse MEJ, van Bunnik BAD: Are
Food Animals Responsible for Transfer of Antimicrobial-Resistant Escherichia coli
or Their Resistance Determinants to Human Populations? A Systematic Review.
Foodborne Pathogens and Disease 2018.

10.

Hoelzer K, Wong N, Thomas J, Talkington K, Jungman E, Coukell A: Antimicrobial
drug use in food-producing animals and associated human health risks: what, and
how strong, is the evidence? BMC Veterinary Research 2017, 13(1):211.

11.

Scott AM, Beller E, Glasziou P, Clark J, Ranakusuma RW, Byambasuren O, Bakhit M,
Page SW, Trott D, Mar CD: Is antimicrobial administration to food animals a direct
threat to human health? A rapid systematic review. International Journal of
Antimicrobial Agents 2018.

12.

van Duijkeren E, Greko C, Pringle M, Baptiste KE, Catry B, Jukes H, Moreno MA,
Pomba MC, Pyorala S, Rantala M et al: Pleuromutilins: use in food-producing
animals in the European Union, development of resistance and impact on human
and animal health. The Journal of antimicrobial chemotherapy 2014, 69(8):2022-2031.

13.

FDA: Fact Sheet: Veterinary Feed Directive Final Rule and Next Steps. Available
from https://wwwfdagov/animalveterinary/developmentapprovalprocess/ucm449019htm
Accessed September 18, 2018 2015.

226

14.

Duane S, Domegan C, Callan A, Galvin S, Cormican M, Bennett K, Murphy AW,
Vellinga A: Using qualitative insights to change practice: exploring the culture of
antibiotic prescribing and consumption for urinary tract infections. BMJ open 2016,
6(1).

15.

Braun V, Clarke V: Using thematic analysis in psychology. Qualitative Research in
Psychology 2006, 3(2):77-101.

16.

Alliance TD: 2017 Tennessee Dairy Facts. http://thedairyalliancecom/wpcontent/uploads/2017/05/Tennessee-State-Sheetpdf Accessed August 30 2018 2017.

17.

Lee T, Reinhardt C, Schwandt E, Thomson D: Producer Opinions on Antibiotic Use in
the Beef Industry. Kansas Agricultural Experiment Station Research Reports 2017,
3(1):7.

18.

McEwen SA, Angulo FJ, Collignon PJ, Conly JM: Unintended consequences
associated with national-level restrictions on antimicrobial use in food-producing
animals. The Lancet Planetary Health 2018, 2(7):e279-e282.

19.

FDA: CVM_Response_VFD_Questions.pdf.
http://wwwndanebraskagov/animal/feed/cvm_response_vfd_questionspdf Accessed
October 06, 2018 2016.

20.

Laxminarayan R, T. Van Boeckel, Teillant A: The Economic Costs of Withdrawing
Antimicrobial Growth Promoters from the Livestock Sector: OECD Publishing.

21.

Aarestrup FM, Jensen VF, Emborg H-D, Jacobsen E, Wegener HC: Changes in the use
of antimicrobials and the effects on productivity of swine farms in Denmark.
American Journal of Veterinary Research 2010, 71(7):726-733.

227

22.

Speksnijder DC, Wagenaar JA: Reducing antimicrobial use in farm animals: how to
support behavioral change of veterinarians and farmers. Animal Frontiers 2018,
8(2):4-9.

23.

Parsonage B, Hagglund PK, Keogh L, Wheelhouse N, Brown RE, Dancer SJ: Control of
Antimicrobial Resistance Requires an Ethical Approach. Frontiers in Microbiology
2017, 8(2124).

228

CONCLUSIONS, RECOMMENDATIONS AND FUTURE
RESEARCH DIRECTIONS
General conclusions

To my knowledge, this is the first study to comprehensively investigate the epidemiology
of veterinary AMU among clinicians at UTVMC and among TN dairy and beef cattle producers.
The findings of this research can help improve veterinary AMU among clinicians in UTVMC
and among TN cattle producers. After controlling for UTVMC clinicians’ primary patient load,
clinicians’ concern about AMR decreased among those who graduated after 1999 compared to
those that have been in clinical practice for longer.
Tennessee cattle producers generally perceived their use of antimicrobials to be discreet.
Compared to beef producers, the use of culture and sensitivity tests for on-farm pathogen
surveillance and for selecting antimicrobials is a more common practice among TN dairy
farmers. Blanket dry cow therapy is still commonly practiced by some dairy producers in TN.
The proportion of TN beef producers keeping farm records on antimicrobial purchases and AMU
may have increased over the last 10 years. Many TN cattle producers were either not familiar or
were slightly familiar with the VFD and perceived it as not useful. Disposal of VFD feed could
be problematic for many producers in the state. Due to similarities in cattle production systems,
the findings from the studies with the TN cattle producers could hold true for most of the
southeastern U.S. Similar studies need to be conducted in other parts of the U.S.
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Recommendations
This dissertation recommends the following as key strategies for antimicrobial
stewardship in the studied populations.
1. An AMS program should be developed and implemented at UTVMC hospital.
2. Awareness about judicious AMU practices as well as AMR among clinicians and clients
at UTVMC, and among cattle producers, should be increased. Client education on
prudent AMU and on AMR should be integrated into routine clinical practice at
UTVMC. Cattle producer education on prudent AMU should be integrated in routine
farm visits by the veterinarian.
3. Campaign efforts targeting behavioral change on AMU among producers should focus
on encouraging producers to continue benchmarking AMU practices from peers.
4. Selective dry cow therapy should be promoted among TN dairy cattle producers and
blanket dry cow therapy discouraged. A policy shift towards banning blanket dry cow
therapy in TN and the entire US should be explored.
5. Use of written antimicrobial treatment protocols among TN cattle producers should be
promoted.
6. More awareness regarding the VFD and its associated benefits should be conducted
among cattle producers in TN.
7. For antimicrobial stewardship purposes, campaigns targeting improved animal health in
cattle farms should be stepped up to contain the likely unintended compensatory increase
in AMU due to the VFD.
8. Awareness among producers of the FDA guidance on disposal of un-used/left over VFD
feed should be conducted. Veterinarians and beef/dairy extension agents should conduct
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routine producer awareness regarding the TN requirements (or local area requirements)
for disposal of medicated feeds.

Future research directions
Future studies investigating AMU in TN and perhaps other parts of the U.S. should consider
evaluating the following:
1. Antimicrobial use practices of clinicians in primary care veterinary practices.
2. Judicious /non-judicious AMU in the teaching as well as first opinion (primary care)
veterinary hospitals using actual prescription records.
3. The types of antimicrobial purchases and antimicrobial use records used by cattle
producers in TN so that areas for improvement are identified for appropriate, and
accurate data collection on AMU.
4. Objective, reproducible, and transparent methods for quantifying on-farm AMU in TN
and the U.S.
5. The appropriateness of dosage rates indicated on drug labels for currently used veterinary
antimicrobials in the U.S.
6. The actual impact of the VFD on the use of injectable antimicrobials among TN and U.S.
cattle producers.
7. The actual impact of the VFD on un-regulated access to in-feed antimicrobials among TN
and U.S. cattle producers in general.
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APPENDICES
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Appendix 1: Survey questionnaire for antimicrobial use practices at a U.S. veterinary
teaching hospital
Thank you for participating in this study. Please read the informed consent statement before
proceeding by clicking on this link. (Consent form will open in a new window or tab.)
Approved informed consent statement
I have read and understood the above informed consent statement and I have voluntarily chosen
to participate in this study.

o Yes
o No
Skip To: End of Survey If Answer = No
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Q1. Which of the following best describes your primary patient load?

o Small animal
o Equine
o Food animal
o Mixed animal
o Exotic
o Others ________________________________________________
Q2. Which of the following best describes the nature of your clinical position?

o Faculty member with clinical duty expectations
o Resident
o Intern
Q3. Which of the following best describes your areas of service? (Please check all that apply)

▢

Oncology and radiation oncology

▢

Ophthalmology
234

▢

Nutrition

▢

Radiology and veterinary imaging service

▢

Rehabilitation and physical therapy

▢

Soft tissue surgery

▢

Orthopedic surgery

▢

Avian, exotic and zoological medicine

▢

Neurology

▢

Internal medicine

▢

Emergency/critical care/ICU

▢

Dermatology

▢

Cardiology

▢

Anesthesia

▢

Behavioral medicine

235

▢

Dentistry

▢

Field services-equine

▢

Field services-food animal

▢

In - hospital equine

▢

In - hospital food animal

▢

Theriogenology

▢

Others ________________________________________________

Q4. Which of the following describes the period of your graduation from veterinary school?

o 1960s
o 1970s
o 1980s
o 1990s
o 2000s
o 2010 and above
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Q5. Which of the following best describes your total number of years in clinical practice from
the time you graduated from veterinary school?

o < 1 year
o 1 - 5 years
o 6 – 10 years
o 11 - 15 years
o 16 - 20 years
o 21 - 25 years
o 26 - 30 years
o > 30 years
Q6. How many years have you been in clinical practice at UT Veterinary Medical center?

o < 1 year
o 1 - 5 years
o 6 – 10 years
o 11 - 15 years
o 16 - 20 years
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o 21 - 25 years
o 26 - 30 years
o > 30 years
Q7. From where did you obtain your veterinary degree?

o U.S veterinary school
o Non - U.S veterinary school
Q8. Do you have specialty board certification?

o Yes
o No
o Approved for exam, but not yet certified
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Q9. What proportion of your total professional activity is dedicated to clinical practice?

o Less than 20%
o 20-39%
o 40-59%
o 60-79%
o 80-100%
Q10. How often do you prescribe antimicrobials for therapeutic treatment of infectious diseases
in your clinical setting?

o Never
o Once a week
o 2 times a week
o 3 - 5 times a week
o > 5 times a week
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Q11. How often do you prescribe antimicrobials for metaphylaxis?

o Never
o Once a week
o 2 times a week
o 3 - 5 times a week
o > 5 times a week
Q12. How often do you prescribe antimicrobials for prophylaxis of infectious diseases?

o Never
o Once a week
o 2 times a week
o 3 - 5 times a week
o > 5 times a week
Skip To: Q16 If Q12 = Never
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Q13. How often do you prescribe antimicrobials for peri-operative prophylaxis of infections?

o Never
o 1 - 2 cases out of every 10 surgical patients
o 3 - 5 cases out of every 10 surgical patients
o 6-8 cases out of every 10 surgical patients
o > 8 cases out of every 10 surgical patients
Q14. How often do you prescribe antimicrobials for pre-operative prophylaxis of infections?

o Never
o 1 - 2 cases out of every 10 surgical patients
o 3 - 5 cases out of every 10 surgical patients
o 6 - 8 cases out of every 10 surgical patients
o > 8 cases out of every 10 surgical patients
Q15. How often do you prescribe antimicrobials to prevent post-operative infections?

o Never
o 1 - 2 cases out of every 10 surgical patients
o 3 - 5 cases out of every 10 surgical patients
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o 6 - 8 cases out of every 10 surgical patients
o > 8 cases out of every 10 surgical patients
Q16. How familiar are you with "The Veterinarian-Client-Patient-Relationship"?

o Not familiar at all
o Slightly familiar
o Moderately familiar
o Very familiar
o Extremely familiar
Q17. How often do you utilize "The Veterinarian-Client-Patient-Relationship" in your
antimicrobial prescription practice?

o Never
o Rarely
o Sometimes
o Often
o Always
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Q18. Which one of the following best represents your opinion about antimicrobial use at UT
Veterinary Medical Center?

o Antimicrobials are sometimes prescribed based on no documented evidence of infection.
o Antimicrobials are sometimes prescribed for suspected (but not confirmed) infections.
o Antimicrobials are prescribed based only on confirmed infection.
o Not sure
Q19. How important are the following factors in determining your choice of antimicrobial for
clinical use?
Not at all
important

Slightly
important

Moderately
important

Very
important

Extremely
important

Clinical signs

o

o

o

o

o

History of
previous
antimicrobial use
on the animal

o

o

o

o

o

o
o
o

o
o
o

o
o
o

o
o
o

o
o
o

Pressure from
clients/producers
Peer or colleague
recommendations
Cost implications
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Not at all
important

Slightly
important

Moderately
important

Very
important

Extremely
important

Results of
cytological
evaluation

o

o

o

o

o

Results of
bacteriological
culture and
antimicrobial
susceptibility
testing

o

o

o

o

o

o
o
o

o
o
o

o
o
o

o
o
o

o
o
o

UT Veterinary
Medical Center
antimicrobial use
policy/guidelines

o

o

o

o

o

Potential for
adverse reactions

o

o

o

o

o

Route of
administration
Frequency of
administration
Medication size
or volume
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Not at all
important

Slightly
important

Moderately
important

Very
important

Extremely
important

Availability of
antimicrobial
agent(s)

o

o

o

o

o

Concerns about
antimicrobial
resistance issues
in animals

o

o

o

o

o

Concerns about
antimicrobial
resistance issues
in humans

o

o

o

o

o

Fear of litigation
by the
client/producer in
the event of an
undesirable
clinical outcome

o

o

o

o

o

o
o
o

o
o
o

o
o
o

o
o
o

o
o
o

o

o

o

o

o

Concerns about
animal welfare
Prudent use
guidelines
Drug withdrawal
periods
Compliance by
the
client/producer to
the prescription
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Q20. How important are the following sources of antimicrobial information in determining your
choice of antimicrobial for clinical use?
Not at all
Important

Slightly
important

Moderately
important

Very
important

Extremely
important

Pharmaceutical
company
representative

o

o

o

o

o

Label or
package insert

o

o

o

o

o

Peer-reviewed
scientific
literature

o

o

o

o

o

Peers within
my service

o

o

o

o

o

Peers outside
of service
(clinician or
pharmacist)

o

o

o

o

o

Veterinary
Information
Network
(VIN)

o

o

o

o

o

UTCVM
formulary

o

o

o

o

o

Online
resource e. g.
blog, media
post, or web
search

o

o

o

o

o

Textbook or
drug handbook

o

o

o

o

o

Applications
on a smart
phone or tablet

o

o

o

o

o

Online
formulary

o

o

o

o

o
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Q21. How would you rank the following classes of antimicrobials based on your frequency of
prescription?

Aminoglyosides
Cephalosporins
Fluoroquinolones
Lincosamides
Macrolides
Penicillins
Sulfas
Tetracyclines

Never

Rarely

o
o
o
o
o
o
o
o

o
o
o
o
o
o
o
o

Sometimes

o
o
o
o
o
o
o
o

Very often

o
o
o
o
o
o
o
o

Always

o
o
o
o
o
o
o
o

Q22. To what extent did your DVM (veterinary medical) training alone, adequately equip you
with knowledge on rational use of antimicrobials?

o Not at all
o A little
o Somewhat
o Quite a bit
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o Very much
Q23. Do present day veterinary medical students receive adequate training on rational use of
antimicrobials?

o Not at all
o A little
o Somewhat
o Quite a bit
o Very much
Q24. How frequently do you read FDA/AVMA guidelines for judicious use of antimicrobials?
(Check only one.)

o Never
o Rarely
o Sometimes
o Very often
o Always
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Q25. Antimicrobial stewardship programs are coordinated interventions designed to improve and
measure the appropriate use of antimicrobials by promoting the selection of optimal
antimicrobial regimen, dose, and duration of therapy and route of administration. Does the UT
Veterinary Medical Center have an antimicrobial stewardship program?

o No
o Not sure
o Yes
Display This Question:
If Antimicrobial stewardship programs are coordinated interventions designed to improve and
measure... = No
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Q26. Do you think the UT Veterinary Medical Center should develop and implement an
antimicrobial stewardship program?

o Yes
o No
o Not sure
Q27. Which one of the following best represents your opinion about antimicrobial prescription at
the UT Veterinary Medical Center?

o Antimicrobials are under prescribed
o Antimicrobials are optimally prescribed
o Antimicrobials are over-prescribed
Q28. How do you rate your degree of concern about antimicrobial-resistant infections?

o Not concerned
o Slightly concerned
o Moderately concerned
o Quite concerned
o Very concerned
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Q29. How do you rate other veterinarians’ concerns about antimicrobial resistance?

o Not concerned
o Slightly concerned
o Moderately concerned
o Quite concerned
o Very concerned
Q30. How do you rate the majority of your clients’ concerns about antimicrobial resistance?

o Not concerned
o Slightly concerned
o Moderately concerned
o Quite concerned
o Very concerned
Q31. To what extent do you agree or disagree with the following statement? "Antimicrobial
classes commonly used in human medicine should not be used in veterinary medicine because
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their use in veterinary medicine selects for antimicrobial resistance in microbes affecting
humans."

o Strongly disagree
o Disagree
o Neither disagree nor agree
o Agree
o Strongly agree
Q32. To what extent do you agree or disagree with the following statement? "Antimicrobial drug
use in veterinary practice may lead to antimicrobial resistance in pathogens affecting humans."

o Strongly disagree
o Disagree
o Neither disagree nor agree
o Agree
o Strongly agree
Q33. To what extent do you agree or disagree with the following statement? "Veterinarians who
grew up on farms tend to prescribe antimicrobials more often than veterinarians who did not
grow up in farms."
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o Strongly disagree
o Disagree
o Neither disagree nor agree
o Agree
o Strongly agree
Q34. What are the 5 antimicrobial drugs that you commonly prescribe? (Rank from the most to
the least.)

o 1. Most used ________________________________________________
o 2. ________________________________________________
o 3. ________________________________________________
o 4. ________________________________________________
o 5. Least used ________________________________________________
Q35. What is your year of graduation from veterinary school?
________________________________________________________________
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Q36. Which of the following best describes your gender?

o Male
o Female
o Prefer not to answer
Additional comments:
________________________________________________________________
________________________________________________________________
Appendix 2: Focus group interview guide
Appendix 2A: The first focus group interview guide
General questions
1. Is your current use of antimicrobial agents in feed additives or in treatment of ill animals
and how does the Veterinary Feed Directive (VFD) improve or hinder effective your
cattle production?
2. How far is your closest food animal veterinarian and does this proximity affect you in
any way in light of the VFD regulations?
3. Who or what influences your decision to start (or continue/discontinue) the use of
antimicrobials? Take a piece of paper and jot down the factors (things) that are important
to you when deciding to use antimicrobial drugs.
4.

There is a proposal by certain groups that antimicrobials that are essential for human
use, should not be used in animals, even if they are useful to animals. Is restriction of
254

antimicrobial agents for treatment of ill animals in cattle production feasible in your
production practice?
5. What can producers, veterinarians, consumers and regulatory authorities do, in order to
make antimicrobial use in cattle better?
6.

If you are called to give your advice to the secretary of Health and Human Services on
antimicrobial resistance problems in food animals and in humans, what do you think are
the contributors to the development of antimicrobial resistance problems in food animals
and in humans and what advice would you give the secretary for prevention of this
challenge?

7. Have you used or thought about using alternative agents that are not antimicrobial agents
in your production and what are those?
8. In your opinion, what specific type of information would you as cattle producers need
and like to be receiving about antimicrobial use? What is the best format for receiving
this information?
9. In one word, describe the current VFD.
10. Of all the things we have talked about antimicrobial use, what is most important to you?
Appendix 2B: The modified focus group interview guide
1. What kind of operation do you run?
2. How do you use antibiotics?
3. How does the veterinary feed directive affect your cattle production?
4. How easy is it to access a food animal veterinarian in your area?
5. Who or what influences your decision to start or discontinue the use of antibiotics? Please
share things that are important to you when deciding to use antibiotics.
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6. What is your opinion about restricting antibiotics for human use only? How would this
affect your production practice? What do you believe about antibiotic resistance?
7. What can producers, consumers, veterinarians, and regulatory authorities do in order to
make antibiotic use in cattle better?
8. What would you advice the secretary of health and human services to do about the causes
and solutions of human and animal antibiotic resistance?
9. Please share other management practices or products besides antibiotics that you use to
prevent or treat disease.
10. In your opinion, what specific type of information would you as cattle producers need
and like to be receiving about antibiotic use? What is the best format?
11. What is important to you about this topic?
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Appendix 3: Survey questionnaire for antimicrobial use practices of cattle producers in
Tennessee
Thank you for participating in this study. Please read the attached informed consent statement
before proceeding.
I have read and understood the information in the above informed consent statement. Please
choose the option below that best represents your consent.

o I agree to participate in the survey and have the chance to win $10 Wal-Mart gift card (If
checked, take the survey and then provide your information in the attached form for the raffle
drawing).

o I do not agree to participate in the survey, but I want to participate in the raffle for $10
Wal-Mart gift card (If checked, provide your information in the attached form for the raffle
drawing).

o I do not agree to participate in the survey and I do not want to participate in the raffle for
$10 Wal-Mart gift card (If checked, you may exit the survey).

257

Q1. Which of the following best describes your primary cattle production?

o Beef production
o Dairy production
o Other (specify) ________________________________________________
If your primary cattle production is dairy, please respond to questions 2 to 7. If beef
production is selected, then skip to Q8.

Q2. How are antibiotic-treated cows distinguished from the rest of the milking herd at milking?

o Milked with a separate milking unit
o All cows are milked using the same milking unit

Q3. When are antibiotic-treated cows milked?

o Milked first
o Milked in-between
o Milked last
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Q4. Are cows routinely screened after freshening for antibiotics with an antibiotic residue
detection test?

o No
o Not sure
o Yes

Q5. Were there any antibiotic residue violations in your milk in the past 6 months?

o Yes
o Not sure
o No
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Q6. To what extent do you agree or disagree with the following statement? “If all dairy
producers in Tennessee followed best practices in the use of antibiotics, overall use of
antibiotics in Tennessee dairy cattle would decrease".

o Strongly disagree
o Disagree
o Neither agree nor disagree
o Agree
o Strongly agree
Q7. To what extent do you agree or disagree with the following statement? "If all dairy
producers in Tennessee followed best milk quality practices, overall use of antibiotics in
Tennessee dairy cattle would decrease".

o Strongly disagree
o Disagree
o Neither agree nor disagree
o Agree
o Strongly agree
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If your primary cattle production is beef, please respond to Q8-Q13 below. If your primary
cattle production is dairy, then skip to Q14.

Q8. Which of the following best describes your beef production system? (check all that apply).

▢

Cow-calf production

▢

Backgrounding-stocking

▢

Feedlot operations

▢

Seed stock

▢

Other (specify) ________________________________________________

Q9. Do you think there is over-use of antibiotics in beef production?

o Yes
o Not sure
o No
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Q10. In which of the following beef production systems do you think, antibiotics are used most?

o Cow-calf production
o Backgrounding-stocking
o Feedlot operations
o Not sure
o Other (specify) ________________________________________________

Q11. Were there any antibiotic residue violations in beef (meat products) from cattle raised on
your farm in the last year?

o Yes
o Not sure
o No
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Q12. To what extent do you agree or disagree with the following statement? “If all beef
producers followed best practices in the use of antibiotics, overall use of antibiotics in
Tennessee beef cattle would decrease".

o Strongly disagree
o Disagree
o Neither agree nor disagree
o Agree
o Strongly agree
Q13. To what extent do you agree or disagree with the following statement? “If all beef
producers followed best practices in the management of their herds, overall use of antibiotics
in Tennessee beef cattle would decrease".

o Strongly disagree
o Disagree
o Neither agree nor disagree
o Agree
o Strongly agree
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Q14. How familiar are you with the Veterinary Feed Directive (VFD)?

o Not familiar at all
o Slightly familiar
o Moderately familiar
o Very familiar
o Extremely familiar

Q15. What is your opinion about the Veterinary Feed Directive (VFD)?

o I am not familiar with VFD
o VFD is not useful
o VFD is neither useful nor beneficial
o VFD is somewhat useful
o VFD is very useful
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Q16. Were you aware of the Veterinary Feed Directive (VFD) before its implementation?

o Yes
o Not sure
o No
Q17. How has the Veterinary Feed Directive (VFD), from the time it became effective,
influenced your use of veterinary services?

o VFD has reduced my use of veterinarian services
o VFD has not influenced me to seek veterinarian services
o VFD has caused me to seek veterinarian services more frequently
o Other (specify) ________________________________________________
Q18. Antibiotic resistance is the ability of bacteria (disease causing germs) to resist or be
unaffected by the effects of medication. How familiar are you with the subject of antibiotic
resistance?

o Not familiar at all
o Slightly familiar
o Moderately familiar
o Very familiar
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o Extremely familiar
Q19. How do you rate your degree of concern about antibiotic-resistant infections in cattle
production?

o I am not familiar about antibiotic-resistant infections in cattle production
o Not concerned
o Moderately concerned
o Very concerned

Q20. How often do you observe antibiotic drug withdrawal times in your farm?

o Never
o Sometimes
o About half the time
o Most of the time
o Always
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Q21. How often do you use bacterial culture to determine the cause of disease on your farm?

o Never
o Sometimes
o About half the time
o Most of the time
o Always

Q22. How often do you use bacterial culture to select the most appropriate antibiotics to use on
your farm?

o Never
o Sometimes
o About half the time
o Most of the time
o Always
If you answered never above, please skip to Q24.
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Q23. Who makes the laboratory request for bacterial culture testing for your farm?

o The producer
o The manager
o The veterinarian
o Other (specify) ________________________________________________
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Q24. Thinking about your practices BEFORE the Veterinary Feed Directive-final rule became effective on January 1, 2017, how
important were the following factors in determining the choice of antibiotics used in your farm?
Not at all

Slightly

Moderately

Very

Extremely

important

important

important

important

important

Recommendations from other producers

o

o

o

o

o

Clinical signs and symptoms

o

o

o

o

o

Cost of the antibiotic

o

o

o

o

o

Veterinarian's prescription

o

o

o

o

o

Positive culture and susceptibility tests

o

o

o

o

o
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Not at all

Slightly

Moderately

Very

Extremely

important

important

important

important

important

Your farming experience

o

o

o

o

o

Drug withdrawal times

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Recommendations from pharmaceutical company
representatives

Recommendations from feed mill operatives
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Not at all

Slightly

Moderately

Very

Extremely

important

important

important

important

important

Availability of antibiotic(s)

o

o

o

o

o

The ability of the drug to cure the infections

o

o

o

o

o

Concerns for animal welfare

o

o

o

o

o

Concerns for food security

o

o

o

o

o
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Q25. Thinking about your practices AFTER the Veterinary Feed Directive-final rule became effective on January 1, 2017, how
important are the following factors in determining the choice of antibiotics used in your farm?
Not at all

Slightly

Moderately

Very

Extremely

important

important

important

important

important

Recommendations from other producers

o

o

o

o

o

Clinical signs and symptoms

o

o

o

o

o

Cost of the antibiotic

o

o

o

o

o

Veterinarian's prescription

o

o

o

o

o

Positive culture and susceptibility tests

o

o

o

o

o
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Not at all

Slightly

Moderately

Very

Extremely

important

important

important

important

important

Your farming experience

o

o

o

o

o

Drug withdrawal times

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

Recommendations from pharmaceutical company
representatives

Recommendations from feed mill operatives

273

Not at all

Slightly

Moderately

Very

Extremely

important

important

important

important

important

Availability of antibiotic(s)

o

o

o

o

o

The ability of the drug to cure the infections

o

o

o

o

o

Concerns for animal welfare

o

o

o

o

o

Concerns for food security

o

o

o

o

o
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Q26. To what extent do you agree or disagree with the following statements?
Neither
Strongly
Disagree

disagree nor

Agree

Strongly agree

disagree
agree
The Veterinary Feed Directive (VFD) has
limited your access to antibiotics
Most veterinarians do not know how to write
VFD prescriptions
VFD needs to be updated to accommodate
current flaws in execution
My veterinarian can write an accurate VFD
prescription

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Neither
Strongly
Disagree

disagree nor

Agree

Strongly agree

disagree
agree
VFD has introduced additional costs of
involving a veterinarian
You are aware of how to properly dispose any
unused feed from the VFD
The VFD would lead to increased use of
injectable antibiotics by producers
The VFD has created more black-market
access to in feed antibiotics by producers

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Neither
Strongly
Disagree

disagree nor

Agree

Strongly agree

disagree
agree

The VFD has increased the costs of feed

The VFD has negatively affected small scale
producers

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

The VFD has set cattle producers up for
financial loss because it has removed access to
preventive in-feed medicines

The VFD is useful for producing safer food

Q27. To what extent do you agree or disagree with the following statements?
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Neither
Strongly

Strongly
Disagree

disagree nor

Agree

disagree

agree
agree

Producers require additional training on prudent use of
antibiotics

Aggressive marketing of antibiotics by pharmaceutical
companies greatly influences producers' use of antibiotics

Training producers on infection control (bio-security) and
vaccination would reduce the use of antibiotics

Some antibiotics you use on your cattle have become
ineffective (there is resistance to antibiotics used in cattle)

Profitability of your operation is an important factor
influencing your decision to use antibiotics on your cattle

Antibiotic drugs work less effectively than in the past

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o
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Q28. Where do you buy antibiotics drugs for your farm?

o From internet sites
o Over-the- counter (local Cooperative/feed retailer)
o From a veterinarian
o Directly from a distributor (pharmaceutical Company Representative)
o Directly from a drug company
o Other (specify) ________________________________________________

Q29. What criteria are used on the farm to determine the need for antibiotics treatment of sick
animals?

▢

Clinical signs and symptoms

▢

Positive culture and sensitivity tests

▢

Other (specify) ________________________________________________

279

Q30. Does your farm keep up-to-date written records of antibiotic drug purchases?

o No
o Not sure
o Yes

Q31. Does your farm keep written records on medicated feeds purchased in the frame work of
the veterinary feed directive?

o No
o Not sure
o Yes

Q32. Does your farm keep up-to-date written records of antibiotic drugs used to treat animals?

o No
o Not sure
o Yes
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Q33. How often does your veterinarian visit your farm?

o Never
o On routine calls
o As needed

Q34. In what format do you receive prescriptions (and other advice) from your veterinarian?

o Through Telephone conversation
o Through text messages
o Through e-mail
o Through face-to-face interactions during farm visits
o Social media
o Other (specify) ________________________________________________
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Q35. What are the 5 antibiotic drugs that you commonly use on your farm? (Rank from the most
to the least)

o 1. Most used ________________________________________________
o2

________________________________________________

o3

________________________________________________

o4

________________________________________________

o 5. Least used

________________________________________________

Q36. What are the 5 diseases/conditions that you commonly treat with antibiotics on your farm?
(Rank from the most to the least)

o 1. Most treated ________________________________________________
o2

________________________________________________

o3

________________________________________________

o4

________________________________________________

o 5. Least treated

________________________________________________
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Q37. Prudent (responsible) use of antibiotics in farms involves decreasing unnecessary or
inappropriate use of antibiotics. How often do you discuss about prudent antibiotic use with your
veterinarian?

o Never
o Sometimes
o About half the time the veterinarian visits
o Most of the time
o Always

Q38. Are the cattle in your farm sometimes treated with antibiotics at dosages higher than the
label instructed?

o No
o Not sure
o Yes
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Q39. In your farm, who administers the antibiotic medications to the animals? (Check all that
apply)

▢

Producer

▢

Herdsman

▢

Milk hand

▢

Veterinarian

▢

Manager

▢

Other (specify) ________________________________________________
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Q40. What are the appropriate methods for communicating information about prudent use of
antibiotics to you? (Check all that apply)

o Producer's handbook on prudent use
o Laminated posters
o Videos
o Brochures
o Flow charts for the barn
o Educational seminars
o Other (specify) ________________________________________________
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Q41. In what language(s) would you like to be receiving information about prudent use of
antibiotics?

o English
o English and Spanish
o Spanish
o Other (specify) ________________________________________________
Q42. Do you use antibiotics for treatment of diseases other than those listed on the
bottle/package insert that comes with the medicine)?

o Yes
o Not sure
o No
If you answered yes above, please answer Q43. Otherwise, skip to Q44.
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Q43. How is the use antibiotics for treatment of diseases other than those listed on the
bottle/package insert done at your farm?

o Based on past use on the farm for treatment of diseases other than those listed on the
bottle/package insert

o Based on recommendation of other farmers/producers
o Based on the prescription (written guidelines) from a veterinarian
o Based on my experience as a producer
o Other (specify) ________________________________________________

Q44. Do you strictly follow the prescribed course of treatment for each antibiotic medication?

o Never
o Sometimes
o About half the time
o Most of the time
o Always
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Q45. Does your farm have written protocols (plans) for treating sick animals with antibiotics?

o Yes
o Not sure
o No

Q46. Is a veterinarian's advice sought before administering antibiotics?

o Never
o Sometimes
o About half the time
o Most of the time
o Always
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Q47. Which of one the following best describes your opinion about the label instructions for
antibiotic medicines?

o Label instructions are difficult to understand and interpret
o Label instructions are easy to understand and interpret

Q48. In what language(s) would you prefer label instructions for antibiotic medicines to be
written?

o English
o Spanish
o English and Spanish
o Other (specify) ________________________________________________

289

Q49. To what extent does the consumer demand for antibiotic-free products influence your use
of antibiotics?

o Not at all
o A little
o To a moderate extent
o Quite a bit
o Very much
Q50. Which of the following best describes your number of years in cattle farming?

o < 5 years
o 6 - 10 years
o 11 -15 years
o 16 - 20 years
o 21 - 25 years
o 26 - 30 years
o > 30 years
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Q51. Were you raised on a livestock farm?

o No
o Yes

Q52. Which of the following best describes your gender?

o Male
o Female
o prefer not to answer
Q53. Which of the following best describes your education level attained?

o No school
o Elementary
o Junior high
o High school
o General Education Development (GED)
o Vocational
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o College
o Professional
o Other (specify) ________________________________________________
Q54. Which of the following best describes the number of cattle in your production unit?

o 1 - 49
o 50 - 99
o 100 - 149
o 150 - 199
o 200 - 299
o 300 - 399
o 400 - 499
o 500+
Q55. Which of the following best describes your age group?

o 19 years and below
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o 20 - 29 years
o 30 - 39 years
o 40 - 49 years
o 50 - 59 years
o 60 -69 years
o 70 -79 years
o 80+ years
Q56. Any additional comments/recommendations?

We thank you for taking our survey.
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Appendix 4: Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist
No

Item

Domain 1: Research team and reflexivity
Personal characteristics
1
Interviewer/facilitator

Guide
questions/description

Which author/s conducted
the interview or focus
group?
What were the researchers’
credentials?

2

Credentials

3

Occupation

What was their occupation
at the time of study?

4

Gender

5

Experience and training

Was the researcher male or
female
What experience did the
researcher have?
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All the authors attended all the focus groups. The third author
(EBS) moderated the focus group discussions.
1st author (JEE): BVM, MVM, PgD, PhD Candidate
2nd author (MC): BS, DVM, PhD, DACVIM
3rd author (EBS): BA, MSSW, PhD
4th author (CCO): DVM, MS, PhD, DACVPM (Epi)
JEE: Graduate Research Assistant/PhD Candidate.
MC: Assistant Professor, Large Animal Clinical Sciences.
EBS: Director Veterinary Social work/ Clinical Associate
Professor.
CCO: Assistant Professor, Epidemiology and Food safety.
Male: JEE, MC, CCO
Female: EBS
JEE: Underwent qualitative research methods training while at
graduate school and has experience in veterinary clinical practice,
teaching senior veterinary students at a veterinary school.
CM: Has extensive experience in food animal veterinary practice.
EBS: Has wide experience in moderating group meetings.
CCO: Has wide experience in epidemiology and food safety.

No

Item

Relationship with participants
6
Relationship established

7

Participant knowledge of
the interviewer

8

Interviewer
characteristics

Domain 2: Study design
Theoretical framework
9
Methodological
orientation and theory

Guide
questions/description
Was a relationship
established prior to study
commencement
What did the participants
know about the researcher?
e.g. personal goals, reasons
for doing the research
What characteristics were
reported about the
interviewer/facilitator?
E.g. bias, assumptions,
reasons and interests in the
research topic.

What methodological
orientation was stated to
underpin the study? e.g.
grounded theory, discourse
analysis, ethnography,
phenomenology, content
analysis

295

No relationship was established prior to study commencement.

Prior to the meetings, the participants knew nothing about the
researchers. However, at the beginning of each focus group
discussion, participants were informed about the purpose of the
study as part of obtaining an informed consent prior to commencing
with the discussions.
Participants were informed that the moderator was a nonveterinarian with a background in the behavioral sciences (social
work).

Researchers were at liberty to use either inductive or the
theoretical/deductive approach to thematic analysis.

No

Item

Participant selection
10
Sampling

11

Method of approach

12

Sample size

13

Non-participation

Setting
14

Setting of data collection

15

Presence of nonparticipants

16

Description of sample

Guide
questions/description
How were participants
selected? E.g. purposive,
convenience, consecutive,
snowball
How were participants
approached? E.g. face-toface, telephone interview,
mail, email
How many participants
were in the study?
How many people refused
to participate or dropped
out? Reasons?

Participants were purposively selected.

Where was the data
collected? Home, clinic,
workplace?
Was anyone else present
besides the participants
and researchers?
What are the important
characteristics of the
sample? e.g. demographic
data, date

Data was collected at county extension centers or at local
restaurants were the focus groups were held.
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Participant recruitment e-mail was sent to the leadership of the
Tennessee Cattlemen’s Association (TCA) who then shared this
email with TCA members and then purposively selected the
volunteers for this study.
39 beef producers and 23 dairy producers
No participant dropped out of the focus groups.

No

Perceived age: ranged from late twenties to early seventies.

No

Item

Data collection
17
Interview guide

18

Repeat interviews

19

Audio/video recording

20

Field notes

21

Duration

22

Data saturation

23

Transcripts returned

Guide
questions/description
Were questions, prompts,
guides provided by the
authors? Was it pilot
tested?
Were repeat interviews
carried out? If yes, how
many?
Did the researchers use
audio or visual recording
to collect the data?
Were field notes made
during and/or after the
interview or focus group?
What was the duration of
the interviews or focus
groups?
Was data saturation
discussed?
Were transcripts returned
to participants for
comment and/ or
correction?
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Yes, interview guide was provided. There was no specific separate
pilot testing done. However, the interview guide was modified
based on participant comments after the first focus group.
No repeat interviews were carried out.

Data was video recorded.

Yes

The beef focus groups lasted approximately 90 minutes while the
dairy focus groups lasted approximately 60 minutes.
Data saturation was reached at the end of the 5th beef focus group.
For dairy focus groups, saturation was not reached.
No. Participants could not be identified since data was de-identified
at collection for protection of human subjects in research.

No

Item

Domain 3: Analysis and findings
Data analysis
Number of data coders
25

Description of the of the
coding tree

26

Derivation of themes

27

Software

28

Participant checking

Reporting
29

Quotations presented

30

Data and findings
consistent

31

Clarity of major themes

32

Clarity of minor themes

Guide
questions/description

How many data coders
coded the data
Did authors provide a
description of the coding
tree?
Were themes identified in
advance or derived from
the data?
What software, if
applicable, was used to
manage the data?
Did participants provide
feedback on the findings?

All the four authors coded the data

Were participant
quotations presented to
illustrate the
themes/findings? Was
each quotation identified
e.g. participant number
Was there consistency
between the data presented
and the findings?
Were major themes clearly
presented in the findings?
Is there a description of
diverse cases or discussion
of minor themes?

Yes, quotations were presented verbatim (in participants’ own
words) to illustrate the themes/findings. Each quotation was
identified by participant number, except for a few un-identified
participants.
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The coding is described in the manuscript

Themes were not identified in advance. Final themes presented in
the manuscript were arrived at after two review & harmonization
meetings to compare individual data coding.
NVivo qualitative data analysis Software; QSR International Pty
Ltd. Version 11, 2017 was used.
No. Participants were de-identified, hence could not be traced back.

Yes

Yes
Yes

VITA
John was born in Tororo district in eastern Uganda. He graduated with a Bachelor of
Veterinary Medicine (BVM) degree in January 2009, at Makerere University, Uganda. From
August 2010 to October 2013, he pursued a Master of Veterinary Medicine (Food Animal Health
and Production) degree at Makerere University and graduated in January 2014. He further
enrolled for a postgraduate Diploma in Public Policy and Governance, at the Uganda
Management Institute (2013-2014) and graduated in May 2015. John has also undergone other
management training programs in Uganda.
In August 2009, upon graduation with his BVM degree (DVM equivalent), John joined
the College of Veterinary Medicine, Animal Resources and Biosecurity at Makerere University,
as a Teaching Assistant, in the Department of Veterinary Pharmacy, Clinical and Comparative
Medicine, and actively served up to December 2015. John has been active in the clinical training
of veterinary students in Uganda. He has also been active in training of biomedical laboratory
students in special clinical and diagnostic technologies at Makerere University. John is licensed
to practice Veterinary Medicine in Uganda. Alongside, his teaching job, he practiced Veterinary
Medicine in Uganda, from June 2008 to December 2015—60% large animal and 40% small
Animal. In October 2008 and March 2009, John worked in Gulu/Amuru districts of northern
Uganda as a volunteer veterinarian with the USAID/ U.S military project-VETCAP, contributing
to the post-conflict reconstruction of northern Uganda.
In August/September 2012, John was a research scholar at Jilin Agricultural University,
in Changchun, North East China-primarily studying the prevention and treatment of animal
epidemics in China. He was sponsored by the Chinese Government. In September 2013, John
299

was a research scholar at the Plum Island Animal Disease Center in New York, studying
International Trans-Boundary Animal Diseases (sponsored by the USDA and CDC).
John is interested in furthering his career in the academia—teaching and research—in the
field of epidemiology. His research and career interests are in: aspects of antimicrobial use,
epidemiology and mechanisms of antimicrobial resistance, food safety epidemiology, zoonosis,
epidemiology and ecology of infectious diseases, dynamics of disease transmission at the
human-livestock-wildlife interface, neglected tropical diseases, and study designs in clinical
trials.

300

